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 ABSTRACT  
Transcriptional control of tissue-resident memory T cell generation 
Filip Cvetkovski 
 
Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are 
maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung 
TRM can be generated in response to respiratory infection or vaccination, however, the molecular 
pathways involved in CD4+TRM establishment have not been defined. Here, we performed 
transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to 
identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM 
displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of 
a gene network induced by the transcription factor IRF4, a known regulator of effector T cell 
differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene 
sets previously described in tissue-resident regulatory T cells. Up-regulation of 
immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory 
role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate 
that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells 
during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, 
and maintained high levels of CD62L compared to wild type, suggesting a defect in complete 
differentiation into lung-tropic effector T cells. This finding identifies IRF4 as an important 
regulator of CD4+TRM generation in response to respiratory infection.  
Furthermore, comparing whole transcriptome profiling of mouse and human lung memory 
T cell subsets, we define a lung CD4+TRM gene signature common to mice and humans. IRF4 
 protein was specifically up-regulated in lung CD4+TRM but not in circulating memory subsets, in 
both humans and mice previously infected with influenza. This result suggest that high expression 
of IRF4 contributes to a cross-species conserved molecular pathway of long term maintenance of 
CD4+TRM in the lung. Overall, our findings confirm lung CD4+TRM as a unique memory T cell 
subset regulated by tissue-specific transcription factors. These results have important implications 
in focusing future studies of tissue resident memory T cells to factors with translational potential. 
Importantly, by determining the lung CD4+TRM gene signature common to mice and humans, we 
motivate future genetic studies that could lead to the complete identification of the mechanisms of 
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Chapter 1 : Introduction 
The mammalian immune system 
Mammalian organisms are protected from infectious agents by a variety of effector cells 
and molecules that comprise the immune system. To effectively protect against disease, the 
immune system has evolved mechanisms for recognition and elimination of pathogens. However, 
the ability to self-regulate itself and adapt to previously encountered pathogens are crucial for 
maintaining a healthy organism throughout life. Based on the specific abilities and functions of 
each immune cell type, the immune system can broadly be divided on innate and acquired 
immunity. Innate immune responses are the first line of defense and occur rapidly, however they 
lack the ability to differentiate between certain pathogens. On the other hand, adaptive immunity 
is characterized by high specificity in the recognition of pathogens, and thus can generate a strong 
and focused response. Activated cells of the adaptive immune system differentiate into long-lived 
memory subsets that offer a more effective response upon reinfection. The unique feature of the 
adaptive immune system to ‘learn’ from previous exposure to an infectious agent is called 
immunological memory.  
Innate immunity 
 The innate immune system initiates inflammatory responses and recruits innate and 
adaptive immune cells to the site of infection. Recognition and inflammation either leads to 
clearance through lysis and phagocytosis of invading pathogens, or activation of the adaptive 
immune system through antigen presentation. Invading microorganisms are recognized through 
germline-encoded pattern-recognition receptors (PRRs) expressed on cells of the innate immune 
system [1]. PRRs recognize essential structural or functional microbial components and can initiate 
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the expression of inflammatory cytokines and interferons – a critical step in the activation of the 
innate and adaptive immune responses. The innate immune system is composed of phagocytic 
cells (neutrophils, macrophages, and dendritic cells (DCs)), and cells that target and lyse pathogen-
infected cells: granulocytes and natural killer cells [2]. Important soluble mediators secreted by 
innate immune cells upon activation include tumor necrosis factor alpha (TNFalpha), Type I 
interferons (IFNalpha and IFNbeta), granulocyte–macrophage colony-stimulating factor 
(GM-CSF), interleukins IL-1, IL-6, IL-12 and IL-23, and chemokines such as CXCL8 [3]. In 
addition to the inflammatory response, ligation of PRRs on macrophages and DCs results into their 
maturation into antigen presenting cells (APCs). Depending on the context, several immune cell 
subsets can act as APCs, however DCs are considered the most potent [4]. Antigen presentation 
includes the processing of intracellular or extracellular proteins and displaying of their fragments 
on the cell surface for screening by cells from the adaptive immune system. DCs are present in the 
blood and throughout the tissues of the body, and are comprised of two subsets: myeloid or 
conventional DCs (cDCs), and plasmacytoid DCs (pDCs). Conventional DCs, express high levels 
of CD11c and can be further subdivided by expression of the mucosal alpha-E integrin CD103 and 
the myeloid marker CD11b into CD103+CD11b(low) and CD103-CD11b(high) subsets [5]. The 
main functions of DCs include sensing inflammation, acquiring and processing antigen, migrating 
and presenting the antigen to cells of the adaptive immune system.  
Adaptive immunity 
The adaptive immune system consist of two major lymphocyte classes, T cells and B cells. 
However, DCs are an important link between the innate and adaptive immune systems and are 
necessary for lymphocyte activation. Lymphocytes are constantly produced from precursor cells 
that reside in the bone marrow. Progenitor T cells migrate to the thymus where they undergo 
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maturation to naïve T cells. Naive T cells have not encountered their cognate antigen before, and 
can be found in the spleen and lymph nodes. The hallmark of the adaptive immune response in the 
high specificity of each B and T cell for a particular antigen. While B cells carry antibody 
molecules (immunoglobulins) that confer specificity to antigen, most T lymphocytes carry a T cell 
receptor (TCR) that is a heterodimer composed of an alpha and a beta polypeptide. Importantly, T 
cells only recognize antigens that are processed into short peptides and presented on the surface in 
an antigen presentation molecule, the major histocompatibility complex (MHC). MHC class I 
molecules are found on all nucleated cells, whereas MHC class II are only present on DCs, B cells, 
and macrophages. There are two classes of T cells, CD4+ and CD8+T cells. CD4+lymphocytes 
carry TCRs that recognize antigen presented by MHC Class II but not MHC Class I molecules, 
and, conversely, CD8+T cells recognize antigens presented by MHC Class I molecules, but not 
MHC Class II molecules. More importantly, CD4+ and CD8+T lymphocytes play out different 
roles in the adaptive immune response. Upon activation, CD8+lymphocytes lyse infected cells and 
produce cytokines that stimulate or attract other immune cells. In contrast, CD4+T cells play a 
more central role in organizing the broader immune response by helping the B cell and CD8+T cell 
response to specific pathogens, in addition to being potent producers of anti-microbial cytokines. 
Because T cells require contact with a host cells to recognize antigen and generate an immune 
response, migration patterns of naive T cells are aimed at increasing the chance of antigen 
encounter. In humans and mice, naive T cells recirculate between blood and secondary lymphoid 
organs (spleen and lymph nodes) where antigen from peripheral tissues is drained. When a naive 
T cell encounters its antigen in a secondary lymphoid organ, it undergoes extensive proliferation 
and differentiation before migrating to the site of infection to target infected cells. Once the 
pathogen is eventually cleared, most of the expanded effector T cell population is lost. However, 
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a fraction of antigen-experienced T cells are maintained long-term as memory T cells with 
functional potential for an improved response in case of re-challenge by the same pathogen. The 
focus of this study is on T lymphocytes, and accordingly the following sections describe in depth 
the development, function, and maintenance of this cell class of the adaptive immune system.  
T lymphocyte development  
 All T lymphocytes are generated from precursor stem cells that reside in the bone marrow. 
Progenitor T cells migrate from the bone marrow to the thymus where they undergo development 
to naïve T cells. The development of T cells in the thymus shapes the adaptive immune repertoire 
by selecting mature T cells with functional TCRs that are not specific for self-antigens expressed 
by the organism itself. This process ensures sufficient breadth of TCR repertoire to recognize 
various pathogens without breaking tolerance to the host self. The thymus consists of immature T 
cells and a network of epithelial cells and intrathymic DCs. The interaction of T cells with 
epithelial/dendritic cells and macrophages drives the differentiation and selection of mature T cells 
that are allowed to migrate into the periphery. When T cell progenitors enter the thymus, they lack 
the surface molecules CD4 and CD8 and are referred to as double negative thymocytes. The double 
negative stage of development is accompanied by transient expression of the adhesion molecule 
CD44 and CD25, the alpha chain of the IL-2 cytokine receptor. Successful gene rearrangement 
and surface expression of the beta TCR chain leads to formation of a pre-TCR complex with a 
surrogate alpha TCR chain. Signaling through the pre-TCR complex leads to cell proliferation and 
co-expression of CD4 and CD8, referred to as the double positive stage of thymocyte development. 
Successful gene rearrangement of the alpha TCR chain leads to formation of a functional alpha 
beta TCR at the cell surface. The next steps of thymocyte development involve the interaction 
between the TCR and peptide-presenting MHC molecules, and thus contribute to shaping of the 
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immune repertoire of mature T cells exported into the periphery. Thymic epithelial and dendritic 
cells present self-peptide to double positive thymocytes with recently formed TCRs. Most 
frequently, double positive thymocytes fail to recognize the MHC complex and undergo cell death. 
However, some double positive cells are rescued by signaling events triggered through interaction 
between TCR and self-peptide:MHC complexes, in a process known as positive selection. In 
addition, positive selection also coordinates the lineage specification of the developing double 
positive thymocyte. Namely, double positive thymocytes with functional TCRs that bind MHC 
class I go on to generate CD8 single positive thymocytes. Accordingly, double positive thymocytes 
recognizing self-peptide:MHC class II complexes downregulate CD8 and become CD4 single 
positive thymocytes. However, positive selection does not preclude the generation of self-antigen-
reactive T cells that carry potential for breaking immune tolerance in peripheral tissues. 
Appropriately, strong TCR signaling induced during self-peptide:MHC recognition of developing 
thymocytes leads to apoptosis in a process known as negative selection. The choice between 
positive and negative selection is an area of investigation, however, it has been widely accepted 
that the strength of the self-peptide:MHC complex binding is the key factor. Finally, thymocytes 
that have undergone the selection process are exported from the thymus into the periphery where 
they carry a randomly generated yet highly specific antigen recognition potential.   
The T cell receptor 
 The function of each T cell is inherently connected to its antigen specificity - the particular 
combination of V(D)J gene fragments that encode the heterodimeric T cell receptor. The TCR 
confers the extraordinary selectivity of the adaptive immune system by determining whether a T 
cell responds to an antigen or ignores it. The T cell receptor is a transmembrane heterodimer 
composed of two disulfide-linked polypeptide chains. T lymphocytes stimulated by their cognate 
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antigen generate cell progeny that carry the identical TCR specificity - a process called clonal 
expansion. The majority of T cells carry a TCR chain composed of an alpha and beta TCR chain 
heterodimer (alpha beta T cells), however some T cells carry a combination of gamma and delta 
TCR chains (gamma delta T cells), and comprise a separate T cell subset [6]. Each TCR alpha and 
beta chain consists of a variable (V) amino-terminal region and a constant (C) region. The V is the 
region that undergoes gene rearrangement, which accounts for generation of unique sequences to 
code for unique T cell receptor proteins. The TCR alpha chain V region is built from two gene 
segments (V and J segments), whereas the TCR beta V locus contains three types of gene 
segments: V, J and an additional D gene segment. The T cell repertoire is generated through gene 
rearrangement events referred to as V(D)J recombination. As T cells develop, DNA sequences 
undergo recombination events of specific gene fragments in the V (variable), D (diversity), and/or 
J (joining) loci. DNA rearrangements are guided by conserved noncoding sequences called 
recombination signal sequences (RSSs) that are found adjacent to each V, D, or J gene segment. 
The main components of the complex of enzymes that carry out V(D)J recombination are the 
proteins RAG-1 and RAG-2 specifically expressed in developing lymphocytes. Each V, D, and J 
locus contains multiple gene segment copies that can contribute to a TCR chain V region. Gene 
rearrangements generate V region sequences by randomly picking a single gene copy from each 
of the V, D, and J loci. Each combination of VDJ segments leads to a different TCR chain. In 
addition to the combinatorial diversity, the imperfect biochemistry of excising and rejoining DNA 
segments creates additional TCR sequence diversity through nucleotide deletion and addition at 
gene segment junctions (also called junctional diversity). It is this final repertoire diversification 
step that leads to a unique TCR specificity for each T cell clone, resulting in a potential diversity 
of >1013 unique T-cell immune receptor sequences [7]. The structure of each TCR chain contains 
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three regions that contact the antigen, and are called complementarity-determining region (CDRs). 
In fact, most of the combinatorial and junctional diversity of a TCR chain is found in the CDR3 
region - which contains the V - J junction in the alpha and respectively the V-D and D-J junctions 




Figure 1-1. TCR gene rearrangement through V(D)J recombination and peptide:MHC 
presentation to T cells 
 
(A) TCR diversity is generated by combinatorial joining of variable (V), joining (J), and diversity 
(D) gene fragments. During development, each T cell undergoes DNA rearrangement of the TCR 
alpha and beta genomic loci to generate a surface protein with unique specificity for antigen. (B) 
T cell recognition of antigen requires recognition of not only the peptide epitope presented but also 
the antigen presentation molecule itself, the major histocompatability complex (MHC). The MHC 
class I and class II molecules are recognized by CD8+ and CD4+T cells, respectively. Peptides 8-
10 (left) or 13-25 (right) amino acid residues in length interact with the complementarity regions 







T cell priming and activation  
 The activation of T cells requires a series of interactions with dendritic cells that can be 
divided into three molecular ‘signals’. The initial step comprises of DCs presenting peptides in the 
context of MHC molecules. If nearby T cells possess a TCR specific for the presented antigen, 
then a T cell-APC junction referred to as immunological junction is formed [8]. In addition to 
binding of the TCR and MHC-peptide complexes, T cells also require co-stimulation through the 
interaction of CD28 expressed on the surface of the T cell, with CD80 and CD86 expressed on the 
surface of the activated APC [9, 10]. Other co-stimulatory molecules that may play a role during 
T cell priming include CD2, OX40, ICOS, 4-1BB, and GITR [11]. Co-stimulation is regarded as 
the second key signal during activation of a naïve T cell, and is required to avoid T cells becoming 
refractory to stimulation, a cell state named anergy [12]. Finally, the third activation signal includes 
the cytokines produced by the DCs during encounter with the naïve T cell. The cytokine 
environment during activation guides the differentiation of CD4+T cells towards different effector 
subsets.   
Signaling pathways induced by T cell receptor stimulation 
 Signaling through the T cell receptor results in the activation of IRF4, RUNX, and three 
families of transcription factors - AP-1, NFAT and NFkappaB. Each of these factors cooperate to 
drive up-regulation of genes encoding cytokines and master regulators. One of the downstream 
effects of TCR stimulation is the influx of calcium into the cell. Intracellular calcium binds to the 
messenger protein calmodulin, resulting in the activation of the phosphatase calcineurin, which 
dephosphorylates NFATs, allowing nuclear translocation of these transcription factors. Among the 
targets of NFAT are the cytokines involved in driving CD4+T cell differentiation, as the deletion 
of NFATc1 and NATc2 resulted in decreased production of IL-2, IFNgamma, IL-4, and IL-5 in 
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response to T cell stimulation [13]. NFAT binding sites have been found in promoters of genes 
encoding IFNgamma [14], IL-17 [15, 16], and FOXP3 [17], demonstrating roles for the NFAT 
protein family in driving T cell subset-specific cytokines.  
 The NFkappaB family of transcription factors is composed of 5 family members, RelA 
(p65), NFkappaB1 (p50/p105), NFkappaB2 (p52/p100), c-Rel, and RelB [18]. Key functions of 
NFkappaB in the immune system are associated with activation of proinflammatory cytokines 
[19], however  NFkappaB is also activated upon stimulation of the T cell receptor in a PKCtheta-
dependent manner [18]. Transgenic mice generated to express a mutant form of IkappaBalpha that 
acts as an inhibitor of NFkappaB activity, have reported decreased IFNgamma production, and 
increased IL-4 production in activated T cells [20]. Moreover, mice deficient in the p50 subunit of 
NFkappaB show deregulated effector differentiation, with decreased GATA3, IL-4, IL-5 and IL-
13 expression [21]. Furthermore, deletion of the NFkappaB family member c-Rel resulted in 
decreased RORgammat and IL-17 expression in mouse models of autoimmune disease [22]. In 
addition, c-Rel deficient mice exhibit decreased abundance of Treg cells in lymphoid sites [23, 
24]. Thus, similarly to the role of NFAT proteins, NFkappaB signaling drives the expression T cell 
subset-specific cytokines.  
 The AP-1 transcription factor is a heterodimeric protein composed of members of the Jun 
(cJun, JunB, JunD), Fos, Maf, and ATF (including BATF) families [25, 26]. These factors are 
activated in response to the induction of the MAP kinase cascade upon T cell stimulation. BATF1, 
BATF2 and BATF3 proteins have compensatory actions with each other in several immune cell 
lineages. For example, T cells that are deficient in both BATF and BATF3 lack IL-10 production, 
unlike BATF−/− or BATF3−/− T cells [27]. BATF-deficient mice demonstrated a defect in IL-17 
expression that could not be rescued via overexpression of the master regulator retinoid orphan 
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receptor gamma t (RORgammat) [26]. Transcription factors BATF and IRF4 are both up-regulated 
within 4 h of TCR stimulation [28-30], and together with JunB, form a complex that is able to bind 
DNA and drive the expression of key genes during T cell activation and early effector 
differentiation [31, 32]. As IRF4 binds weakly to DNA on its own, however, IRF4 ChIP-Seq 
analysis identified AP-1 binding sites as the motif most highly associated with IRF4 binding [31, 
32]. In mice, the loss of either BATF or IRF4 resulted in decreased DNA binding of the other 
binding partner, indicating the requirement for both factors for efficient DNA binding and target 
gene expression.  Moreover, BATF-IRF4-dependent gene induction relies on interactions of IRF4 
with several amino acid residues of BATF, namely His55, Lys63, and Glu77 [33]. In fact, IRF4, 
BATF, and JunB bind key genes required for differentiation of effector T cells, including genes 
encoding PRDM1, MAF, AHR, IL-4, IL-5, IL-10, IL-13, IL-17A, IL23R, and IL-12RB1 [29, 31, 
32, 34]. However, how each of these transcription factors influence the differentiation of effector 
to memory T cells, or their role in maintenance/reactivation of memory T cells in vivo, remains 
understudied.  
CD4+T helper subsets 
 Activated CD4+T cells respond to infections by differentiating into distinct T helper (Th) 
lineages with unique functions to best oppose the particular pathogen type [35]. The complex 
processes of what determines the fate of a T cell are still investigated. However, the current Th 
paradigm suggests that different pathogens elicit different combinations of cytokines to be 
produced by innate immune cells, which in turn leads to expression of lineage-defining Th master 
regulators [36, 37]. IFNgamma-producing Th1 cells are generated in immune response to viruses 
and intracellular bacteria. Th1 cells are induced by IL-12 signaling, which leads to STAT4 
activation that drives the expression of the Th1 lineage-defining transcription factor TBET. On the 
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other hand, Th2 cells mediate protection from parasites, but are also associated with allergic 
reactions to environmental antigens [38]. The key cytokines produced by Th2 cells are IL-4, IL-5 
and, IL-13. Th2 differentiation is triggered by IL-4-mediated activation of STAT6 signaling, which 
induces the transcription factor GATA3. Th17 cells are induced by fungi and extracellular bacteria, 
however they may also contribute to autoimmune pathology [39, 40]. Differentiation of Th17 cells 
is driven by IL-6 and TGFbeta in the environment, and downstream activation of STAT3 drives 
the expression of the master regulator RORgammat. Th17 cells are abundant in the intestine and 
the skin, and can produce IL-17 and IL-22 cytokines [41]. In addition to Th1, Th2, and Th17 cells, 
CD4+T cells develop into T follicular (Tfh) cells that specialize in providing help to B cells [42]. 
Tfh cells reside within B cell follicles in the spleen and lymph nodes, express the chemokine 
receptor CXCR5 and produce the cytokine IL-21. In contrast to protective Th subsets, CD4+T cells 
can generate regulatory T (Treg) cells that act to suppress immune responses and maintain immune 
tolerance to self [43]. Tregs can be thymus-derived (tTregs) or induced in the periphery (pTreg), 
express the master regulator FOXP3, and produce anti-inflammatory cytokines TGFbeta and IL-
10.  More recently, new Th subsets such as Th9 and Th22 have been described [44, 45]. The ability 
of each Th subset to undergo re-differentiation into another (T cell plasticity) is under 
investigation. Overall, it remains to be determined how each particular Th subset continues to 




Figure 1-2. CD4+T helper subsets 
 
Upon activation by APCs, the CD4+T cells proliferate and differentiate into several subtypes, each 
with specific functional capabilities: Th1, Th2, Th17, Tfh, and induced or peripheral Treg. Th1 
cells specialize in intracellular pathogen clearance. Th2 CD4+T cells engage parasites, while Th17 
cells are generated in response to extracellular bacteria and fungi. T follicular helper cells promote 








Immunological memory is the defining feature of the adaptive immune system. Naïve T 
cells differentiate into memory T cells after antigenic stimulation. Memory T cells carry the 
information of a previous exposure to an antigen and comprise the cellular unit of immunological 
memory. A typical T cell response to viral infection or vaccination consists of three phases: (1) 
clonal expansion and differentiation into effector antigen-specific T cells, (2) contraction of the 
effector cell population through programmed cell death, and (3) generation of a long-lived 
population of memory cells. During the primary infection, activated naïve T cells undergo clonal 
expansion, which leads to a substantial increase in the frequency of antigen-specific cells [46, 47]. 
During this proliferative burst, naive T cells also undergo transcriptional reprogramming and up-
regulate genes required for cytolytic attack on target cells or secretion of interleukins and cytokines 
[48, 49]. Effector CD8+T cells release perforin, a molecule that punctures the plasma membrane 
of the target cell leading to lysis. In addition, CD8+cells secrete granzymes, which pass through 
the channels in the target cell and trigger apoptosis. Cytokines such as IFNgamma, IL-2, and 
TNFalpha are released by effector CD8+T cells to promote inflammation and recruitment of other 
immune cell types [48, 49]. Similarly, CD4+T cells undergo clonal expansion and differentiate into 
effectors that help CD8+T cell and B cell response, while also releasing distinct cytokines in 
reaction to different pathogen types [35]. Effector T cell responses peak in the second week of 
infection and, if the pathogen is cleared, the number of antigen-specific T cells significantly 
contracts through apoptosis. After the contraction phase, the number of antigen-experienced T 
cells stabilizes and undergoes further changes in gene expression to generate long-lived memory 
populations. Improved immunological protection is thus founded on several functional capabilities 
that memory T cells possess but are not present in naïve, antigen-inexperienced T cells. First, 
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higher frequency of T cells specific to a given antigen in turn increases the chance of pathogen 
recognition [50]. Second, memory T cells generate cytotoxic molecules and cytokines more 
rapidly and in higher quantities compared to naïve T cells [49, 51, 52]. Despite the great potential 
of harnessing T cell memory for vaccine design, further studies are needed to determine the exact 
differentiation steps that control the generation of highly potent memory T cells from quiescent 
naïve T lymphocytes.  
Heterogeneity of memory T cells 
In humans, the longevity of immunological memory has been observed to last for decades 
[53, 54].  Memory T cells in humans are classically distinguished by the expression of the CD45RO 
isoform and by lack of CD45RA isoform expression (CD45RO+CD45RA−) [55, 56]. In mice, 
expression of the adhesion molecule CD44 is increased during T cell activation and is used as a 
memory T cell marker [57]. Long-term immunity in both mouse and humans is maintained as 
heterogeneous memory T cell populations in circulation and tissue sites. Circulating memory 
subsets were originally delineated based on lymph node homing receptor CD62L and CCR7 
expression. Effector memory (TEM, CD62L-CCR7-) and central memory (TCM, CD62L+CCR7+) 
cells migrate through peripheral and lymphoid sites, respectively [58]. TCM cells exhibit a higher 
proliferative capacity than the TEM subset [59, 60], with proposed differentiation models placing 
TCM as an intermediate stage in the development of naïve T cells into TEM cells [61]. Both TCM 
and TEM cells can produce effector cytokines, including IFN gamma and TNF alpha, in response 
to pathogens [59, 60, 62, 63]. Among TCM subsets, CD8+TCM but not CD4+TCM have an 
enhanced ability to secrete IL-2 relative to their TEM counterpart [64]. In addition to TCM and 
TEM subsets, new memory T cells subsets have been characterized in humans and mice. Stem cell 
memory T cells, expressing the death receptor CD95 (also known as FAS) and the memory-
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associated marker CD122 (also known as IL-2Rbeta), have higher self-renewing and proliferative 
capacities than those of central and effector memory T cell subsets [65, 66]. In humans, stem cell 
memory T cells express a naïve-like CD45RA+CD45RO- profile, and are associated with high 
levels of the co-stimulatory receptors CD27 and CD28, IL-7 receptor alpha-chain (IL-7Ralpha), 
CD62L and CCR7 [67]. Collectively, analysis of memory T cell subsets was focused on human 
blood and mouse secondary lymphoid organs. More recently, it has been established that a 
significant fraction of TEM-phenotype cells persist as non-circulating subsets of tissue-resident 
memory T cells (TRM) in multiple sites, including lungs, intestines, skin, liver, brain, and other 
mucosal surfaces [68]. Phenotypically, CD4+ and CD8+TRM are distinguished from circulating T 
cell subsets by the constitutive expression of the early activation marker CD69 [68]. TRM mediate 
protection against site-specific re-infection through rapid secretion of cytokines that enhance 
activation and recruitment of adaptive and innate immune cells [69].   
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Figure 1-3. Generation of T cell memory 
 
A typical T cell response to viral infection or vaccination consists of three phases: (1) clonal 
expansion and differentiation into effector antigen-specific T cells, (2) contraction of the effector 
cell population through programmed cell death, and (3) generation of a long-lived population of 
memory cells. There are three major types of memory T cells: central memory T cells (TCM), 
which circulate between blood, lymphoid and nonlymphoid sites; effector-memory T cells (TEM), 
which circulate through peripheral tissues via the vasculature; and tissue-resident memory T cells 








Memory homeostasis and persistence - role of cytokines and MHC 
Memory T cells can persist for up to the lifetime of an individual through long‐term 
homeostasis and turnover [70-72]. The main cytokines involved in the homeostasis of memory T 
cells belong to the family of cytokines sharing the common gamma chain receptor, also known as 
CD132 or IL-2 receptor gamma. The cytokine family includes IL-2, IL-4, IL-7, IL-9, IL-15, and 
IL-21 [73]. From this cytokine family, IL-7 and IL-15 signaling have been shown to be important 
in the long-term maintenance of T cell memory by promoting cell survival or inducing a slow, 
consistent proliferation referred to as homeostatic turnover. IL-15 can signal through the dimeric 
IL-2R, composed of IL-2Rbeta (CD122) and the common gamma chain receptor, but efficient IL-
15 signaling requires a trimeric receptor consisting of the above dimer and IL-15Ralpha [74]. On 
the other hand, IL-7 binds to the dimer of IL-7Ralpha (CD127) and the common gamma chain 
[74]. Loss-of-function experiments indicate reduced memory CD4+T cells in IL-15−/− and IL-7−/− 
mice [75, 76]. Similarly, IL-7 and IL-15 are critical for memory CD8+T cell homeostasis [77-79]. 
In addition to cytokine survival signals, long-term maintenance of memory CD4+T cells requires 
TCR stimulation and engagement with MHC class II [80-83]. In contrast, memory CD8 T cells 
have been shown to persist independent of TCR signaling and MHC class I engagement [71, 84]. 
While roles for these factors have been well established for T cell memory in general, our 
understanding of the factors necessary for long-term maintenance of TRM cells remain 
incompletely understood. 
Influenza virus 
Influenza infection is a significant cause of morbidity and mortality worldwide. In the 
United States, influenza illness results in 200,000 hospitalizations each year with an associated 
economic burden of over $10 billion [85-87]. The virus is spread primarily via aerosolized 
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respiratory droplets, and disproportionately affects individuals at the extremes of age, with highest 
rates of illness and hospitalization occur in children younger than 2 years of age and in adults older 
than 65 years [88]. The median estimated number of global influenza-associated respiratory deaths 
annually is ~400,000 [89]. Current influenza virus vaccines are annually reformulated to elicit 
protection toward the virus strains that are predicted to circulate in the upcoming influenza season. 
These vaccines provide limited protection in cases of antigenic mismatch, when the vaccine and 
the circulating viral strains differ [90].  
Influenza viruses are a collection of enveloped, single-stranded, negative-sense segmented 
RNA viruses belonging to the group Orthomyxoviridae [91]. There are three major viral types; A, 
B and C. The vast majority of disease in both humans and animals is associated with influenza A 
viruses (IAV). The genome of IAV (from now on referred to as influenza) consists of eight RNA 
segments encoding 11 proteins [92]. Viral particles consist of a ribonucleoprotein core containing 
genomic single-stranded RNA segments complexed with nucleoprotein (NP) monomers packaged 
with the three viral polymerase proteins. The three viral proteins include polymerase basic protein 
1 (PB1), polymerase basic protein 2 (PB2) and polymerase acidic protein (PA). This core is 
surrounded by a host-derived lipid bilayer membrane studded with matrix 2 (M2), hemagglutinin 
(HA) and neuraminidase (NA) proteins. Viral matrix 1 (M1) sits just below the lipid bilayer while 
nuclear export protein/nonstructural protein 2 (NEP/NS2) is contained within the viral particle 
between the core and the enveloped membrane. Two of the encoded proteins are not contained in 
the mature virion, but are expressed during the intracellular phase of the viral lifecycle. 
Nonstructural protein 1 (NS1) is vital for viral mRNA translation and antagonizes the host anti-
viral type I interferon (IFN) responses [93]. Finally, PB1-F2 is expressed during replication and 
plays a role in enhancing viral virulence [94]. Influenza A viruses are further divided into subtypes 
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based on the expression of various HA and NA surface glycoproteins. Humans are commonly 
infected with viruses containing H1, H2 or H3 hemagglutinin and N1 or N2 neuraminidase 
serotypes. Less common subtypes derived from avian strains that contain H5, H7, and H9, have 
been identified in outbreaks [91].  
Influenza HA and NA proteins are critical for entry to and budding from host cells. Viral 
HA binds to alpha 2,6-linked or alpha 2,3-linked sialic acid residues expressed by airway and 
alveolar epithelial cells and mediates viral endocytosis by host cells in conjunction with M2 [95]. 
Primary infection and viral replication occur within the epithelial cells of the respiratory tract [96]. 
Following replication and budding, NA cleaves sialic acid residues from the surface of the host 
cell, thus preventing their interaction with HA present on newly synthesized viral particles and 
allowing for release of new mature virions. Due to the error-prone nature of the viral polymerase 
during replication, viral genes are susceptible to mutation [97]. The selective pressures of the host 
immune system upon the antigenic HA and NA molecules make these molecules particularly 
subject to variability. The accumulation of such point mutations over time is referred to as 
antigenic drift. Furthermore, the segmented nature of the influenza genome allows for the 
exchange of entire genome segments between viruses co-infecting a single cell. Infection with 
more than one strain can result in the generation of novel reassortant strains, a phenomenon 
referred to as antigenic shift.   
Adaptive immune responses to influenza infection 
 The respiratory tract is a major entry site for viruses into the body. A severe infection of 
the respiratory tract can induce life-threatening damage to the lungs. Viral clearance and resolution 
of infection requires activation of the local innate immune response and recruitment of adaptive 
immune cells. Following influenza infection CD103+ and CD11b(high) DC subsets accumulate 
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within the lung interstitium [98-100]. Within the infected lung, both subsets take up viral particles 
and influenza-derived antigens, resulting in their activation and maturation. Subsequently, DCs 
that have taken up viral antigens from the lung DCs up-regulate the lymph node homing marker 
CCR7 and migrate to the lung-draining medistinal lymph node (MLN) to activate adaptive immune 
cells [101, 102]. Migrant CD103+respiratory DCs reach maximum numbers in the draining lymph 
nodes early (2–4 days) following respiratory virus infection [103, 104]. CD11b(high) respiratory 
DCs reach peak numbers in the draining lymph nodes at later time points (5–7 days) following 
influenza virus infection [103, 104]. Naïve T cells expressing lymphoid homing receptors, 
including CD62L (also known as L-selectin) and CCR7, and traffic through the MLN where they 
interact with activated DCs bearing viral antigen, resulting in the activation of virus specific T 
cells. Newly activated T cells begin to up-regulate canonical activation markers including CD44 
and CD69 as well as CD25, the high-affinity IL-2 receptor. Priming, activation, and expansion of 
naïve T cells in the MLN occurs in the first 3 to 4 days following infection [105-107]. The cytokine 
environment during influenza infection is dominated by cytokines IL-12, generated by DCs, and 
IFNgamma generated by Th1 cells [108, 109]. Both responding CD4+ and CD8+T cells up-regulate 
expression of TBET and secrete the characteristic Th1 effector cytokines TNFalpha and 
IFNgamma [109]. CD4+T cells additionally continue to secrete high levels of IL-2. Despite the 
dominance of Th1-type responses in infection, studies have demonstrated the robust generation of 
Tfh populations in the MLN as well as the spleen following influenza exposure [110] and these 
responses drive B cell activation and the generation of robust T-dependent antibody responses to 
influenza [111]. The CD8+T cell response is focused towards internal proteins of the virus (NP, 
PA, and PB1) [112-114]. In contrast, CD4+T cells generate responses to both internal and external 
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HA-NA proteins [115-118]. Generation of T cell immunity cross-reactive toward multiple 
influenza strains presents great potential for design of a universal influenza vaccine [119].   
T cell homing to the lung  
Concomitant with their differentiation into primary effectors, newly activated virus-
specific T cells down-regulate expression of CD62L and CCR7 allowing them to exit the MLN 
and traffic to the lung. Influenza-specific effector T cells upregulate adhesion molecules and 
chemokine receptors that help guide the lymphocytes to the lung. Multiple mechanism of T cell 
homing to the lung have been investigated. Upregulation of CCR4 on CD4+T cells facilitates 
homing to the lung [120] where the chemokine receptor’s ligands MCP-1, CCL3 (MIP-1-alpha), 
and CCL5 (RANTES) are expressed during influenza infection [121-124]. The process of 
imprinting the T cells for migration to the lung is driven by lung-derived DC subsets, since DCs 
from other tissue sites fail to up-regulate CCR4 on effector CD4+T cells [120]. However, CCR4 
loss-of-function experiments in mouse models of airway allergic inflammation describe an 
increase of CD4+effector and memory T cells [125]. With no reported studies on CCR4-deletion 
in mice infected with influenza, the importance of this molecule in T cell homing to the lung 
remains undefined. Another molecular mechanisms that contributes to T cell homing to the lung 
during influenza infection includes the chemokine receptors CXCR3 and CXCR4. Influenza-
specific effector CD8+T cells up-regulate CXCR4 and are guided by lung-infiltrating neutrophils 
that produce CXCL12 (also known as stromal cell–derived factor-1 alpha) [126], however no 
infection models in CXCR4-deficient mice have been reported. In addition, while CD4+effector T 
cells up-regulate CXCR3, and CXCR3 ligands CXCL9 and CXCL10 are IFNgamma-inducible 
chemokines that are highly expressed in inflamed tissue [127], the importance of this signaling 
pathway for T cell homing to the lung remains undefined. Namely, mixed BM chimeras generated 
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from WT and CXCR3 receptor-deficient mice infected with Sendai virus demonstrated a 5-10 fold 
decrease of CXCR3−/− CD4+T cells in the lung of infected animals [128]. In contrast, CXCR3-
deficient mice infected with sendai virus generate normal numbers of CD4+effector T cells in the 
lung [128], suggesting a CXCR3-independent mechanism of T cell homing. In CD8+T cells 
CXCR3 is important for memory T cell access to the respiratory tract, but not the lung in general 
[127], suggesting CXCR3 independent mechanisms of lung homing [127]. Both in CD4+and 
CD8+T cells, deficiency in a single chemokine receptor leads to mild defect in lung homing, 
suggesting that a complex mechanism with multiple redundancies regulates T cell homing to the 
lung.   
Cytokine signals in Th1 differentiation  
The induction and maintenance of each CD4+Th subsets is controlled by the cytokine 
environment. Following ligation of the cell-surface cytokine receptor, distinct members of the 
signaling transducer and activator of transcription (STAT) protein family are activated and drive 
T cell differentiation. Upon binding of cytokines to their cognate receptors, receptor associated 
Janus kinases (JAK) are activated and proceed to phosphorylate the intracellular domains of the 
receptor to allow for STAT binding. In turn, activated JAKs phosphorylate STATs, which in turn 
induce the expression of the transcription factor master regulators [129, 130]. The STAT and 
master regulator controlling each Th subset have been defined as follows, STAT4/TBET (Th1), 
STAT6/GATA3 (Th2), STAT3/RORgammat (Th17), STAT5/FOXP3 (Treg), and STAT3/BCL6  
(Tfh) [131]. Th1 differentiation is generally induced by IL-12 secreted from antigen presenting 
cells [109]. STAT4-deficient mice demonstrate impaired Th1 responses and decreased IFNgamma 
production, highlighting the requirement of STAT4 for IL-12 signaling [132-134]. STAT4 leads 
to up-regulation of genes encoding IFNgamma, IL-12RB2, and TBET [134, 135]. In turn, 
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IFNgamma signals in an autocrine manner through STAT1 to further drive TBET expression [136, 
137]. It has been demonstrated that TBET directly activates IFNgamma expression [138-140]. 
Thus, during Th1 differentiation, IL-12 and IFNgamma signaling provide a positive feedback loop 
to stabilize TBET expression and Th1 transcriptional identity. In addition, IL-12 signaling is 
required for maintaining Th1 identity during recall responses [141].  
Lung TRM 
The respiratory tract is a major entry site for viruses and bacterial pathogens into the body.  
Preventing the recurrence of infection with seasonal pathogens such as influenza requires long-
lasting and site-specific immune memory responses. Indeed, mouse models of respiratory viral 
infections induce long-lived TEM populations within the lung [142-144]. When lung-derived 
memory T cells obtained from previously influenza-infected mice are transferred into secondary 
recipients, they preferentially recirculate back to the lungs, suggesting that this subset has an 
intrinsic mechanism for specific homing to and/or retention in the lung [145]. More importantly, 
the transferred virus-specific lung TRM increased survival following lethal challenge, but 
transferred spleen influenza-specific TEM did not [145]. In human tissue studies, lung-derived 
CD4+ and CD8+ T cells, but not peripheral blood cells responded to stimulation with influenza 
virus [146, 147]. Furthermore, while memory CD8+T cells specific for the systemic virus 
cytomegalovirus (CMV) were distributed in both the lung and spleen of human donors, influenza-
specific CD8+T were only found in the lung, suggesting localization of pathogen-specific T cells 
based on sites of pathogen encounter [147]. Despite the strong protective potential of lung TEM, 
it was unclear whether these memory subsets were circulating or remained resident in lung tissue. 
Mouse models utilizing parabiotic surgery, wherein the blood circulation of two individual mice 
is conjoined, allowed the assessment of whether T cells can migrate from peripheral sites of one 
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parabiont to the other [148]. Circulating T cells would be expected to reach an equilibrium between 
partner mice. In contrast, non-circulating tissue-resident T cells generated by previous infection 
prior to parabiosis would be expected to remain in specific tissues of the antigen-experienced 
mouse. Indeed, parabiosis experiments showed the memory T cells in the lung persisted as a unique 
subset of non-circulating, tissue-resident memory T cells. [145]. Furthermore, following influenza 
virus infection, CD4+TRM resided in a distinct anatomical niche of the lung near airways [149]. 
Alternatively, a less laborious technique for identifying TRM in mouse lungs (and other mucosal 
tissues) includes in vivo labeling of circulating cells [149, 150]. By means of intravascular injection 
of fluorochrome-conjugated antibodies, which rapidly mark all cells accessible to the vasculature, 
T cells that are tissue resident at the time of injection are “protected” from circulating antibody. 
Imaging studies of tissue section from mice that underwent in vivo labeling confirm that the 
method allows rapid assessment of localization T cells in the lung [149].  
In addition to bona fide infection, TRM can be generated by means of vaccination. 
Specifically, intranasally administered live-attenuated, but not injectable inactivated influenza 
vaccine generated lung CD4+TRM and virus-specific CD8+TRM, similar in phenotype to those 
generated by influenza virus infection [151]. More importantly, these vaccine-generated TRM 
mediated cross-strain protection, independent of circulating T cells and neutralizing antibodies, 
which persisted long-term after vaccination. Furthermore, it has been demonstrated that CD4+T 
cells within the lung assist in the establishment of CD8+TRM cells during infection [152]. 
Understanding the molecular pathways active in mediating lung TRM generation could aid in the 
future design of influenza vaccines.  
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TRM in nonlymphoid tissue sites 
In addition to TRM subsets in the lung, adoptive transfer models in mice that enabled the 
tracking of pathogen specific CD8+T cells during systemic viral or bacterial infection 
demonstrated abundance of memory T cells in mucosal sites [153, 154]. Similarly, CD4+T cells 
specific to a model antigen generated long-lived memory populations in non-lymphoid sites such 
as lung, liver, intestine and salivary gland [155].  Again, parabiosis experiments showed the 
memory T cells in nonlymphoid sites did not recirculate [156-158]. Although, parabiosis 
experiments have been instrumental in identifying TRM, other methods have corroborated the 
unique features of this memory subset. For example, transplantation experiments of nonlymphoid 
tissues that contain memory T cells were crucial to further characterize T lymphocyte tissue-
residency. When skin from a previously infected mouse was transplanted to a naive mouse, virus-
specific CD8+T cells remained in the transplanted tissue of the naive mouse with no detectable 
egress to lymphoid sites [159]. In addition, persistence of donor T cell populations in allografts of 
recipients of human intestine and lung transplants highlighted TRM as a long-lived memory 
lineage independent from and not replenished from circulating memory T cells in humans [160, 
161]. Over the last few years, the TRM subset has been described in the lung, intestine, female 
reproductive tract, skin, liver, brain [159, 162-166]. Functionally, TRM differ most prominently 
from circulating memory T cells in their rapid secretion of inflammatory cytokines at barrier sites 
[69]. Overall, these findings have demonstrated that TRM are a distinct, non-circulating population 
of long-lived memory T cells. 
Phenotype of TRM 
 Defining surface markers that definitively distinguish TRM from circulating subsets is a 
subject of ongoing studies. Memory T cells that remained tissue-resident during parabiosis 
30 
 
experiments in mice phenotypically resembled TEM cells (CD44+CCR7-CD62L-) with 
constitutive expression of the early activation marker CD69 [158]. In humans, expression of CD69 
within the TEM subset in tissues delineates a transcriptional profile that is distinct from that of 
CD69-negative memory T cells in tissues and blood [167]. Hence, mouse and human TRM can be 
distinguished from circulating T cell subsets by the constitutive expression of CD69 [156, 161, 
166-169]. However, surface expression of CD69 on TRM does not suggest a recently activated T 
cell subset, as other T cell activation markers such as CD25, CD38, and HLA-DR are not co-
expressed on TRM [167]. A proportion, however, of CD4+ and CD8+T cells localized within the 
tissues and protected from intravascular antibody labeling do not express CD69 [149]. In addition 
to CD69, CD8+TRM co-express the integrin CD103 (the alpha chain of the alphaEbeta7 integrin) 
in both mouse [163, 165, 170] and human [167, 171]. However, CD103 is only selectively 
expressed on CD4+TRM [52, 149, 164, 167, 172, 173]. Therefore, CD69 expression, in 
conjunction with CD103 in certain sites, most reliably distinguishes mouse and human TRM from 
their circulating counterparts. Additional cell surface markers highly expressed on TRM include 
the integrin CD49a and chemokine receptor CXCR6. CD49a (integrin alpha1) binds to CD29 
(integrin beta1) to form very late activation antigen 1 (VLA-1), an integrin specific to collagen 
[174]. Mouse and human CD4+ and CD8+ TRM express the integrin CD49a in the lung and skin 
[146, 159, 165, 167, 175]. CXCR6, a chemokine receptor that binds CXCL16, is expressed on 
human CD4+ and CD8+TRM in lung and spleen [167]. In mouse models, CXCR6 promotes tissue-
residence of CD8+memory T cells in the skin and liver [176, 177]. Furthermore, TRM in some 
sites constitutively express surface molecules that might also regulate their function. Human 
CD4+and CD8+TRM in the lung, spleen, and liver, express the marker of T cell exhaustion, 
programmed death-1 (PD-1) [167, 171, 178, 179]. In addition to PD-1, virus-specific mouse skin 
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CD8+TRM expressed inhibitory molecules cytotoxic T-lymphocyte protein-4 (CTLA-4), 
lymphocyte activating gene-3 (LAG3), and T cell immunoglobulin mucin-3 (TIM-3) [180, 181].  
Function of TRM  
The functional importance of TRM in protection from re-infection has been demonstrated 
in a number of different tissue sites in several pathogen models. TRM control the spread of herpes 
simplex virus in the skin and female genital tract [159, 182], while brain TRM protect against local 
infection with Listeria monocytogenes [163]. Furthermore, TRM suppress tumor development in 
mouse models of melanoma [183], and the presence of TRM phenotype cells in solid tumors has 
been associated with improved survival rates in patients [184, 185]. The enhanced protective 
ability of TRM is mediated by several different mechanisms. Firstly, TRM are localized at sites of 
pathogen encounter. TRM are thus increasing the responsiveness of the immune system to tissue 
tropic antigens. Instead of relying on encounters of circulating memory T cells in secondary 
lymphoid organs with cognate antigen, and subsequent migration to the site infection, TRM ‘meet’ 
their target pathogen directly at barrier sites and can initiate an in situ immune response [186]. In 
mouse experiments with parabiotic hosts, the host having only circulating memory T cells 
exhibited greatly reduced viral clearance to a skin infection compared to the host with virus-
specific TRM [156]. In addition to direct cytotoxic activity, TRM mediate pathogen clearance 
through immune cell recruitment. TRM have been demonstrated to rapidly produce 
proinflammatory cytokines following antigen re-exposure including IFNgamma and TNFalpha. 
Such cytokine production by TRM has been shown to induce the maturation of local DCs and NKs 
cells and recruit circulating cells, including circulating memory CD8+T cells and B cells, to the 
site of infection [69, 187, 188]. Importantly, TRM are also able to induce the mobilization of local 
tissue innate immune responses, such as induction of type I IFN, which can protect from specific 
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reinfection as well as provide ‘bystander’ protection against non-related pathogens [69, 187]. 
These results support an emerging concept of TRM as a key component of protective immunity 
and immunosurveillance.    
Mechanisms of TRM tissue retention 
 Following the resolution of infection, TRM cells are maintained at the site of pathogen 
encounter and confer protection against secondary challenge. Retention of T cells within peripheral 
tissues is regulated by integrins and transcription factors. As previously discussed, the integrin 
CD103 is expressed by mouse and human CD8+TRM cells in mucosal and barrier sites. Loss-of-
function experiments in mice have illustrated the importance of CD103 expression in 
generation/maintenance of CD8+TRM. Specifically, the formation of CD8+TRM in the skin of 
CD103-deficient mice is reduced in number compared with wild type controls [165, 189]. 
Moreover, loss of CD103 in fully differentiated small intestine CD8+TRM led to defective 
retention [190]. In addition, CD103 was not required for effector CD8+T cells to access the lungs, 
however CD103 helped retain CD8+TRM after viral clearance [191]. The role of CD103 on CD4+ 
TRM is less clear. CD103+CD4+TRM can be detected in the lungs, intestines, and skin [167, 192-
194]. No CD4+T cell studies on the effect of CD103 on TRM generation/maintenance have been 
reported.  
  CD69, originally defined as an early T cell activation marker, is considered a canonical 
TRM marker in mice and humans. However, the functional role of CD69 in TRM retention is 
unclear. CD69 expression on recently activated effector T cells serves to retain them in the LNs 
[195]. However, the functional role of CD69 in TRM in unclear. Genetic ablation of CD69 in mice 
results in reduction of CD8+TRM in the lung and skin [157, 165], while CD4+TRM in the Peyer’s 
patches develop independently of CD69 [196]. 
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 Mouse and human CD4+ and CD8+TRM express the integrin CD49a, which together with 
CD29 form VLA-1. Genetic deletion of VLA-1 in mice results in impaired retention of influenza-
specific CD8+TRM in the respiratory tract and the liver, with a mild decrease in cell numbers in 
the lung [176]. Moreover, CXCR6, another chemokine receptor and marker of TRM in both human 
and the mouse, has been shown to promote CD8+TRM establishment in skin and the liver [177, 
189]. The role of VLA-1 and CXCR6 in CD4+TRM establishment is unknown.   
 In addition to integrins, retention of T cells within peripheral tissues is regulated by 
transcription factors and key molecules in metabolic pathways. Down-regulation of the Krüppel-
like factor 2 (KLF2), which controls S1PR1 expression, is essential for TRM formation in mice, 
as forced expression of S1PR1 or KLF2 prevented the establishment of TRM following systemic 
viral infection [197].  
The metabolic pathways that enable the long-term survival of TRM at barrier sites are still 
under investigation. Mouse CD8+TRM in the skin express high levels of several molecules that 
mediate lipid uptake and intracellular transport, including fatty-acid-binding proteins 4 and 5 
(FABP4 and FABP5) [198]. T cell-specific deletion of FABP4 and FAB5 impairs exogenous free 
fatty acid (FFA) uptake by CD8+TRM cells and greatly reduces their long-term survival in vivo, 
while having no effect on the survival of central memory T (TCM) cells in lymph nodes [198]. In 
contrast to circulating memory T cells, which internally generate fatty acids to drive energy supply 
thorough fatty acid oxidation [199], TRM rely on direct uptake of FFA from the environment.  
Generation of TRM 
The molecular pathways of TRM generation and/or maintenance have been largely studied 
by the tracking of pathogen-specific CD8+T cells in mouse infection models. Transcriptional 
profiling of CD8+memory T cells has revealed a network of transcription factors differentially 
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expressed in TRM compared to circulating subsets. Down-regulation of the transcription factor 
KLF2, and its target S1PR1, is required for tissue retention [197]. The transcription factor Hobit 
(ZNF683 in human, or Zfp683 in mouse) was found to be specifically up-regulated in CD8+TRM 
and, together with Prdm1, to mediate the development of TRM in skin, gut, liver, and kidney in 
mice [200]. Furthermore, Runx3 is essential for CD8+TRM generation and maintenance in non-
barrier tissue sites, as well as in the skin, lung, and small intestine [201]. Finally, the Notch 
signaling axis, which comprises of a family of surface receptors-ligand pairs and a DNA-binding 
factor Rbpj, promotes the maintenance of CD8+TRM in the mouse lung [171].  
While identifying transcription factors in mouse models provides valuable advances into 
defining the differentiation steps required for TRM generation from activated effector T cells, they 
also highlight a number of outstanding challenges. Importantly, most TRM studies fail to confirm 
whether CD4+TRM are similarly controlled by key transcription factors. Recently it was reported 
that CD4+T cells deficient in Hobit/Prdm1 generate normal cell numbers of gut TRM [193]. 
Similarly, Notch signaling-deficient CD4+T cells in the lung have lower frequencies of CD103 
expression in naïve mice [194], however no response to an infectious challenge was attempted or 
reported. The predominance of TRM studies focusing on CD8+T cells highlights the lack of 
understanding of CD4+TRM generation and/or maintenance. Moreover, mouse models are widely 
used in studies of the immune system, however, the extent of transcriptional divergence of the 
human compared to the mouse CD4+TRM is unknown. For example, the expression of Hobit is 
not associated with human lung CD4+ or CD8+TRM, questioning the role of this transcription 
factor in generation or maintenance of human lung TRM.  
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IRF4 regulates T cell differentiation 
In contrast to other members of the interferon regulatory factor protein family, expression 
of IRF4 in T cells is regulated by TCR signaling, and not by type I or type II interferons [30]. 
Simulation of T cells with anti-CD3 antibody or mitogen (PMA/Ionomycin) in vitro results in 
strong up-regulation of IRF4 within 4 hours [202-204]. The molecular mechanisms regulating the 
induction of IRF4 in response to TCR stimulation involve the NFkappaB signaling pathway. 
Specifically, p50/c‐Rel dimers can bind to the IRF4 promoter upon TCR stimulation and c‐Rel‐
deficient lymphocytes fail to up-regulate IRF4 at all [204]. The IRF4 promoter also contains 
regulatory elements that can be bound by transcription factors STAT4 and STAT6 [205], however 
the roles of IL-4 or IL-12 signaling in TCR-independent maintenance of IRF4 expression have not 







Figure 1-4. Induction of IRF4 expression in T lymphocytes 
 
During quiescence, the inhibitory IkappaB proteins bind to and inhibit cytosolic dimers of the 
NFkappaB family p50/c-Rel. Upon TCR stimulation and costimulatory signaling, PKCtheta 
activates the CARD11-BCL10-MALT1 signaling complex. This leads to activation of the IKK 
complex, and the IKKbeta kinase mediates the targeting of the inhibitory IkappaB for the 
ubiquitin-proteasome pathway. The degradation of the IkappaB protein releases the p50/c-Rel 
dimer to localize into the nucleus, and bind to and activate transcription of the locus encoding 







 As a transcription factor, IRF4 functions in T cell differentiation begin via interactions with 
DNA.  Studies on the role of IRF4 indicated that it could function as either a transcriptional 
activator or repressor depending on the context of the DNA-binding sequences and/or protein-
interacting partners. Interestingly, IRF4 has poor DNA-binding properties [27], and all DNA-
binding motifs associated with this transcription factor require at least heterodimerization with 
other factors. In B cells and T cells, IRF4 forms a complex with a heterodimer composed of the 
transcription factor BATF ('basic leucine zipper transcription factor, ATF-like') and transcription 
factor Jun, which binds DNA at a specific sequence motif: the AICE ('activator protein 1 (AP-1)–
interferon-regulatory factor (IRF) composite element' [31, 32, 206]. AICEs are located in 
conserved proximal, distal or intronic enhancer elements in most BATF–IRF4-dependent genes in 
T cells, including those that encode IL-17, IL-21, IL-10, cytotoxic T lymphocyte antigen 4 
(CTLA4) and IL-23R Furthermore, two variants of the AICE motif were characterized: AICE1 
(TTTCNNNNTGASTCA, where 'N' indicates any nucleotide, and 'S' indicates cytosine or 
guanine) and AICE2 (GAAATGASTCA). More recently, sequences outside of the AICE motifs 
have been reported to affect binding of the IRF4-BATF complex. Specifically, a thymidine located 
4 base pairs upstream of the AICE2 IRF4 binding motif (GAAA) may regulate the binding of the 
IRF4-BATF complex the AICE [29].  
IRF4, BATF, and JunB bind key genes required for Th17 differentiation, including genes 
encoding IL-17A, IL-12, IL23R, and IL-12RB1 [31, 32, 34]. In addition to playing a key role in 
Th17 differentiation, IRF4 is required for complete Th2 differentiation of activated CD4+T cells. 
IRF4-deficient CD4+T cells display diminished GATA3 expression and IL-4 production upon in 
vitro differentiation in Th2-polarizing conditions [207, 208]. In a mouse model of Leishmania 
infection, Th1 differentiation was defective as measured by IFNgamma production [208]. 
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Moreover, studies in Treg cells show IRF4 interacting with FOXP3 to drive expression of Th2 
genes [209]. Treg-specific deletion of IRF4 led to loss of expression of ~ 20% of Treg-associated 
genes, including those encoding ICOS, CCR8, MAF and the IL-33R (Il1rl1) [209]. In turn, IRF4-
deficient Tregs failed to control conventional Th2 cells in lymphoid sites, which led to increased 
IL-4 production and lymphoproliferative disease [209]. How IRF4 and FOXP3 interact remains to 
be further characterized. IRF4 also plays a role in Tfh differentiation, as IRF4-deficient mice fail 
to form germinal centers and lack Tfh cells [210]. Examination of IRF4 and STAT3 binding to 
DNA during Tfh differentiation showed strong overlap, suggesting cooperativity in regulation of 
gene expression [211]. In addition, STAT3 binding to target genomic loci was diminished or lost 
in the absence of IRF4. Together, these results show IRF4 up-regulate genes encoding PRDM1, 
MAF, AHR, IL-4, IL-5, IL-10, IL-13, IL-17A, IL23R, and IL-12RB1. While IRF4 is central in the 
differentiation of Th1, Th17, Tfh, and Treg subsets, the list of coregulators is understudied in Th1 
differentiation and memory T cell populations. Studies on the function of IRF4 indicated that it 
could function as either a transcriptional activator or repressor depending on the context of the 
DNA-binding sequences and/or protein-interacting partners. 
Given the large number of transcription factors involved in the differentiation of CD4+T 
cell subsets, studies have started to look at transcription factor networks in the regulation of 
differentiation. To examine the interactions of transcription factors during Th17 differentiation, 
ChIP-Seq was performed with antibodies against STAT3, IRF4, BATF, c-Maf, RORgammat, and 
p300 in cells undergoing Th17 differentiation [206]. Of these factors, IRF4 and STAT3 appear to 
have a pioneering role in changing the epigenomic landscape of naive CD4+T cells. Loss of BATF 
or IRF4 in Th0 or Th17 cells had little if any effect on genomic loci already accessible in naive 
cells, but most loci with inducible accessibility exhibited marked reductions in BATF- or IRF4-
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deficient mice compared to wild-type cells, suggesting that IRF4 and BATF remodel the chromatin 
landscape and potentially facilitate subsequent recruitment of TFs involved in regulating 
expression of Th17-relevant genes [206]. In addition, the quality of TCR signaling determined 
differential affinities of enhancers for the IRF4-BATF complex, indicating that the initial T-cell 
activation amplitude also shapes IRF4-BATF-mediated activation of Th subset-specific gene 
expression programs [29, 212].  
The role of IRF4 during in vivo development of effector and memory T cell subsets  
 The initial IRF4 loss of function studies in mice revealed a profound effect of this molecule 
on general homeostasis of T and B lymphocytes [213]. At 4 to 5 weeks of age, lymph nodes and 
spleens of IRF4−/− mice showed a relatively normal lymphocyte distribution and abundance 
compared to wild type animals. Interestingly, at 10 to 15 weeks of age, the spleens of IRF4−/− 
mice were enlarged 3 to 5 times, while lymph nodes were enlarged ~10 times compared to wild 
type. In vitro activation assays where IRF4−/− T cells were incubated with anti-CD3 antibody, 
concanavalin A, or the bacterial superantigen staphylococcal enterotoxin A displayed reduced 
proliferation and cytokine production (IL-2, IL-4, and IFNgamma) [213]. Interestingly, analysis 
of early events after T cell activation, such as calcium influx or the expression of the activation 
molecules CD25 and CD69, revealed no difference between IRF4−/− and control T cells [213]. 
Responding to a systemic LCMV infection, IRF4-deficient mice could not generate cytotoxic 
activity. However, the observed results could not be attributed to a specific molecular defect, such 
as for example failed differentiation or reduced numbers of antigen-specific T cells in the absence 
of IRF4. More recently, multiple studies have addressed the role of IRF4 in regulating Th 
differentiation. In vivo, T cell numbers in lesion-draining lymph nodes of IRF4−/− mice infected 
with Leishmania major were normal at 4 weeks, but were strongly reduced compared to wild type 
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hosts at 7 weeks post infection [214]. Additional in vitro assays demonstrated enhanced TCR 
stimulation-induced death after restimulation of activated IRF4−/− CD4+T cells [214]. IL-4 has 
been shown to protect lymphocytes from apoptosis, and CD4+T cells display a defect in responses 
to IL-4 during Th2 differentiation [207, 215]. At least in vitro, neutralization of IL-4 increased the 
rate of apoptosis to almost identical levels in both IRF4−/− and IRF4+/+ Th cells. In contrast, the 
addition of IL-4 protected IRF4+/+ Th cells from apoptosis [214]. Together, these results suggest 
the presence of an IL-4-dependent protective role of IRF4 in T cells that re-encounter antigen.  
 The differentiation of activated T cells is accompanied by metabolic remodeling required 
for supplying the increased energy demands of effector cells. Glycolysis and oxidative 
phosphorylation (OXPHOS) are the two metabolic processes that supply ATP (energy) within 
cells. Upon activation, T cells increase OXPHOS and their glycolytic rate [199]. A critical step in 
the activation and differentiation of T cells is the increase in the glucose transporter Glut1 
expression [216]. Effector T cell function in immune responses is tied together with glycolysis via 
hypoxia-inducible factor 1 alpha (HIF-1alpha), a transcription factor induced by hypoxia that 
activates glycolysis [217]. Knowing that TCR signaling strongly up-regulates IRF4 expression, 
studies in mice were performed to investigate potential regulation of metabolic remodeling by this 
transcription factor [218]. In vitro, CD8+T cell activation in the absence of IRF4 was normal, based 
on markers CD69, CD44, CD25, and CD62L. In vivo, adoptively transferred pathogen-specific 
IRF4−/− CD8+T cells were reduced ~100-fold compared to wild type cells in lung and spleen of 
influenza-infected mice around peak of infection [218]. Thus, in CD8+T cells, IRF4 is dispensable 
for early activation, but required for maintenance of effector T cells. Assessing the metabolic 
fitness of IRF4-deficient CD8+T cells, IRF4 was required for the induction of increased oxygen-
consumption rate and improved glycolytic capacity found 48 h after TCR stimulation of naive T 
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cells [218]. In addition, IRF4−/− CD8+T cells failed to uptake extracellular glucose compared to 
wild type cells, suggesting a defect in glucose transport into cells. Gene expression studies of IRF4-
deficient CD8+T cells, combined with ChIP-Seq of the transcription factor in wild type cells 
demonstrated binding and regulation of genes required for cellular metabolism. Specifically, genes 
encoding transcription factors important for cellular metabolism FOXO1 [219], FOXO3 [220], 
and HIF-1alpha [221] were down-regulated in IRF4−/− T cells [218]. Moreover, genes encoding 
key regulators of glycolysis, including the glucose transporters Glut1 and Glut3 (Slc2a1 and 
Slc2a3), hexokinase 2 (Hk2), 6-phosphofructo-2-kinase–fructose-2,6-biphosphatase 3 (Pfkfb3) 
and aldolases (Aldoa, Aldoc and Aldoart) [222] were all reduced in IRF4−/− compared to wild 
type T cells [218]. Similar findings have been reported for CD4+T cells [223, 224]. Thus, IRF4 is 
a critical regulator of metabolic adaptation during T cell differentiation.  
While the role of IRF4 in T cell activation and effector differentiation has been extensively 
studied, how IRF4 affects memory T cell subsets is less known. Differential expression of IRF4 
has been mentioned in multiple studies of TRM [163, 167, 171, 194, 201, 225, 226]. Recently, two 
studies have addressed the role of IRF4 in long term maintenance of T cells [227, 228]. In a mouse 
model of allograft heart transplant, graft-infiltrating CD4+T cells express high levels of IRF4. 
Depletion of IRF4 in T cells prevents allograft rejection due to lack of allograft infiltration by T 
cells and/or generation of dysfunctional CD4+T cells [227]. The dysfunction of CD4+T cells was 
characterized by higher expression of exhaustion markers PD-1, CD160, CD73, folate receptor 4 
(FR4) [178, 229], and transcription factor Helios (encoded by Ikzf2). Mechanistically, IRF4 
deficiency generated an active chromatin state around the Pdcd1 locus, leading to higher PD-1 
levels in IRF4-deficient T cells. Interestingly, treating hosts with anti-PD-L1- and CTLA-4-
specific antibodies counteracts the dysfunction in IRF4-deficient CD4+T cells, and improves 
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effector function and survival. However, functionality of IRF4−/− CD4+T cells could only be 
restored with checkpoint blockade during the first week post transplantation. At later stages post 
transplantation (~4 weeks), IRF4-deficiency generates memory T cells refractory to reactivation 
by checkpoint blockade. These results suggests that IRF4 gradually shapes the functionality of 
memory CD4+T cells and is required for prevention of T cell exhaustion [227].  
A different study discovered IRF4 overexpression in CD8+T cells that have experienced 
continuous TCR engagement due to a chronic infection [228]. Specifically, when investigated at 
the memory stage, CD8+T cells generated from a chronic infection express higher levels of IRF4 
when compared to memory T cells generated by an acute infection [228]. IRF4 overexpression 
was correlated with higher expression of inhibitory molecules PD-1, TIM-3, Lag3, 2B4, TIGIT 
and CTLA-4. Partial ablation of IRF4 reduced the expression of inhibitory molecules, and 
improved the expression of effector cytokines IFNgamma and TNFalpha [228]. Interestingly, 
lowered IRF4 expression in CD8+T cells increased immune pathology, indicating that fine-tuned 




Figure 1-5. The role of IRF4 in the differentiation of CD4+T cells 
 
Transcription factors BATF and IRF4 are both up-regulated within 4 h of TCR stimulation, and 
together with JunB, form a complex that is able to bind DNA and drive the expression of key genes 







Studies in mouse models and humans indicate that tissue-resident memory T cells are 
essential in protecting peripheral sites from infectious agents. Mucosal sites that are under constant 
threat from viral and bacterial challenge require efficient reactivation of the immune system upon 
recognition of a previously encountered pathogen. In addition to protection from infection, TRM 
cells can also actively suppress cancer progression in barrier sites. Furthermore, tumor-infiltrating 
T lymphocytes phenotypically resemble tissue-resident subsets in healthy tissues, suggesting that 
new immunotherapies would benefit from greater understanding of TRM cell biology. Infection 
models in mice have served to define CD8+TRM as a distinct subset with transcriptional identity 
driven by several transcription factors, such as HOBIT, PRDM1, RUNX3, and RBPJ. 
Identification of TRM-specific regulatory factors has been facilitated by an abundance of gene 
expression studies characterizing mouse CD8+TRM. The lack of comprehensive gene expression 
studies of pathogen-specific CD4+TRM precludes the analysis of how important the above 
mentioned transcription factors are for maintaining CD4+TRM identity. Thus, it remains unknown 
whether CD4+TRM can be considered a distinct subset until its transcriptional profile has been 
described and key transcriptional regulators thereof identified and perturbed.         
Our goals are to understand how CD4+tissue-resident memory T cells are generated 
and maintained in non-lymphoid tissue sites, and how this biological process is conserved 
between mouse models and humans. This work investigates the hypothesis that 
CD4+tissue-resident memory T cells in non-lymphoid sites are regulated by specific 
molecular mechanisms for tissue-retention and long-term survival not required for 
maintenance of circulating memory populations. Understanding the regulation of CD4+TRM 
maintenance may provide avenues to enhance tissue-specific immunity to pathogens and cancers.  
47 
 
In the lung, rapid recall of memory CD4+T cells is crucial for protection against influenza 
and Mycobacterium tuberculosis. The protective capacities of tissue-resident memory T cells 
suggest that vaccination strategies targeting their generation and persistence may provide enhanced 
immunity compared to vaccines relying on circulating responses. The lack of mechanistic 
understanding of the factors contributing to generation and maintenance of lung CD4+TRM 
preclude development of vaccine capable of generating long-lived, tissue-resident T cell memory. 
Our first objective is to examine the transcriptional profile of influenza-specific CD4+memory T 
cells in the lung, and identify tissue-specific mechanisms that are required for their maintenance.  
Mouse models are widely used in studies of the immune system, however, the extent of 
transcriptional divergence between humans and mouse models is unknown. Developing strategies 
that could harness the potential of TRM in the clinic require the integration of human and mouse 
studies. While mouse models allow the careful tracking of activation and differentiation of T cell 
populations during the course of infection, it is controversial to claim that every finding in a model 
organism has translational potential. Genetically inbred mouse models kept in a controlled 
environment cannot recapitulate the diversity of exposures to pathogens over decades of life in 
humans. In order to narrow down which findings in CD4+TRM are generalizable and applicable 
to humans, our second objective is to integrate genes expression studies of mouse and human 
CD4+TRM to define molecular mechanisms of maintenance that are conserved across species.    
In total, this body of work contributes to an enhanced understanding of the transcriptional 
regulation of CD4+TRM generation in humans and mice. Results from our first objective revealed 
that influenza infection in mice generates two subsets of CD4+T cell memory: TRM in the lung 
and a predominantly TEM population in the spleen. Lung CD4+TRM displayed a unique 
transcriptional profile distinct from spleen memory, including up-regulation of a gene network 
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induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In 
addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously 
described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules 
such as CTLA4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. 
Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the 
generation of lung-localized pathogen-specific effector CD4+T cells during the first two weeks of 
influenza infection. This finding identifies IRF4 as an important regulator of CD4+TRM generation 
in response to respiratory infection. Furthermore, comparing whole transcriptome profiling of 
mouse and human lung memory T cell subsets, we define a lung CD4+TRM gene signature 
common to mice and humans. IRF4 protein was specifically up-regulated in lung CD4+TRM but 
not in circulating memory subsets, in both humans and mice previously infected with influenza. 
This result suggest that high expression of IRF4 contributes to a cross-species conserved molecular 
pathway of long-term maintenance of CD4+TRM in the lung. Overall, our findings confirm lung 
CD4+TRM as a unique memory T cell subset regulated by tissue-specific transcription factors. The 
generation of pathogen-specific lung CD4+TRM during influenza infection in mice requires IRF4, 
and this transcription factor contributes to the long-term maintenance of CD4+TRM in the human 
lung. These results have important implications in focusing future studies of tissue resident 
memory T cells to factors with translational potential. Importantly, by determining the lung 
CD4+TRM gene signature common to mice and humans, we motivate future genetic studies that 




Chapter 2 : Materials and Methods 
 
Mouse strains and genotyping 
C57BL/6J (B6 WT, strain number 000664), BALB/cJ (BALBC WT, strain number 
000651), B6.SJL-PtprcaPepcb/BoyJ (CD45.1, strain number 002014), 
B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-II, strain number 004194), B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ 
(CD4 Cre, strain number 022071) mice were purchased from the Jackson Laboratory  or bred and 
maintained under specific pathogen–free conditions in a BSL2 biocontainment room within 
Columbia University Medical Center (CUMC) animal facilities. B6.129S1-Irf4tm1Rdf/J (IRF4 
floxed) mice [230] were provided by Dr. S. Reiner (Columbia University, New York, NY) or 
purchased (Jackson Laboratory, strain number 009380) and crossed with CD4 Cre OT-II mice to 
generate CD4 Cre OT-II IRF4 floxed mice. CD69−/− mice on BALB/c genetic backgrounds [231] 
were provided by Dr. T. Nakayama (Chiba University, Chiba, Japan). The offspring were screened 
by PCR of genomic DNA extracted from ear punches using the Clontech Terra PCR Direct 
Polymerase Mix kit (Takara Bio) with the following primers: 
(1) Cre forward, 5'-CGATGCAACGAGTGATGAGG-3';  
(2) Cre reverse, 5'-CGCATAACCAGTGAAACAGC-3';  
 
(3) IRF4 forward common, 5’-TGGGCACCTCTACTGTCTGG-3’; 
(4) IRF4 wild type reverse, 5’-CTCTGGGGACATCAGTCCT-3’; 
(5) IRF4 mutant reverse, 5’-CGACCTGCAGCCAATAAGC-3’; 
 
(6) CD69 WT F, 5’-TCTTCTGGCCACCAACAGCAC-3’; 
(7) CD69 WT R, 5’-CCTTCTGCCCTCTCTCCAGAT-3’; 
(8) CD69 KO F, 5’- ATTCGGCTATGACTGGGCACAACA -3’; 




All animal studies and procedures were conducted according to the National Institutes of Health 
guidelines for the care and use of laboratory animals and were approved by the CUMC Institutional 
Animal Care and use Committee. 
Influenza virus infection 
Mice were anesthetized by inhalation of isoflurane (5% induction/3% maintenance), 
delivered through a vaporizer within the CUMC animal facilities, and infected intranasally with 
200-500TCID50 of recombinant A/PR8/34 influenza virus expressing peptide (323-339) of chicken 
ovalbumin (PR8-OVA) [232]. Mice were monitored daily for weight loss and morbidity. 
T cell adoptive transfer 
Splenocytes taken from OT-II mice were enriched for CD4+ T cells with the EasySep 
Mouse CD4+ T Cell Isolation Kit (STEMCELL Technologies). Purified CD4+ T cells from OT-II 
mice (CD45.2) were transferred by intravenous (i.v.) injection into the tail vein of congenic 
CD45.1 mice (2 X 105cells/mouse). One day later, recipient mice were infected with PR8-OVA 
virus as described above.  
Intravascular labeling for identification of tissue-resident T cells 
For in vivo antibody labeling, mice were given 2μg fluorochrome-conjugated anti-CD90.2 
(clone 30-H12) by i.v. injection 12min prior to tissue harvest. Lungs were then perfused with 




Lymphocyte isolation from mouse tissues 
Lung tissue was mechanically disrupted using the gentleMACS tissue dissociator (Milteny 
Biotech). Tissue homogenates were then incubated for 30-60min at 37°C with digestion medium 
RPMI (Thermo Fisher) containing 10% fetal bovine serum (FBS) (Thermo Fisher), L-glutamate 
(Thermo Fisher), sodium pyruvate (Thermo Fisher), nonessential amino acids (Thermo Fisher), 
penicillin-streptomycin (Thermo Fisher), collagenase D (1 mg/ml, Roche), trypsin inhibitor (1 
mg/ml, Thermo Fisher) and DNase I (0.1 mg/ml, Roche). After digestion, samples were once again 
mechanically disrupted using the gentleMACS dissociator, followed by a passing through a 100μm 
filter. After centrifugation, samples were depleted for red blood cells using ACK Lysing Buffer 
(Thermo Fisher) for 5min at room temperature. After washing and resuspending in RPMI 
containing 5% FBS, samples are filtered through a 70μm filter and kept on ice in the dark.  
Lymphocytes from mediastinal lymph nodes (MLN) and spleens, were isolated by first 
pressing the tissues through a 100μm filter with a plunger of a 1mL syringe to generate cell 
suspensions in RPMI containing 5% FBS. Spleen cell suspensions were further depleted for red 
blood cells using ACK Lysing Buffer as described above. Cells were then washed, resuspended, 
filtered through a 70μm filter and kept on ice until processing for flow cytometric analysis.  
Immunostaining for flow cytometry 
Immunostaining of cells was performed in FACS buffer (PBS/1% fetal bovine 
serum/0.02% sodium azide). Mouse samples were incubated with TruStain FcX (Biolegend) prior 
to immunostaining. Staining for surface molecules was performed for 30 to 45 min at room 
temperature in the dark. Intracellular staining was done for 60 to 90 min using the Invitrogen 
eBioscience Fixation/Permeabilization Kit (Thermo Fischer Scientific). Stained cells were 
acquired using a BD LSRII or BD Fortessa (BD Biosciences) flow cytometer and analyzed using 
52 
 
FlowJo V10 (Tree Star, Inc., Ashland, OR). Cell numbers were determined using CountBright 
Absolute Counting Beads (Thermo Fisher) Fluorescently-conjugated antibodies and reagents for 




Table 2-1. Fluorophore-conjugated antibodies used for flow cytometry of mouse samples 
 
Cell Surface Stain 
Marker Clone Fluorophore Manufacturer 
CD3ε 145-2C11 PE/Cy7 Biolegend 
CD4 GK1.5 Alexa Fluor 700 Biolegend 
CD8 53-6.7 Brilliant Violet 650 Biolegend 
CD44 IM7 APC/Cy7 Biolegend 
CD45.1 A20 Brilliant Violet 785 Biolegend 
CD45.2 104 
Brilliant Violet 421, 
PerCP/Cy5.5, FITC 
Biolegend 
CD62L MEL-14 PE Biolegend 
CD69 H1.2F3 PerCP/Cy5.5, PE/Cy7 Biolegend 
CD90.2 30-H12 Alexa Fluor 647 Biolegend 
PD-1 RMP1-30 PE Biolegend 
Intracellular stain 
Marker Clone Fluorophore Manufacturer 
IRF4 3E4 PE Thermo Fisher Sci. 
FOXP3 FJK-16s eFluor 450 Thermo Fisher Sci. 
CTLA-4 UC10-4B9 PE Biolegend 
ICOS 7E.17G9 PE Biolegend 
Cell Sorting Stain (Influenza-specific memory) 
Marker Clone Fluorophore Fluorophore 
CD4 GK1.5 Alexa Fluor 647 Biolegend 
CD8 53-6.7 Brilliant Violet 650 Biolegend 
CD45.1 A20 FITC Biolegend 
CD45.2 104 PerCP/Cy5.5 Biolegend 
TCR Vα2 B20.1 PE Thermo Fisher Sci. 




Table 2-2. Fluorophore-conjugated antibodies used for flow cytometry of human samples 
 
Cell Surface Stain 
Marker Clone Fluorophore Manufacturer 
Viability - Zombie Aqua Biolegend 
CD3ε UCHT1 BUV395 BD Biosciences 
CD4 RPA-T4 APC/Cy7 Biolegend 
CD8 SK1 BUV737 BD Biosciences 
CD45RA HI100 Brilliant Violet 605 Biolegend 
CCR7 G043H7 BV421 Biolegend 
CD69 FN50 Brilliant Violet 711 BD Biosciences 
CD103 Ber-ACT8 PE/Cy7 BD Biosciences 
Intracellular stain 
Marker Clone Fluorophore Manufacturer 




Sample preparation for confocal microscopy  
After euthanasia, the trachea of the mouse was exposed and partially severed, and the lungs 
inflated with 1ml 3% agarose (at 55 °C) using a syringe and a catheter. The trachea was clamped 
and the lung bathed in cold PBS then removed. Lungs were fixed overnight in 4% PFA. Lung 
sections (~200μm) were prepared from inflated lung lobes using a VT1000 vibrating blade 
microtome (Leica Biosystems, Nussloch, Germany). Tissue slices were first treated with PBS with 
1% rat serum then stained with fluorescein-labeled ECL lectin, PE-conjugated anti-CD4 mAb 
(clone GK1.5) and Alexa Fluor 647-conjugated anti-CD45.2 antibody. Images were acquired and 
analyzed using a LSM 700 Laser Scanning Microscope and ZEN image analysis software (Zeiss, 
Thornwood, NY). 
Human tissue acquisition 
Human lung tissues and peripheral blood were obtained from deceased (brain dead) organ 
donors at the time of organ acquisition for life-saving clinical transplantation through an 
approved protocol and material transfer agreement with LiveOnNY. Organ donors were free of 
chronic disease and cancer and were negative for HIV and hepatitis B and C. The study did not 
qualify as human subjects research, as confirmed by the Columbia University institutional 
review board because tissue samples were obtained from deceased individuals. Tissues were 
obtained and processed for single-cell suspensions, as previously described [168, 169]. 
RNA Isolation 
After sorting using a BD Influx (BD Biosciences) sorter, cells were centrifuged and 
transferred into microcentrifuge tubes for extraction of RNA. Pellets of sorted cells were 
resuspended in 700ul of QIAzol Lysis Reagent (QIAGEN) and vortexed. Lysed samples were 
homogenated in the TissueLyser LT (QIAGEN) by shaking for 5min at 50Hz. Samples were left 
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to rest for additional 5min at room temperature for complete dissociation of nucleoprotein 
complexes. Homogenized lysates were centrifuged through QIAshredder filters (QIAGEN). 100ul 
of gDNA eliminator solution was added. Samples received 140μl of chloroform followed by 
vortexing. Finally, samples were spun at 12,000 x g for 15min at 4°C. After centrifugation, the 
two phase solution contains RNA in the top transparent phase. The RNA phase was collected and 
transferred into a new microcentrifuge tube. An equivalent volume of 70% ethanol was added to 
the RNA-containg solution. The RNA/ethanol solution was transferred to an RNeasy MinElute 
spin column (QIAGEN) and washed with Buffer RWT and two rounds of Buffer RPE (QIAGEN). 
Following a final wash of the column with 80% ethanol, the RNA was eluted using RNase-Free 
water and stored at -80°C. Quality and quantity of total RNA was determined using the RNA 6000 
Pico chip run on 2100 Bioanalyzer (Agilent Technologies).  
RNA Sequencing  
Library preparation and RNA sequencing was performed by the Columbia University 
Genome Center. Total RNA samples were submitted and enriched for mRNA using a poly-A pull 
down strategy. Sequencing was performed on Illumina HiSeq 2500 (single-end 100 base-pair reads 
at a depth of 30 million) or Illumina NovaSeq 6000 (paired-end 100 base-pair reads at a depth of 
20 million). 
Differential gene expression analysis 
Reads were aligned to a reference transcriptome (mouse: GRCm38.cdna.all; human 
GRCh38.cdna.all) using kallisto v0.44.0 [233]. Downstream analysis was done using R 
programming language. Transcript counts were summarized to gene counts of protein-coding 
genes using R packages biomaRt [234] and tximport [235]. Differentially expressed genes were 
identified using DESeq2 [236]. We considered genes to be significantly differentially expressed 
57 
 
between two groups if the absolute value of log2 fold change was greater than 1 and the p value 
adjusted for multiple hypothesis testing was below 0.05. Poorly expressed genes were filtered out 
if in at least one sequencing run gene abundance was lower than 0.25 or 0.1 transcript per million 
(TPM) for mouse and human datasets, respectively. Principal component analysis (PCA) and gene 
heatmaps were generated using TPM values. PCA was performed using the prcomp function in R 
on log2-transformed TPM values. PCA plots were generated using the R package ggplot2 [237]. 
Heatmaps were generated using the R package Complex heatmaps [238] on row-scaled (Z-score) 
TPM values.     
Gene Set Enrichment Analysis  
Gene Set Enrichment Analysis [239] was performed using the R package fgsea [240]. We 
ranked genes according to the log2 fold-change values generated by two group comparisons in 
DESeq2 and looked for enrichment in T cell related gene sets in the C7 collection: Immunologic 
Signatures, and C5 collection: Gene Ontology (GO) from the Molecular Signatures Database 
(MSigDB version 6.1). Differentially expressed genes were categorized using gene lists from 
multiple sources. Transcription factors were downloaded from Animal TFDB version 3.0 [241]. 
Specific GO categories were downloaded from QuickGo [242]. Used GO categories: (1) 
Cytokines, chemokines, and their receptors: GO:0004896, GO:0004950, GO:0005125, and 
GO:0008009; (2) Biological adhesion: GO:0022610; (3) Cell surface: GO:0009986; (4) Immune 
response: GO:0006955; (5) T cell costimulation: GO:0031295.  
Analysis of CD8+TRM gene signature 
Comparison of lung CD4+TRM to CD8+TRM gene signature was done using whole 
transcriptome profiling of CD8+memory T cell subsets published in [200]. The following RNA-
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Seq samples were downloaded, aligned and differentially expressed genes between TRM and TEM 












SRR2097396 Spleen TEM LCMV 
LCMV effector memory CD8 T 
cells, spleen, rep1 
SRR2097397 Liver TEM LCMV 
LCMV effector memory CD8 T 
cells, liver, rep1 
SRR2097398 Liver TRM LCMV 
LCMV tissue-resident memory 
CD8 T cells, liver, rep1 
SRR2097399 Gut TRM LCMV 
LCMV tissue-resident memory 
CD8 T cells, gut, rep1 
SRR2097405 Spleen TEM LCMV 
LCMV effector memory CD8 T 
cells, spleen, rep2 
SRR2097406 Liver TEM LCMV 
LCMV effector memory CD8 T 
cells, liver, rep2 
SRR2097407 Liver TRM LCMV 
LCMV tissue-resident memory 
CD8 T cells, liver, rep2 
SRR2097408 Gut TRM LCMV 
LCMV tissue-resident memory 
CD8 T cells, gut, rep2 
SRR2097414 Skin TRM HSV 
HSV tissue-resident memory 
CD8 T cells, skin, rep1 
SRR2097415 Skin TRM HSV 
HSV tissue-resident memory 
CD8 T cells, skin, rep2 
SRR2097418 Spleen TEM HSV 
HSV effector memory CD8 T 
cells, spleen, rep1 
SRR2097419 Spleen TEM HSV 
HSV effector memory CD8 T 
cells, spleen, rep2 
 
(TEM – effector memory T cells, TRM – tissue-resident memory T cells, LCMV – Lymphocytic 





Generating lists of IRF4-regulated genes 
BATF/IRF4 complex ChIP-Seq data was published in [29] and gene lists are found in the 
Supplementary Table 1 of that publication (See Appendix for complete list of genes and filtering 
of the genes that underwent nomenclature updates). The additional list of IRF4-regulated genes 
was generated through whole transcriptome profiling of WT and IRF4-deficient effector CD4+T 
cells published in [243]. The following RNA-Seq samples were downloaded, aligned and 





Table 2-4. Generating lists of IRF4-regulated genes 
 
Sample Genotype Online information 
SRR5099240 IRF4 KO 11-16-15-KO_S116.1 
SRR5099241 IRF4 KO 11-6-15-KO_S114.1 
SRR5099243 IRF4 KO 12-23-15-KO_S125.1 
SRR5099242 IRF4 KO 12-11-15-KO_S120.1 
SRR5099239 IRF4 KO 10-23-15-KO_S112.1 
SRR5099244 WT 11-16-15-WT_S115.1 
SRR5099246 WT 11-6-15-WT_S113.1 
SRR5099249 WT 12-23-15-No-Dox_S123.1 
SRR5099248 WT 12-18-15-No-Dox_S121.1 
SRR5099247 WT 12-10-15-NoDox_S117.1 
SRR5099245 WT 1-12-16-No-Dox_S126.1 
 




T cell receptor repertoire analysis  
RNA-Seq fastq files were processed using default parameters in MiXCR (version 2.1) 
[244]. Analysis of TCR beta reads was performed using VDJTools (version 1.2.1) [245]. 
Clonotype matching was done using the ‘strict’ parameter which requires full match of the receptor 
nucleotide sequence (CDR3nt & V & J). The function PlotQuantileStats was used to generate the 
composition of the clonal space based on abundance of each clone in a sample (singleton = 1 copy, 
doubleton = 2 copies, high-order = 3 or more copies of a clonotype in one sample). The function 
CalcDiversityStats was used to generate the normalized clonality index (clonality = 1- normalized 
Shannon-Wiener index). The function OverlapPair was used to calculate shared clones and 
generate Jaccard overlap index measures for sample pairs. The scripts used from MiXCR and 
VDJtools can be found in the Appendix.  
Statistical tests 
Descriptive statistics for flow cytometry data, such as percent, mean, and standard error of 
the mean (SEM), were calculated using Prism (Graphpad software, San Diego, CA). R 
programming language was used to generate statistics values for gene expression analysis and 
Gene Set Enrichment. Significance between mouse experimental groups was determined by 
Student’s t test and corrected for multiple comparisons as indicated, assuming a normal 
distribution for all groups. Significance between protein expression values in human samples was 





Chapter 3 : Gene expression analysis of tissue-resident memory T cells across species 
uncovers requirement for IRF4 in T cell homing to the lung  
Introduction 
 Memory T cells maintain long-term immunity as heterogeneous populations in circulation 
and tissue sites. Circulating memory subsets were originally delineated based on lymph node 
homing receptor expression CD62L and CCR7. Effector memory (TEM, CD62L-CCR7-) and 
central memory (TCM, CD62L+CCR7+) cells migrate through lymphoid and peripheral sites, 
respectively [58]. More recently, it has been established that a significant fraction of TEM-
phenotype cells persist as non-circulating subsets of tissue-resident memory T cells (TRM) in 
multiple sites, including lungs, intestines, skin, liver, brain, and other mucosal surfaces. TRM 
mediate protection against site-specific re-infection through rapid secretion of cytokines that 
enhances activation and recruitment of adaptive and innate immune cells [69]. TRM control the 
spread of herpes simplex virus in the skin and female genital tract [159, 182], while brain TRM 
protect against local infection with Listeria monocytogenes [163]. Furthermore, TRM suppress 
tumor development in mouse models of melanoma [183], and the presence of TRM phenotype 
cells in solid tumors has been associated with improved survival rates [184, 185]. These results 
support an emerging concept of TRM as a key component of protective immunity and 
immunosurveillance. 
We previously identified a population of non-circulating lung CD4+TRM that are retained 
in specific niches within the lung tissue, and mediate optimal protection against respiratory 
infection with influenza virus compared to circulating TEM cells [145, 149]. Influenza infection 
generates both lasting antibody and T cell responses [232], however, only virus-specific T cells 
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recognize epitopes derived from conserved internal viral proteins [114, 118] and thus provide 
heterosubtypic, cross-strain protection [246]. TRM subsets have been successfully generated by 
vaccination, however, different vaccine formulations vary in their potential to generate T cell 
responses and mediate protection [151].  In addition to viral respiratory infections, lung TRM are 
able to control bacterial infections with Mycobacterium tuberculosis and Bordetella pertussis [247, 
248], highlighting the importance of development of TRM-generating vaccines. Development of 
new vaccines is hindered by the lack of understanding in the mechanisms of generation of TRM.  
 CD4+ and CD8+TRM are distinguished from circulating T cell subsets by the constitutive 
expression of the early activation marker CD69 [145, 156, 161, 166-169]. CD69 promotes tissue 
retention through interaction with the sphingosine-1 phosphate receptor (S1PR1), and thus inhibits 
S1P-mediated egress [195]. However, the functional role for CD69 in TRM maintenance remains 
unknown, with reports of CD69-independent tissue retention [157, 196].  In addition to CD69, 
CD8+TRM co-express the integrin CD103 in both mouse [163, 165, 170] and human [167, 169, 
171]. TGFbeta-induced CD103 expression promotes CD8+TRM generation and maintenance 
through interaction with E-cadherin on epithelial cells [165, 190].  However, CD103 is only 
selectively expressed on CD4+TRM [149, 167, 168] and CD103-CD4+TRM may depend on other 
adhesion molecules for retention in tissues. TRM also express CD49a, which when in complex 
with a beta1 integrin, binds collagen found in the extracellular matrix of tissues [167, 176].      
The molecular pathways of TRM generation and/or maintenance have been largely studied 
by the tracking of pathogen-specific CD8+T cells in mouse infection models. Transcriptional 
profiling of CD8+memory T cells has revealed a network of transcription factors differentially 
expressed in TRM compared to circulating subsets. Down-regulation of the transcription factor 
KLF2, and its target S1PR1, is required for tissue retention [197]. The transcription factor Hobit 
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(ZNF683 in human, or Zfp683 in mouse) was found to be specifically up-regulated in CD8+TRM 
and, together with Prdm1, to mediate the development of TRM cells in skin, gut, liver, and kidney 
in mice [200]. Furthermore, Runx3 is essential for CD8+TRM generation and maintenance in non-
barrier tissue sites, as well as in the skin, lung, and small intestine [201]. Finally, the Notch 
signaling axis which comprises of a family of surface receptors-ligand pairs and a DNA-binding 
factor Rbpj, promotes the maintenance of CD8+TRM in the mouse lung [171].  
While identifying transcription factors in mouse models provides valuable advances into 
defining the differentiation steps required for TRM generation from activated effector T cells, they 
also highlight a number of outstanding challenges. Importantly, most TRM studies fail to confirm 
whether CD4+TRM are similarly controlled by key transcription factors. Recently it was reported 
that CD4+T cells deficient in Hobit/Prdm1 generate normal cell numbers of gut TRM [193]. 
Similarly, Notch signaling-deficient CD4+T cells in the lung have lower frequencies of CD103 
expression in naïve mice [194], however no response to an infectious challenge is attempted or 
reported. The predominance of TRM studies focusing on CD8+T cells, highlights the lack of 
understanding of CD4+TRM generation and/or maintenance. Moreover, mouse models are widely 
used in studies of the immune system, however, the extent of transcriptional divergence of the 
human compared to the mouse CD4+TRM is unknown. For example, the expression of Hobit is 
not associated with human lung CD4+ or CD8+TRM, questioning the role of this transcription 
factor in generation or maintenance of human lung TRM.  
We performed transcriptional profiling of mouse influenza-specific lung CD4+TRM and 
human lung CD4+CD103+/- TRM subsets and defined a species-conserved TRM gene signature. 
We generated a list of ~450 genes highly conserved in both human and mouse TRM compared to 
circulating or spleen memory. Genes expressed in lung CD4+TRM included a number of 
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transcription factors with potential roles in maintaining tissue-residence of this cell subset. Using 
gene set enrichment analysis and publicly available ChIP-Seq data, we found high expression of a 
network of IRF4-regulated genes in lung CD4 TRM, suggesting a role for IRF4 in 
generation/maintenance of tissue-resident T cells. IRF4−/− TCR transgenic CD4+T cells 
adoptively transferred into wild type hosts infected with OVA-expressing influenza proliferated in 






Adoptive transfer model generates influenza-specific CD4+T cell memory in the lung and 
spleen 
To study the generation of virus-specific memory CD4+T cells in different tissues, we used 
CD4+T cells from transgenic mice [249] expressing an alpha- and beta-chain T cell receptor 
specific for chicken ovalbumin 323-339 (OVA) peptide in the context of I-Ab MHC (referred to 
as OT-II T cells). OT-II T cells were transferred into congenic hosts that were subsequently 
infected with recombinant PR8-OVA virus. At different time points post-infection, we examined 
the frequency of influenza-specific OT-II T cells in the lung and spleen (Figure 3-1A). During the 
acute response, at day 7 post-infection, effector OT-II T cells were extensively recruited to the 
lung and predominated among total CD4+T cells in the lung, averaging 60% (Figure 3-1B left & 
Figure 3-1C). At the same time point, OT-II CD4+T cells averaged around 20% of total splenic 
CD4+T cells (Figure 3-1B left & Figure 3-1C). In the lung, OT-II memory T cells persisted as a 
substantial proportion (average 15%) of CD4+T cells at day 28 post-infection (Figure 3-1B right 
& Figure 3-1C). At the same time point, OT-II memory CD4+T cells in the spleen comprised a 
small proportion (~1%) of total CD4+T cells after resolution of the infection (Figure 3-1B right & 
Figure 3-1C). 
 The proportion of OT-II CD4+T cells among total CD4+T cells in the lung of influenza-
infected hosts reflected a pattern of strong initial expansion (~60% at day 7), followed by a 
contraction phase (~30%, days 14-21), and establishment of a memory subset (~15% at day 28) 
(Figure 3-2C). Similarly, the kinetics of the proportion of OT-II T cells in the spleen of infected 
hosts followed the expected pattern of early proliferation (20% at day 7) with a substantial 
reduction and variable frequency in the latter stages of the infection (~1%, days 14-28). The 
68 
 
absolute numbers of OT-II T cells in the lung peaked around day 7 post-infection (~1 million cells) 
followed by a reduction over time to a few 100,000 cells (Figure 3-2C, right). In the spleen, 
absolute numbers of OT-II T cells were found in the range between 500,000 to 1 million cells at 
the acute response (day 7), but were highly variable during the resolution of the infection and 
antigen clearance (~50,000 cells at days 21-28). 
Previous imaging studies have identified a spatially distinct niche around airways in the 
lung where influenza-specific T cells are expanded and maintained long term as TRM [149].  We 
used confocal microscopy to examine the localization of lung OT-II CD4+T cells. In acutely 
infected lungs of mice that previously received naïve OT-II CD4+T cells, we stained with an 
anti-CD4 antibody (red). Additionally, an anti-CD45.2 antibody was used to differentiate the OT-II 
(yellow/orange) from the endogenous (non-OT-II) T cells (CD45.1) recruited to the infected lung. 
For visualization of lung tissue structures, we used fluorescently conjugated ECL lectin that binds 
Type I alveolar epithelial cells (as done previously, [149]). During acute infection, both OT-II and 
endogenous CD4+T cells are recruited to the space between the airways and lung parenchyma 
(Figure 3-2). Together, these results show that influenza-specific CD4+T cells generate memory 




Figure 3-1. Adoptive transfer infection model generates influenza-specific CD4+T cell 
memory in the lung and spleen 
 
(A) Schematic for the adoptive transfer model to follow the fate of influenza-specific CD4+T cells 
in vivo. Ovalbumin peptide-specific OT-II T cells (CD45.2) were transferred into B6.CD45.1 
congenic hosts, and one day later hosts were infected with recombinant PR8-OVA virus. T cell 
responses in the lung and spleen were assessed at 7-28 days post-infection. (B) Representative 
flow cytometry plots of host (CD45.1) and transferred (CD45.2) cells in the lung (top) and spleen 
(bottom) of mouse recipients of OT-II T cells at day 7 and 28 post-infection. (C) Compiled 
frequency (mean±SEM) of OT-II T cells in the lung (closed symbol) and spleen (open symbol) at 
7-28 days post-infection. Results compiled from 3-6 mice per time point. (D) Compiled absolute 
numbers (mean±SEM) of OT-II T cells in the lung (closed symbol) and spleen (open symbol) at 








Figure 3-2 Influenza-specific OT-II cells co-localize with polyclonal influenza-specific 
CD4+T cells in the lung 
 
At day 5 post-infection 200μm-thick lung slices were stained with an anti-CD4 mAb (red), anti-
CD45.2 mAb (yellow), and ECL (green). Representative images show the localization of OT-II 








Influenza-specific lung T cells exhibit features of tissue residence   
We next assessed the localization and phenotype of OT-II T cells in PR8-OVA infected 
hosts. To distinguish circulating from tissue-localized T cells, we used an intravenous in vivo 
antibody labeling technique (i.v. Ab) whereby i.v. infusion of fluorescently-conjugated anti-T cell 
antibodies results in fluorescent labeling of circulating T cells while T cells retained within tissues 
are protected from antibody binding [149, 150]. “Protected” and “labeled” T cells revealed by i.v. 
Ab, exhibit phenotypic markers of TRM and circulating T cells, respectively, and segregate into 
distinct niches of the lung [149]. Using this technique, we found that lung OT-II T cells were 
almost exclusively in the lung parenchyma throughout the course of infection, with more than 90% 
protected from the in vivo administered anti-CD90.2 fluorescent antibody (Figure 3-3A). We 
further assessed whether influenza-specific OT-II T cells generated effector (CD44+CD62L-, 
TEM) or central memory (CD44+CD62L+, TCM) subsets in the lung and spleen of infected hosts. 
Lung OT-II T cells were exclusively of the effector memory phenotype (Figure 3-2B). Spleen OT-
II T cells were predominantly of TEM phenotype, averaging 70% (Figure 2B). Finally, we assessed 
whether lung OT-II cells expressed the TRM marker CD69. The majority of OT-II T cells in the 
lung at day 28 post-infection expressed CD69 (Figure 3-3C). In contrast, influenza-specific OT-II 
T cells in the spleen were CD69-negative (Figure 3-3C).       
Overall, these results established that the adoptive transfer model generates lung OT-II 
TRM that occupy a spatially distinct niche in the lung and exhibit a CD69+CD44+CD62L- 
phenotype, whereas influenza-specific memory OT-II T cells in the spleen are CD69-CD44+ and 
predominantly CD62L-. From now on, we will refer to lung OT-II memory T cells derived from 




Figure 3-3. Influenza-specific lung T cells exhibit features of tissue residence 
 
(A) Influenza-specific memory CD4+T cells were generated using the adoptive transfer influenza 
infection mouse model described in Figure 3-1. Representative flow cytometry plots (left) and 
frequency (right, mean±SEM) of lung OT-II T cells showing staining with in vivo administered 
anti-CD90.2 antibodies at day 7 and 28 post-infection. Results compiled from 2-4 mice per time 
point. (B) Representative flow cytometry plots (left) and frequency (right, mean±SEM) of CD44 
and CD62L expression of lung and spleen OT-II T cells at day 28 post-infection. Results compiled 
from 3 mice. (C) Representative histogram (left) and frequency (right, mean±SEM) of CD69 









Transcriptional analysis of lung TRM and spleen memory CD4+T cells 
 In order to investigate the mechanisms of in situ maintenance of influenza-specific 
CD4+TRM in the lung, we sorted lung and spleen OT-II T cells between 21-28 days post influenza 
infection, RNA was extracted from sorted cells and submitted for whole transcriptome profiling 
by RNA sequencing (RNA-Seq) (Figure 3-4). After accounting for statistical significance and 
abundance thresholds (absolute value of log2 fold-change > 1, multiple hypothesis testing p 
adjusted value < 0.05, and abundance higher than 0.25 transcripts per million for each sample 
replicate), we identified 1,659 differentially expressed genes (964 up-regulated and 695 down-
regulated) in lung CD4+ TRM compared to spleen CD4+ memory cells (Table 4-1 in the Appendix).  
Although whole transcriptome profiling has become a routine tool in immunology studies, 
extracting biological insight from gene expression profiles remains a challenge [239]. To avoid 
limitations of single-gene analysis of complex cellular processes, we performed Gene Set 
Enrichment Analysis (GSEA). Unbiased pathway analysis using Gene Ontology (GO) gene sets 
(MSigDB C5) revealed enrichment of genes associated with cell adhesion, cell surface molecules, 
receptor signaling as well as signal transduction activity (Figure 3-5A).   
 To investigate signaling events and/or gene expression regulators that could promote long-
term survival of lung CD4+TRM, we analyzed differential gene expression of two groups of genes 
related to T cell function: (1) cell adhesion molecules, immune co-stimulatory molecules, 
cytokines, chemokines and their receptors (Figure 3-4B); and (2) transcription factors (Figure 
3-4C). Transcripts corresponding to interferon gamma (Ifng), transforming growth factor beta 
(Tgfb1), and colony stimulating factor 1 (Csf1) were highly up-regulated in lung CD4+TRM 
compared to spleen memory T cells. Furthermore, the receptor for interferon gamma (Ifngr1), as 
well as the CXC chemokines Cxcl10 and Cxcl16, comprise a group of type II interferon signaling 
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genes all highly up-regulated in lung CD4+TRM compared to spleen memory subsets. Moreover, 
cytokine Il15, and cytokine receptors Il21r, Il4ra, Il18r1, Il12rb2, Il1r1 and Il1rl1, were all 
specifically up-regulated in lung CD4+TRM. Chemokine receptors Cxcr4 and Cxcr6, members of 
tumor necrosis factor (TNF) superfamily Tnfsf9, Tnfsf10, and Tnfsf11, as well as TNF receptor 
superfamily members Tnfrsf9, Tnfrsf4, and Tnfrsf18, were all up-regulated in lung CD4+TRM 
compared to spleen memory T cell subsets. Moreover, we found that lung CD4+TRM up-regulated 
molecules with immunomodulatory roles (Tigit, Pdcd1, Icos, and Ctla4). Adhesion molecules with 
potential roles for tissue-retention associated with lung CD4+TRM included Itgae, Itgav, Itga1, 
and Itgb5.  
 Down-regulation of cytokine receptors and/or molecules involved in cell adhesion or 
regulation of T cell activation could also play important roles in lung CD4+TRM maintenance. We 
confirmed the down-regulation of S1pr1 in lung CD4+TRM compared to spleen memory T cells, 
as previously reported in human [167] and mouse CD8+TRM studies [195, 200]. Other lung 
CD4+TRM down-regulated receptor molecules included Il6ra, Il1rl2 and Il7r, in addition to a 
group of TNF superfamily molecules Tnfsf14, Tnfrsf13b, and Tnfrsf14, and adhesion molecule 
Itga6,  that were significantly down-regulated in lung CD4+TRM compared to spleen memory T 
cells.  
 To identify potential transcriptional regulators of the lung CD4+TRM gene expression 
profile, we analyzed genes encoding transcription factors that were differentially expressed (Figure 
3-5C). The genes differentially expressed in lung CD4+TRM compared to spleen memory T cells 
included key molecules found in previous TRM studies in mouse [163, 197, 200] and human [167, 
171, 194]. The transcription factor Klf2, associated with regulation of S1pr1 and Tcf7, was down-
regulated in lung CD4+TRM compared to spleen memory T cells. Hobit (Znf683) and Prdm1, 
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reported in CD8+TRM studies, were up-regulated in lung CD4+TRM versus spleen memory T 
cells. Consistent with previous TRM studies, Notch signaling transcriptional regulator Rbpj was 
highly up-regulated in lung CD4+TRM. Interestingly, Runx2, but not its paralog Runx3 was 
specifically significantly up-regulated in lung CD4+TRM. 
While the up-regulation of the above mentioned transcription factors confirmed the TRM 
profile of lung influenza-specific OT-II memory T cells generated in our model, we observed 
additional T cell transcriptional regulators that may play unknown functional roles in CD4+TRM 
not highlighted in previous CD8+TRM studies. Notably, lung CD4+TRM up-regulated 
transcription factors associated with TH17 cell development or function such as Arid5a, Stat3, 
Irf4, Rora and Bhlhe40. Furthermore, early growth response proteins (Egr1 and Egr3), hypoxia 
inducible factor 1 subunit alpha (Hif1a), Kruppel like factors (Klf4, Klf8, and Klf10), cAMP 
responsive element modulator (Crem), AP-1 transcription factor subunit (Fosl2), as well as Ets2, 
were all consistently up-regulated in lung CD4+TRM compared to spleen memory T cells.  
Additionally, transcription factors associated with tissue adaptation of regulatory T cells such as 
Maf, Id2, Ikzf3, and Irf4 [250] were up-regulated in lung CD4+TRM. Finally, genes encoding 
members of the MAX dimerization protein family (Mxd1, Mxd3, and Mxd4), subunits of the 
nuclear factor kappa B pathway (Nfkb1, and Nfkb2), and orphan nuclear receptors (Nr3c1, Nr4a2, 
and Nr4a3) were all up-regulated in lung CD4+TRM when compared to spleen memory T cells. In 
contrast, transcription factors down-regulated in lung CD4+TRM included Inhibitor of DNA 
Binding 3 (Id3), cell-cycle regulation associated-protein E2f2, lymphoid enhancer binding factor 




Figure 3-4. Sorting strategy for isolation of OT-II lung and spleen memory CD4+T cells 
 
Memory CD4+T cells were generated using the adoptive transfer influenza infection mouse model 
described in Figure 1. Representative gating strategy during cell sorting from lung (top) and spleen 
(bottom) of mice at day 22 post-infection. Cells were gated according to the following strategy 
(left to right): lymphocytes, single cells, live cells, CD4+, adoptively transferred (CD45.2+), and 




















Table 3-1. RNA-Seq sample information for sorting of lung and spleen OT-II memory T 
cells. 
 
Sample Tissue Sequencing strategy # mice Submitted RNA [ng] 
DF007 Spleen Paired-End 2 112.9 
DF008 Spleen Paired-End 2 168.6 
DF009 Lung Paired-End 2 101.9 
DF010 Lung Paired-End 1 69.7 
DF011 Lung Paired-End 1 61.1 
FF024 Lung Single-Read; Low Input 2 3.3 
FF025 Lung Single-Read; Low Input 2 0.68 
FF011 Spleen Single-Read; Low Input 2 0.78 






Figure 3-5 Mouse lung TRM and spleen memory CD4+T cell gene expression analysis 
 
Memory CD4+T cells were generated using the adoptive transfer influenza infection mouse 
model described in Figure 1. At 21-28 days post-infection, OT-II CD4+T cells from lung and 
spleen were sorted from CD45.1 hosts, RNA was isolated, and whole-transcriptome profiling by 
RNA-Seq was performed. Differential gene expression analysis was performed on 5 lung and 4 
spleen isolates sorted from 1-3 mice per experiment. (A) Functional annotation analysis of the lung 
CD4+TRM gene signature. Top 6 most enriched (and statistically significant, padj < 0.05) Gene 
Ontology (GO) categories are displayed for genes up-regulated in the lung subset compared to 
spleen. GO gene sets were taken from the C5 MSigDB database. (B) Heatmap of differentially 
expressed genes selected from GO categories related to cell adhesion molecules, immune co-
stimulatory molecules, cytokines, chemokines, and their receptors. (C) Heatmap of differentially 
expressed transcription factors (Row scaled, Z-Score; see methods for list of GO categories used 








Influenza-specific lung CD4+TRM share a gene signature with CD8+TRM from skin, gut 
and liver 
 The transcriptional profile of CD8+TRM has been elucidated from different infection 
models [200]. Studies of CD8+TRM have utilized tetramer reagents to sort pathogen-specific 
memory T cells from various tissues. Furthermore, CD8+TRM subsets are more easily 
differentiated from their non-resident counterparts using the expression of the CD8+TRM marker 
CD103. These two factors have opened up the way to study CD8+TRM generation and 
maintenance at the mechanistic level. In contrast, the molecular pathways of CD4+TRM generation 
remain unexplored. To identify molecular pathways specific to CD4+TRM generation and/or 
maintenance we compared the gene expression profiles of lung CD4+TRM and CD8+TRM from 
various tissues. We reanalyzed published whole transcriptome profiles of CD8+TRM 
(CD8+CD103+) from skin, gut, and liver tissue sites, and by comparing their gene expression to 
non-circulating subsets from the same tissues or control memory samples from spleen 
(CD8+CD103-) defined a CD8+ TRM gene signature (Figure 3-6A, right; Table 4-2 found in the 
Appendix). The lung CD4+TRM profile was generated (as described in Figure 3-5) by comparing 
lung influenza-specific CD4+TRM to spleen memory (Figure 3-6A, left). After determining the 
statistically significant differentially expressed genes (based on the above mentioned criteria) 
within the CD4+ and CD8+ datasets, we compared the two groups of differentially expressed genes 
for overlap and difference.     
   Analyzing the complete gene expression profile between the mouse CD4+ and CD8+TRM 
datasets revealed 201 up-regulated and 79 down-regulated genes (Figure 3-6B; Table 3-2). 
Molecules involved in regulation of T cell co-stimulation (Icos, Ctla4, Pdcd1, Tnfrsf9) were 
conserved in CD4+ and CD8+TRM cells across multiple tissue sites. Likewise, Cxcr6, was 
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universally up-regulated in CD4+ and CD8+TRM subsets as previously reported in human [167]. 
Moreover, we observe expression of chemokines Ccl3 and Ccl4 conserved across tissues, 
expanding the observations of expressions of these molecules in the brain and partially in the skin 
[163, 251]. Interestingly, the expression of cytokine receptors Il21r, Il4r, and Il12rb2 appear to be 
universally associated with TRM. The genes down-regulated in both CD4+ and CD8+TRM include 
S1pr1, encoding the sphingosine 1-phosphate receptor, lymph node-homing Cd62l (Sell). 
Additionally, the cell adhesion molecules Vcam1, Icam2, as well as the integrin Itga4 were 
universally down-regulated in both CD4+ and CD8+TRM.     
  Key genes found to be uniquely differentially expressed in lung CD4+TRM included 
Cxcr4, a receptor specific for stromal-derived-factor-1 (Sdf1 or Cxcl12) was down-regulated in 
CD8+TRM gene signatures. Cytokine receptors for Il33 (Il1rl1) and Il18 (Il18r1) were also highly 
up-regulated in lung CD4+TRM, but not in CD8+TRM. In contrast, genes specifically down-
regulated in lung CD4+TRM included cytokine receptor Il6ra and integrin Itga6 (which encodes 
Cd49f).   
 Analysis of transcription factors differentially expressed in both CD4+ and CD8+TRM 
highlighted 19 up- and 7 down-regulated genes (Figure 3-6C; Table 3-3). The components of the 
Notch signaling pathway (Rbpj) and Hobit (Zfp683), important for CD8+TRM maintenance were 
also highly expressed in lung CD4+TRM. Furthermore, the aryl hydrocarbon receptor (Ahr), as 
well as the nuclear orphan receptors Nr4a2 and Nr4a3, were consistently up-regulated in both 
TRM subsets. The interferon regulatory factor 4 (Irf4), previously reported as up-regulated in 
human CD8 TRM [167], was also highly expressed in lung CD4+TRM. In addition, transcription 
factors Klf4 and Mxd4 with unknown functions in tissue-residence of T cells were universally up-
regulated in TRM subsets. The conserved transcription factor profile of TRM included a small 
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number of consistently down-regulated transcription factors. Klf2 is required for TRM 
maintenance through down-regulation of S1pr1 [197]. In addition, transcription factors associated 
with T cell proliferation potential, Tcf7 and Lef1 were strongly down-regulated in CD4+ and 
CD8+TRM gene signatures. Interestingly, E2f2, implicated in regulating the TCR activation 
threshold of T cells, was consistently down-regulated in TRM. In addition to conserved expression 
of transcription factors, we discovered a few lung CD4+TRM-specific ones. Notably, lung 
CD4+TRM up-regulated transcription factors Stat3, Rora and Bhlhe40, all associated with Th17 T 
cell development or function [252]. In contrast, transcription factors specifically down-regulated 
in lung CD4+ TRM included Myc, Smad5, and Ikzf1. Taken together, these analyses reveal a 
common gene signature shared between CD4+ and CD8+TRM, while revealing a CD4+TRM-




Figure 3-6. Comparison of CD4+ and CD8+TRM gene expression profiling reveals common 
TRM signature of lung CD4+TRM 
 
 (A) ‘Lung CD4 TRM’ differentially expressed genes were defined as described in Figure 3-5. 
‘CD8 TRM’ differentially expressed genes were identified by comparison of CD103+CD8 subsets 
from gut, liver and skin tissues, versus CD103-CD8 subsets from spleen generated in mouse 
models of LCMV or HSV infection ([200], genes significant if |log2FC| > 1 and padj < 0.05 ). The 
‘Lung CD4 TRM’ and ‘CD8 TRM’ gene expression profiles were analyzed for shared 
differentially expressed genes. (B) Venn diagrams summarize the number of shared differentially 
up-regulated (left) and down-regulated (right) genes found in both the ‘Lung CD4 TRM’ and ‘CD8 
TRM’ signatures. The number of lung CD4 TRM-specific genes found in the ‘Lung CD4 TRM’, 
but not in the ‘CD8 TRM’ gene list are displayed in the green Venn diagrams. The number of CD8 
TRM-specific genes found in the ‘CD8 TRM’, but not in the ‘Lung CD4 TRM’ gene list are 
displayed in the black Venn diagrams. (C) Venn diagrams summarize the number of shared 
differentially up-regulated (left) and down-regulated (right) transcription factor genes found in 
both the ‘Lung CD4 TRM’ and ‘CD8 TRM’ signatures. The number of lung CD4 TRM-specific 
transcription factor genes found in the ‘Lung CD4 TRM’, but not in the ‘CD8 TRM’ gene list are 
displayed in the green Venn diagrams. The number of CD8 TRM-specific transcription factor 
genes found in the ‘CD8 TRM’, but not in the ‘Lung CD4 TRM’ gene list are displayed in the 







Table 3-2. Common TRM signature of CD4+ and CD8+T cell subsets 
 
Upregulated Downregulated 
Abcb1a Dgat1 Itpripl2 Psrc1 1700025G04Rik Pced1b 
Abcb9 Dhrs11 Jaml Ptger4 A430078G23Rik Prkcq 
Abhd15 Diaph3 Kctd12 Ptpn3 AB124611 Qprt 
Actn2 Dst Kif11 Pvrig Acp5 Rap1gap2 
Acvr2a Dusp6 Kif15 Qsox1 AI467606 Rap2b 
Adam19 Edaradd Klf4 Rbpj Arhgef18 Rasa3 
Adam8 Egr3 Lag3 Rgs1 Arl4c Rasgrp2 
Adgrg3 Ehd1 Ldlrad4 Rgs2 Arl5c Ripor2 
Ahr Elovl6 Lgals4 Rhob Atp1b3 S1pr1 
Anxa4 Ets2 Litaf Rhpn2 Aven Scml4 
Arhgap21 Fam213a Lonrf1 Rnf130 B3galt4 Sh3bp5 
Arhgef39 Fasl Lztfl1 Rnf149 B3gnt5 Sidt1 
Armc2 Fgl2 Lzts1 Rrad Baiap3 Slc17a9 
Arrdc3 Fndc3a Maf Sccpdh Bbc3 Slc9a7 
Atp6v0a1 Fndc3b Map4k5 Serpinb1a Bcl9l Spice1 
Aurkb Fosl2 Mapkapk3 Sik1 Bin2 St3gal1 
Axl Frmd4a 43532 Skil Cacna2d4 Stk38 
B4galnt4 Frmd4b Mgat4a Slc15a1 Cdc25b Tcf7 
Baiap2 Fzd5 Mki67 Slc16a10 Cmah Thtpa 
Bcl2a1b Gabarapl1 Mpzl2 Slc16a6 Cpm Tlr1 
Bcl2l11 Gadd45b Mvk Slc22a15 Dcp1b Tmem136 
Birc5 Gcnt1 Mxd4 Slc27a1 Dlg4 Tmem71 
Bpnt1 Gdpd5 Myo6 Smim3 Dnah8 Txk 
Car2 Glmn Ncapg2 Smox E2f2 Vcam1 
Ccl3 Glrx Ncf1 Styk1 Ehd3 Vmn2r84 
Ccl4 Gm45716 Ndrg1 Sult2b1 Fam117a Xrn2 
Ccnb2 Gpr171 Nek6 Susd2 Fam49a Zfhx2 
Ccrl2 Gpr34 Nek8 Swap70 Fam53b Zfp169 
Cdh1 Grb7 Neurl3 Tbc1d16 Fam69a  
Cdk1 Gsto1 Nfil3 Tex2 Fas  
Cdkn1a Gzmb Nol4l Tigit Fgf13  
Cebpb Hemk1 Nr4a2 Tmem176a Gm6904  
Cenpn Hic1 Nr4a3 Tmem176b Gm8369  
Cep170b Hilpda Odc1 Tmem97 Gpr146  
Chn2 Hist1h2bc P2ry10 Tnfrsf1b Gramd4  
Cish Hist1h2bg Padi2 Tnfrsf9 Haao  
Ckap2l Hpgds Pcyox1 Tnfsf10 Icam2  
Coro2a Hpse Pdcd1 Top2a Ifi209  
Cpd Hsd17b7 Pde4a Tpx2 Ifi214  
Cpne2 Icos Pdlim7 Traf4 Ifit2  
Crem Ifitm2 Phactr2 Ubc Itga4  
Crybg2 Ifng Phlpp1 Ube2c Kbtbd11  
Csf1 Ikzf2 Pi4k2b Vav3 Klf2  
Csrnp1 Il12rb2 Pip5k1b Vps37b Klf3  
Ctla4 Il17rd Pkig Wee1 Klhl6  
Ctnna1 Il21r Plac8 Zcchc24 Lef1  
Ctsl Il4ra Plk3 Zdhhc23 Limd2  
Cxcr6 Irak2 Ppfibp1 Zfp683 Ly6c2  
Cyp51 Irf4 Ppp1r16b  Ms4a2  
Dapk2 Itga1 Ppp1r3b  Nod1  









Shared CD4 TRM 
CD8 
TRM 
Shared CD4 TRM CD8 TRM 
Ahr Mxd3 Myc Lef1 Zfp82 Rarg 
Csrnp1 Irf5 Fosb Tcf7 Zkscan7 Rara 
Litaf Ybx3 Smad1 Zfhx2 Zfp442 Zfp658 
Nr4a3 Jazf1 Nfib Klf3 Rere Dmrta1 
Ikzf2 Gm14296 Mafk Zfp169 Arid1a Zfp760 
Nr4a2 Pbx3 Klf9 Klf2 AW146154 Runx1 
Hic1 Foxm1 Bcl6 E2f2 Myc Nfatc3 
Crem AI854703 Jun  5430403G16Rik Zfp354c 
Nfil3 Foxd2 Etv3  Hmga1 Zfp874b 
Zfp683 Nfkb1 Zfp976  Foxk1 Zeb2 
Maf Prdm1 Fos  Zfp992 Nfic 
Ets2 Sub1 Mlxipl  Smad5 Tub 
Egr3 Mxd1 Zfp991  Zfp831 Plek 
Irf4 Nr3c1 Mis18bp1  Zfp964  
Cebpb Stat3 Tgif2  Max  
Fosl2 Arid5a Egr2  Tfam  
Klf4 Tsc22d2 Tulp2  Zfp974  
Rbpj Klf10 Junb  Gm15446  
Mxd4 2210418O10Rik Srebf2  Etv3  
 Repin1 Tsc22d1  Zfpm1  
 Zbtb46 Nr4a1  Zbtb18  
 Dmrta1 Irf8  Zfp771  
 Zfp672 Casz1  Zfp946  
 Mxi1   D130040H23Rik  
 Smad7   Zbtb26  
 Creb3l2   Sp100  
 Id2   Ikzf1  
 Carhsp1   Zscan12  
 Nfkb2   Zfp512b  
 Tbx21   Zfp710  
 Rcor2   Trerf1  
 Zfp619   Zfp661  
 Zfp948   Homez  
 Ikzf3   Zfp14  
 Klf8   Zbtb7b  
 Rora   Zfp213  
 Paxbp1   Zfp3  
 Zbtb42   Zfp526  
 Bhlhe40   Patz1  
 Runx2   Zfp937  
 Zfp874b   Zfp512  
 Zeb2   Snapc4  
 Tub   Thap3  
 Plek   Zfp422  
 Hif1a   Zfp217  
 Epas1   Zfp873  
 Gabpb1   Zfp773  
 Plscr1   Zfp143  
 Parp12   Pbx2  




Transcriptional profiling of human CD4+ and CD8+TRM 
To complement the mouse lung CD4+TRM gene expression study, we wanted to generate 
a comprehensive human lung TRM dataset. In order to compare the gene signature of antigen-
specific mouse lung CD4+TRM, we had to rely on polyclonal CD69+ memory T cells from human 
lung. Our laboratory has previously indicated that CD69 expression distinguishes TRM from 
circulating memory T cell subsets in the lung and other tissue sites [167]. However, while 
CD8+TRM co-express CD103 in both human and mouse, it remains unclear whether CD103 
expression is associated with fully differentiated CD4+TRM. We therefore sorted and performed 
whole transcriptome profiling of CD69+CD103- (single-positive, SP TRM) and CD69+CD103+ 
(double-positive, DP TRM), CD4+ and CD8+T cells from human lung. To compare the lung-
resident to circulating gene expression profiles, we performed RNA-Seq of CD69-TEM subsets 
from blood of healthy donors. Generating a PCA plot revealed two aspects of the global gene 
expression profile of CD4+lung-resident and counterpart circulating memory T cell populations 
from blood (Figure 3-7A, left). First, the samples were separated based on tissue localization along 
the first principal component axis. This result shows that lung SP TRM and DP TRM subsets 
maintain an extensive lung-specific gene expression profile distinct from circulating memory T 
cells. Second, lung SP TRM and DP TRM subsets clustered together, pointing to a high similarity 
of the transcriptional profiles of all lung CD4+TRM. Likewise, we performed a similar PCA 
analysis for CD8+T cell subsets (Figure 3-7A, right). Again, lung SP TRM and DP TRM localized 
away from circulating memory subsets along the first principal component axis. In addition, within 
the lung TRM subsets, SP TRM and DP TRM clustered together, which suggested comparable 
gene expression profiles.  
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 We further compared the gene expression profiles of CD4+ to CD8+T cells in the lung. 
Scatter plots comparing lung CD4+ DP TRM versus circulating TEM on one axis, against lung 
CD8+DP TRM versus circulating TEM on the other axis, display the highly correlated gene 
expression changes in both CD4+ and CD8+DP TRM in the lung (Figure 3-7B, left). Similarly, 
scatter plots comparing lung CD4+ SP TRM versus circulating TEM on one axis, against lung 
CD8+ SP TRM versus circulating TEM on the other axis, demonstrate highly congruous SP TRM 
gene signatures in CD4+ and CD8+ T cell subsets in the lung (Figure 3-7B, right). To quantify the 
extent of shared or distinct gene signatures for the four lung TRM populations (CD4+DP TRM, 
CD4+SP TRM, CD8+DP TRM, and CD8+SP TRM) we computed the overlap and set differences 
for each group of genes differentially expressed in tissues. Specifically, each lung TRM population 
was compared to its circulating counterpart (CD4+DP TRM or CD4+SP TRM vs. CD4+blood TEM, 
CD8+DP TRM or CD8+SP TRM vs. CD8+blood TEM) to generate a list of differentially expressed 
genes (DEG) based on previously defined thresholds. Subsequently, each of the 4 DEGs were 
divided on up-regulated and down-regulated genes, and compared for overlap and set differences. 
We used UpSetR [253] to show intersections of sets and their size in a matrix-based visualization. 
Ordering the intersections/set differences between the 4 DEG groups, we observed that the highest 
number of genes is found in the intersection between all 4 subsets for both up-regulated and down-
regulated DEGs (874 shared up-regulated, Figure 3-7C, left; 790 shared down-regulated, Figure 
3-7C, right). In addition, the second-highest number of genes is found in the uniquely differentially 
expressed genes in the CD8+SP TRM subset compared to blood TEM (394 uniquely up-regulated, 
Figure 3-7C, left; 494 uniquely down-regulated, Figure 3-7C, right). Together, these results 
describe a generally conserved CD4+ and CD8+T cell tissue-adaptation transcriptional program in 
93 
 
the lung, with the CD8+SP TRM subset displaying the highest number of uniquely differentially 




Figure 3-7. Transcriptional profiling of human CD4+ and CD8+TRM 
 
(A) PCA plots of human CD4+ (left) and CD8+lung TRM and corresponding circulating memory 
subsets (right). Samples are clustered based on ~22,000 genes. Each PCA plot contains blood 
(CD69-TEM), lung SP TRM (CD69+CD103-TEM), and lung DP TRM (CD69+CD103-TEM) 
samples. CD4+plot comprises of 5 blood samples from healthy donors, and paired lung SP-DP 
TRM samples from 4 donors. CD8+plot includes 3 blood samples from healthy donors, two paired 
lung SP-DP TRM samples and one unpaired lung DP TRM sample. (B) Scatterplot displays log2 
fold-change of lung DP TRM versus blood for CD8+ subsets on the x axis, and lung DP TRM 
versus blood for CD4+subsets on the y (left). Scatterplot displays log2 fold-change of lung SP 
TRM versus blood for CD8+ TRM subsets on the x axis, and lung SP TRM versus blood for 
CD4+subsets on the y (right). Red dots denote ‘‘shared up-regulated’’ and blue dots denote 
‘‘shared down-regulated’’ genes based on following thresholds (|log2FC| > 1 and padj < 0.05). (C) 
Overlap and set-difference analysis of differentially expressed genes in CD4+ and CD8+, lung SP 
TRM and lung DP TRM samples when compared to respective circulating memory subsets (up-








Cross-species analysis of lung CD4+TRM gene expression profile  
Out laboratory has previously identified the transcriptional profile of human TRM in lung 
and other tissues sites based on CD69 expression [167]. Analysis of T cell subsets taken from 
human donors is crucial for the clinical relevance of immunology studies. However, studies of 
TRM generation or the discovery of molecular factors for long-term maintenance of TRM require 
animal models of T cell differentiation. We sought to identify regulatory pathways of lung 
CD4+TRM common to mice and humans. We focused our cross-species analysis on one-to-one 
ortholog genes found in the genome annotations of mouse and human. A principal-component 
analysis of mouse and human tissue-resident and circulating memory T cells subsets demonstrated 
a separation between samples from the different species along the first principal component 
(Figure 3-8A). However, along the second principal component axis, lymphocytes from the lung 
separated from human blood and mouse spleen OT-II memory subsets. These results show that 
mouse and human lung TRM share a transcriptional profile that is different from that of circulating 
or splenic memory T cells.    
To identify a TRM gene signature conserved across mouse and human, we compared 
differential gene expression by lung DP TRM versus blood TEM subsets sorted from human 
samples, and by lung versus spleen OT-II memory subsets from the mouse influenza infection 
model. The conserved gene expression profile included 294 genes up-regulated and 150 down-
regulated genes in lung CD4+TRM found in human and mouse (Figure 3-8B; Tables 3-4 & 3-5). 
To investigate signaling events and/or gene expression regulators that could promote long-term 
survival of lung CD4+TRM, we analyzed differential gene expression of two groups of genes 
related to T cell function: (1) cell adhesion molecules, immune co-stimulatory molecules, 
cytokines, chemokines and their receptors (Figure 3-8C); and (2) transcription factors 
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(Figure 3-8D). Transcripts corresponding to interferon gamma (IFNG), transforming growth factor 
beta (TGFB1), and the CXC chemokine CXCL16, were highly up-regulated in lung CD4+TRM 
compared to blood/spleen memory T cells. Moreover, the receptor for interferon gamma 
(IFNGR1), as well as the cytokine receptors IL21R, IL4R, IL18R1, IL12RB2, IL1R1 and IL1RL1, 
were all up-regulated in mouse and human lung CD4+ TRM. Furthermore, chemokine receptors 
CXCR4 and CXCR6, TNF superfamily member TNFSF9, as well as TNF receptor superfamily 
members TNFRSF9, and TNFRSF18, were all up-regulated in both mouse and human lung 
CD4+TRM compared to blood/spleen memory T cell subsets. As previously reported for mouse 
lung CD4+ TRM signature, we found that human lung CD4+TRM up-regulated molecules with 
immunomodulatory roles (PDCD1, ICOS, and CTLA4), and adhesion molecules with potential 
roles for tissue-retention (ITGAE, ITGAV, and ITGA1). In contrast, cytokine receptors and/or 
molecules involved in cell adhesion or regulation of T cell activation that were consistently down-
regulated in mouse and human lung CD4+TRM compared to spleen/blood memory T cells included 
S1PR1, IL6R, ITGA6, TNRFRSF13B, and TNFRSF14.  
 In order to highlight potential transcriptional regulators of the lung CD4+TRM gene 
expression profile, we focused our analysis on transcription factor encoding genes (Figure 3-8C). 
Consistent with previous TRM studies, the transcription factor KLF2 was down-regulated in lung 
CD4+TRM compared to circulating/spleen memory T cells. In addition, PRDM1, RBPJ, RUNX2, 
were up-regulated in both mouse and human lung CD4+TRM versus circulating/spleen memory T 
cells, as well as, transcription factors important for TH17 cell development or function IRF4, 
ARIF5A, STAT3, RORA and BHLHE40. Moreover, early growth response protein EGR1, 
hypoxia-induced HIF1A, Inhibitor of DNA Binding 1 and 2 (ID1 and ID2), MAF, IKZF3, CREM, 
FOSL2, and ETS2, were all consistently up-regulated in lung CD4+TRM compared to 
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circulating/spleen memory T cells.  Finally, consistent with the gene expression profile of mouse 
lung CD4+TRM, genes encoding members of the MAX dimerization protein family (MXD1 and 
MXD4), subunits of the nuclear factor kappa B pathway (NFKB1, and NFKB2), and orphan nuclear 
receptors (NR3C1, NR4A2, and NR4A3) were all up-regulated in human lung CD4+TRM up-
regulate when compared to circulating memory T cells. In contrast, transcription factors down-
regulated in lung CD4+TRM included Inhibitor of DNA Binding 3 (ID3), cell-cycle regulation 
associated-protein E2F2, lymphoid enhancer binding factor (LEF1), and the marker for 




Figure 3-8. Transcriptional profiling of mouse and human lung CD4+TRM 
 
(A) PCA plot of human and mouse TRM and circulating subsets. Samples are clustered based on 
~ 15,000 genes filtered for one-to-one orthologs between the two genomes. (B) Scatterplot displays 
log2 fold change of human lung CD69+CD103+TRM versus blood CD69-TEM samples on the x 
axis and mouse lung OT-II versus spleen OT-II samples on the y (B), with red dots denoting 
‘‘conserved upregulated’’ and blue dots denoting ‘‘conserved downregulated’’ transcripts in the 
paired mouse and human subset analysis based on following thresholds (|log2FC| > 1 and padj < 
0.05). Heatmaps of scaled TPM values of differentially expressed genes grouped into ‘Adhesion 








Table 3-4. Cross-species conserved Lung CD4+TRM gene signature (Part 1/2) 
Upregulated 
KIAA0513 CYP51A1 GPNMB LGALS3 PMEPA1 SPDYA 
KIAA0895 CYSTM1 GPR171 LMNA PPP1R16B SPRY1 
ABCB9 DAPK2 GPR34 LMNB1 PPP1R3B SPSB1 
ACOXL DENND4A GPR65 LONRF1 PPP3CA SRGAP3 
ADAM9 DNAJA4 GSN LRRK1 PQLC1 SRGN 
AGO2 DNAJB1 HIC1 LZTFL1 PRDM1 STAT3 
AGPAT4 DNAJB6 HIF1A LZTS1 PRKAR2B STX11 
ALDH7A1 DOCK5 HILPDA MAF PRNP SUCO 
ANGPTL4 DUSP14 HIP1 MAP1LC3A PRRG4 SYTL2 
ANKRD9 DUSP2 HIP1R MAPKAPK2 PTGER4 SYTL3 
ANXA1 DUSP5 HK2 MARCH3 PTPN22 TAF4B 
ANXA2 DUSP6 HOMER1 MASTL PTPRS TFRC 
APLP2 DYRK3 HSPA13 MCOLN2 PWWP2B TGM2 
ARHGEF39 EGR1 HSPA2 METRNL QSOX1 TIPARP 
ARID5A EIF2AK3 HSPH1 MGAT4A RAB8B TLE1 
ARL13B ELL2 ICAM1 MXD1 RAPH1 TMEM140 
ATP2B4 ELOVL5 ICOS MXD4 RBBP8 TMEM231 
AXL ELOVL6 ID1 MXI1 RBPJ TMEM64 
B4GALT4 EMD ID2 MYADM RELL1 TNFRSF18 
BAIAP2 EMP1 IFNG MYO1D RGCC TNFRSF9 
BAMBI EMP2 IFNGR1 NABP1 RGS1 TNFSF9 
BCL2L11 EPAS1 IFRD1 NCMAP RGS16 TRAF4 
BCL3 ERN1 IKZF3 NDRG1 RGS2 TRIP10 
BHLHE40 ERRFI1 IL12RB2 NEDD4 RHOB TSC22D2 
BIK ETS2 IL18R1 NETO2 RHOC TUBB2A 
BTG2 F2R IL1R1 NFIL3 RNF125 TUBB6 
CA2 F2RL2 IL1RL1 NFKB1 RNF130 UAP1 
CASS4 FABP5 IL21R NFKB2 RNF149 UBC 
CBLB FAM129A IL2RB NR3C1 RORA UGCG 
CCNYL1 FAM53C IL4R NR4A2 RUNX2 VAV3 
CCRL2 FAR1 INTU NR4A3 RYBP VIM 
CD44 FARP1 IQGAP1 NRARP SAMSN1 VPS37B 
CD80 FBXO34 IRAK2 NT5DC2 SERPINE2 YBX3 
CDKN1A FES IRF4 NUP98 SERTAD1 ZBTB46 
CEBPB FGFRL1 ISG20 ODC1 SESN2 ZC3HAV1 
CFAP54 FNDC3B ITGA1 OGFRL1 SH2D2A ZCCHC24 
CHST11 FOSL2 ITGAE P2RY10 SKIL ZEB2 
CHSY1 FRMD4B ITGAV PDCD1 SLC16A1 ZNF850 
CKS2 FURIN ITK PDE4B SLC16A3  
CLIC5 GABARAPL1 ITPRIPL2 PDE4D SLC39A8  
CNNM4 GABPB1 ITSN1 PDLIM7 SLC3A2  
CPD GADD45B JAZF1 PDXK SLC43A3  
CREM GAN JMY PERP SLC5A3  
CRYBG1 GCNT1 JUP PHLDA1 SLC7A5  
CSRNP1 GEM KCNK5 PHLPP1 SMAD7  
CTLA4 GFOD1 KRT7 PLAUR SMIM3  
CTNNA1 GLUL L1CAM PLIN2 SMOX  
CTNNAL1 GNA13 LAG3 PLK3 SMTN  
CXCL16 GNA15 LAMB3 PLPP2 SNX9  
CXCR4 GNG2 LAPTM4B PLXND1 SOCS1  





Table 3-5. Cross-species conserved Lung CD4+TRM gene signature (Part 2/2) 
Downregulated 
C9orf85 ID3 RIPOR2 
C1orf131 IKBKE RMND1 
ACTN1 IL16 RPA1 
ADD3 IL6R S1PR1 
C16orf54 ITGA6 SASH3 
ALKBH2 ITGB3BP SELL 
ALS2CL KAT14 SH2D3C 
ANKMY2 KLF2 SH3BP1 
ARHGEF11 KRCC1 SH3BP5 
ARV1 LBH SLFN5 
ATIC LDLRAP1 SMYD4 
BCDIN3D LEF1 ST6GAL1 
BCL7A LIMD2 STAMBPL1 
BIN2 LRRC61 STK38 
BTLA LTB STOML1 
CCDC28B METTL27 TCEANC 
CCDC69 MFSD3 TCF7 
CCM2 MGST2 TESPA1 
CD3EAP MLH3 TIRAP 
CDC25B MLLT11 TLR1 
CDPF1 MRPL58 TMC8 
CPT2 MSRB2 TMEM186 
CSK MTMR4 TMEM229B 
DCK NAPEPLD TMEM268 
DECR1 NHSL2 TMLHE 
DENND2D NRROS TNFRSF13B 
DGKA OAS2 TNFRSF14 
DGKZ OXLD1 TRAF3IP3 
DNAAF5 P2RX7 TRAF5 
DPH5 PARP3 TRAPPC1 
DYRK2 PCED1B TRIB2 
E2F2 PDE6D TRIM32 
EARS2 PDLIM2 TRIM8 
EBAG9 PITPNM2 TRUB1 
EHD3 PLCB2 TSPAN32 
EPHB6 POLI TXK 
FAM53B PPM1M UBE3D 
FAM78A PRKD2 USP28 
FARSB PTPN6 VAMP5 
FHIT PUS7L VARS2 
GGACT PYCARD VIPR1 
GIMAP6 PYM1 WASHC3 
GIMAP7 RAB37 WDR89 
GPR146 RANGRF ZBTB18 
GPR155 RASA3 ZC4H2 
GRK6 RASGRP2 ZDHHC12 
HDAC10 RCSD1 ZNF213 
HDDC2 RGL2 ZNF512 
HMGN3 RGMB ZNF2 
HSH2D RGS14  





Gene set enrichment analysis reveals potential regulatory function of TRM in tissues  
Having described a lung CD4+TRM gene signature common to mice and humans, we next 
sought to search for cross-species conserved molecular pathways of TRM generation and/or 
maintenance. In order to perform an unbiased search for pathways enriched in lung CD4+TRM, 
we utilized GSEA within a pool of ~5,000 of immunology related gene sets (MSigDB C7) to 
investigate both mouse and human CD4+TRM vs circulating memory datasets at the level of 
molecular pathways (Table 3-6). The most highly enriched pathways relevant to T cells included 
gene sets up-regulated in regulatory T cells (Treg) isolated from fat abdominal when compared to 
Tregs isolated from the lymph node or thymus (GSE7852_LN_VS_FAT_TREG_DN and 
GSE7852_THYMUS_VS_FAT_TREG_DN, respectively). Similarly enriched were gene sets 
extracted from conventional T cells isolated from the same sites 
(GSE7852_LN_VS_FAT_TCONV_DN and GSE7852_THYMUS_VS_FAT_TCONV_DN). 
Specifically, the enrichment of these gene sets highlights that lung CD4+TRM phenotype contains 
a conserved tissue-adaptation program shared with regulatory T cells as well as tissue-resident 
lymphocytes in other non-lymphoid tissues. To rule out the possibility that the Treg gene signature 
signal is not due to Foxp3+OT-II memory T cells generated during influenza infection, we 
confirmed that OT-II cells from both lung and spleen were not Tregs (Figure 3-9). These results 
indicate potential regulatory roles for CD4+TRM in tissues. To assess the expression of 
Treg-associated molecules CTLA-4, PD-1 and ICOS, by lung CD4+TRM, we phenotyped 
influenza-specific memory T cells from lung and spleen. Expression levels of CTLA-4 and PD-1 
were highly expressed on lung CD4+TRM compared to spleen memory T cells (Figure 3-9). ICOS 
expression showed a trend of up-regulation in lung CD4+TRM, however was not significantly 
different between lung and spleen influenza-memory T cells.    
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Additionally, the MSigDB C7 immunological signatures gene set collection includes 
pathways related to transcription factor activity.  We were interested to see whether a particular 
regulatory factor would be associated with the gene expression profile of lung CD4+TRM. GSEA 
analysis indicated the transcription IRF4 as a possible conserved regulator of tissue resident gene 
signature in mouse and human TRM. Interestingly, IRF4 is required for maintenance of tissue-
resident Tregs [254]. Together, these results highlighted shared tissue-adaptation and functional 
pathways of human and mouse lung CD4+TRM with regulatory T cells, and suggested a potential 




Table 3-6. Top most highly enriched gene sets in lung CD4+TRM vs circulating memory 
 
Gene set  Mouse ES Human ES 
GSE7852 Fat vs Ln Treg Up 0.55 0.34 
GSE7852 Fat vs Ln Tconv Up 0.48 0.27 
GSE37532 WT vs Pparg Ko Ln Treg Dn 0.48 0.17 
GSE7852 Fat vs Thymus Treg Up 0.43 0.33 
GSE21670 Untreated vs TgfB IL6 Treated Stat3 Ko CD4 Tcell Up 0.42 0.13 
GSE7852 Fat vs Thymus Tconv Up 0.41 0.33 
GSE14415 Induced Treg vs Foxp3 Ko Induced Treg IL2 Culture Up 0.39 0.21 
GSE40274 IRF4 Transduced vs Control Activated CD4 Tcell Up 0.39 0.32 
GSE7852 Treg vs Tconv Fat Up 0.39 0.26 
GSE7852 Treg vs Tconv Thymus Up 0.39 0.24 
 
Abbreviations: 
Mouse ES - enrichment score of a log2FC-ranked gene list generated from whole transcriptome 
analysis of mouse Lung OT-II compared to Spleen OT-II influenza-specific memory T cells 
Human ES - enrichment score of a log2FC-ranked gene list generated from whole transcriptome 







Figure 3-9. Increased expression of CTLA-4 and PD-1 on lung CD4+TRM 
 
Memory CD4+T cells were generated using the adoptive transfer influenza infection mouse model 
described in Figure 1. (A, top) Representative flow cytometry plots of Foxp3 and CD44 staining 
of host (CD45.1) and transferred (CD45.2) CD4+T cells in the lung at day 7 and 28 post-infection. 
(A, bottom) Frequency (mean±SEM) of Foxp3+ host and transferred (OT-II) cells in the lung and 
spleen at 28 days post-infection. Results compiled from two independent experiments and four 
mice. (B) Representative histogram (left) and geometric mean fluorescence intensity (gMFI) 
(right, mean±SEM) of CTLA-4 expression of lung and spleen OT-II T cells at day 28 post-
infection. Results compiled from two independent experiments and four mice. (C) Representative 
histogram (left) and gMFI (right, mean±SEM) of ICOS expression of lung and spleen OT-II T 
cells, and naïve (CD44-) host CD4+T cells at day 28 post-infection. Results compiled from two 
independent experiments and four mice. (D) Representative histogram (left) and gMFI (right, 
mean±SEM) of PD-1 expression of lung and spleen OT-II T cells, and naïve (CD44-) host CD4+T 
cells at day 28 post-infection. Results compiled from two independent experiments and three-four 
mice. Significance was determined by two-tailed Student’s t test with Welch’s correction; ns, P > 







IRF4-regulated genes are enriched in the human and mouse conserved lung CD4+TRM 
profile  
 Unsupervised molecular pathway analysis indicated a potential role for the transcription 
factor IRF4 in organization of the lung CD4+TRM gene signature in mice and humans. We 
hypothesized that IRF4 regulates the expression of genes specifically regulated in lung CD4+TRM 
by directly binding to their genomic loci. Transcription factor IRF4 has been extensively studied 
in multiple cell types of the immune system [255], with several chromatin immunoprecipitation-
coupled with massively parallel sequencing (ChIP–Seq) analyses mapping the genomic occupancy 
of IRF4 and its cofactors during T cell activation differentiation. We utilized previously reported 
ChIP-Seq data of the genomic occupancy by the BATF/IRF4 complex during in vitro activation 
of Th2 CD4+T cells to generated a list of T cell receptor induced genes bound and controlled by 
this transcription factor complex ([29], gene list from now on referred to as ‘IRF4-BATF’, Tables 
4-3 & 4-4 ). Moreover, we integrated an additional study wherein IRF4-deficiency was tested in 
an in vivo immunization model [243]. Specifically, we utilized published whole transcriptome 
profiles of IRF4-deficient and wild type CD4+effector T cells to construct a list of IRF4-dependent 
genes during T cell differentiation (gene list from now on referred to as ‘IRF4 KO’, Tables 4-4 & 
4-5). We sought to investigate how many genes from the conserved human and mouse lung 
CD4+TRM conserved gene expression profile (294 genes up-regulated and 150 down-regulated 
genes) were directly or indirectly regulated by IRF4 (Figure 3-10). A hypergeometric gene overlap 
test (see Methods and Materials Chapter) showed statistically significant enrichment for both the 
IRF4-BATF (p = 1.13 x 10-15) and IRF4 KO (p = 8.1 x 10-26) gene sets in the 444 gene conserved 
TRM signature. In the group of 94 putatively IRF4-regulated genes we found other key 
transcription factors, as well as functional molecules, adhesion molecules and cytokine receptors. 
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Transcription factors found to be possibly regulated by IRF4 included PRDM1, RBPJ, RORA, 
BHLHE40, HIF1A, IKZF3, EPAS1, and MAF. Moreover, IRF4 potentially regulates transcription 
factors TCF1 and ID3 found to be down-regulated in the lung CD4+TRM gene expression profile. 
Adhesion molecules CD44, L-selectin (SELL), ICAM1, and ITGA6 were among the putative 
IRF4-regulated targets. In addition, IRF4 also potentially regulated immunomodulatory molecules 
CTLA4, ICOS, TNFSF9. Finally, we discovered potential signaling pathways involved in TRM 
maintenance, with IRF4 regulating the expression of cytokine receptors IL4R, IL12RB2, IL18R1 
and IL6R.  
We confirmed the constitutive high expression of IRF4 protein in human and mouse lung 
CD4+TRM compared to circulating/spleen memory T cells, suggesting an important role for IRF4 
in TRM maintenance (Figure 3-11). Together, these results describe an IRF4-regulated gene 
expression network that may control the expression of other transcription factors, adhesion and 
immunomodulatory molecules, as well as cytokine receptors in the maintenance of human and 




Figure 3-10. IRF4-dependent gene network contributes to a cross-species conserved 
CD4+TRM transcriptional signature 
Heatmap shows normalized TPM values of differentially expressed genes conserved across human 
and mouse lung CD4+TRM. Barcode plots on the right side of the heatmap display the overlapping 
genes between the species conserved lung CD4+TRM gene signature with ‘IRF4-BATF’ (black 








Figure 3-11. Constitutive expression of IRF4 protein in human and mouse lung CD4+TRM 
 
Memory CD4+ T cells were generated using the adoptive transfer influenza infection mouse model 
described in Figure 1. (A) Representative histogram (left) and gMFI (right, mean±SEM) of IRF4 
expression of lung and spleen OT-II CD4+ T cells at day 28 post-infection. Results compiled from 
two independent experiments and four mice. (B) Representative histogram (left) and gMFI (right, 
mean±SEM) of IRF4 expression of polyclonal lung circulating (‘L Circ.’ CD90.2 i.v. labeling 
positive), polyclonal lung resident (‘L Res.’ CD90.2 i.v. labeling negative) and spleen CD4+ T 
cells at day 28 post-infection. Results compiled from two independent experiments and four mice. 
(C) Representative histogram (left) and gMFI (right, mean±SEM) of IRF4 expression of human 
lung CD69+CD103+TRM and blood CD69-CD103-TEM subsets. Results compiled from paired 








IRF4 is required for the recruitment of OT-II effector CD4+T cells to the lung during 
influenza infection   
 
Having identified IRF4 as a conserved potential regulator in mouse and human TRM, it 
was important to determine its role in TRM development and/or maintenance in vivo. We therefore 
obtained IRF4−/− mice crossed to OT-II TCR transgenic mice to directly analyze in vivo responses 
of CD4+T cells specific to influenza virus.  At different time points post-infection, we examined 
the frequency of influenza-specific IRF4−/− and WT OT-II T cells in the lung, lung-draining 
(mediastinal) lymph node and spleen (Figure 3-12). During the acute response, at day 7 post-
infection, effector IRF4−/− OT-II T cells were almost completely absent from the lung, averaging 
less than 1% of total lung CD4+T cells in the lung (Figure 3-12A, left). In contrast, WT OT-II 
CD4+T cells averaged around 25% of lung CD4+T cells at day 7 post-infection (Figure 3-13B). 
This dramatic difference in frequency reflected an average 57-fold decrease in absolute numbers 
of WT to IRF4−/− OT-II T cells in the lung at day 7 post-infection. Interestingly, the viral infection 
generated IRF4−/− OT-II T cells in the lymph node and spleen of infected hosts. IRF4−/− OT-II 
T cells comprised in average 3% of lymph node CD4+T cells compared to 8% WT OT-II T cells at 
the same time point. IRF4-deficient OT-II T cells averaged 1.5% of total CD4+T cells in the spleen, 
compared to 3% of WT OT-II T cells. In terms of absolute cell counts, we observed a 3-fold 
decrease of wild type to IRF4-deficient OT-II T cells in the lymph node, with no statistically 
significant change in absolute numbers in the spleen at day 7 post-infection. A grossly similar 
distribution trend was observed for IRF4-deficient OT-II T cells throughout the acute response. 
Again, we observed in average less than 1% IRF4−/− OT-II T cells of total CD4+T cells in the 
lung at days 10-14 post-infection, compared to 20 to 40% of WT OT-IIs at the same time points 
(Figure 3-12B). In the lymph node, at days 10-14 post infection we did not observe a difference in 
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absolute cell counts between the wild type and IRF4−/− genotypes. Similarly, the frequency and 
absolute count of IRF4−/− OT-II T cells in the spleen at day 10 and 14 post-infection were 
comparable to WT OT-II T cells. Overall, these results describe a dramatic reduction in frequency 
and absolute count of IRF4−/− OT-II T cells that localize in the lung compared to WT OT-II cells. 
In addition, at the secondary lymphoid organs lymph node and spleen, we observed a mild 
reduction in the proportion of CD4+T cells and absolute numbers of IRF4−/− compared to WT OT-
II T cells.   
We continued to follow the localization of IRF4−/− and WT OT-II T cells during the 
resolution of influenza infection. At days 21-28 post-infection, IRF4−/− OT-II T cells were again 
almost completely absent from the lung, averaging less than 0.1% of total lung CD4+T cells in the 
lung. In contrast, WT OT-II T cells consistently persisted in frequency of more than 20% of total 
CD4+T cells in the lung at the same time points. The establishment of long-lived memory IRF4−/− 
OT-II T cells was similarly diminished in the lymph node and the spleen. While WT OT-II T cells 
maintained a population of 3% (several 10,000 cells) of CD4+T cells in the lymph node, IRF4−/− 
were largely absent beyond day 21 post infection. Similarly, WT OT-II T cells maintained a 
population of 1.5% (several 100,000 cells) of CD4+T cells in the spleen, however IRF4−/− were 
largely absent beyond day 21 post infection. These results suggests that IRF4 is required for lung 
homing of effector OT-II T cells during the first two weeks of influenza infection. At later time 
points (days 21-28), IRF4 is additionally required for generating memory OT-II T cells in the 




Figure 3-12. The role of IRF4 in vivo using IRF4−/− OT-II CD4+T cells in the adoptive 
transfer model with PR8-OVA infection. 
WT or IRF4-deficient ovalbumin peptide-specific OT-II CD4+T cells (CD45.2+) were transferred 
into B6.CD45.1 congenic hosts, and one day later hosts were infected with recombinant PR8-OVA 
virus. T cell responses in the lung and spleen were assessed at 7-28 days post-infection. (A) 
Representative flow cytometry plots of host (CD45.1) and transferred (CD45.2) cells in the lung, 
lung-draining lymph node, and spleen of mouse recipients of WT or IRF4 KO OT-II CD4+T cells 
at day 7 and 14 post-infection. (B) Frequency (top) and absolute numbers (mean±SEM) of OT-II 
cells in the lung, lung-draining lymph node, and spleen at 7-28 days post-infection. Results 
compiled from at least two independent experiments and three-seven mice per time point. 
Significance was determined by two-tailed Student’s t test with Welch’s correction; ns, P > 0.05; 







IRF4-deficient effector T cells exhibited reduced CD44 expression and maintained high 
levels of CD62L 
 In order to understand the defect in homing to the lung during influenza infection, we 
phenotyped IRF4−/− OT-II T cells for expression of CD44 and CD62L. WT OT-II T cells were 
almost exclusively CD44high and CD62L- in the lymph node at day 7 post infection (Figure 
3-13A). In contrast, IRF4−/− OT-II T cells failed to fully express CD44, and maintained high 
levels of CD62L compared to wild type. This result indicated a defect in IRF4-deficient OT-II T 
cells to differentiate into bona fide effectors. Furthermore, we sought to describe the expression of 
CD69 in IRF4−/− OT-II T cells. It remains unclear what signal regulates the constitutive 
expression of CD69 in TRM, and we hypothesized that it involves IRF4. During activation in the 
lung-draining lymph node, IRF4−/− OT-II T cells were able to up-regulate CD69 (Figure 3-13B, 
bottom). However, at the same time point (day 7) and later during the infection (day 14), the small 
number of IRF4−/− OT-II T cells that were found in the lung resident niche failed to up-regulate 
the tissue-residence marker CD69 (Figure 3-13B, top). This result suggests that IRF4 is required 





Figure 3-13. Expression of CD44, CD62L and CD69 on IRF4-deficient OT-II T cells 
 
(A) Representative flow cytometry plots of IRF4-deficient (red), WT (black) OT-II T cells or 
endogenous naïve T cells (grey) showing expression of CD44 and CD62L at day 7 post-infection 
in the lymph node (B) Representative histograms of CD69 expression on IRF4-deficient (red) or 
WT (black) OT-II T cells in the lung resident niche (top) and lymph node (bottom) at day 7 and 
14 post-infection. Results compiled from at least two independent experiments and four-seven 
mice per genotype. Significance was determined by two-tailed Student’s t test with Welch’s 











Defining mechanisms underlying lung CD4+TRM generation and/or maintenance is 
important due to their critical role in mediating protective responses to respiratory pathogens [145, 
247]. We used systems immunology approaches combined with genetic analyses to define 
transcription factors and pathways up-regulated in lung CD4+TRM in mice and humans. We 
uncovered substantial up-regulation of IRF4, and an IRF4-regulated gene network in lung 
CD4+TRM compared to spleen or peripheral blood memory T cells. Through investigation of 
IRF4−/− CD4+T cells, we identified a critical role for IRF4 in differentiation and development of 
persisting lung-tropic effector CD4+T cells during influenza infection. 
Transcription profiling of lung-resident and spleen influenza-specific CD4+T cells revealed 
an extensive lung-specific gene expression profile. Our analysis confirms CD4+TRM as a distinct 
memory T cell lineage with active molecular pathways during steady-state maintenance not found 
in memory subsets isolated from lymphoid sites. Through comparative analysis with published 
CD8+TRM transcriptional studies, we define a common gene signature shared between CD4+ and 
CD8+TRM, while revealing a CD4+TRM-specific expression profile that is enriched for 
immunosuppressive features found in regulatory T cells. We further investigated the 
generalizability of TRM biology discovered in mouse models by characterizing the heterogeneous 
populations of CD4+TRM in the human lung. The cross-species analysis describes a generally 
conserved tissue-adaptation transcriptional program of CD103+ and CD103-CD4+TRM in the 
human lung, with a conserved CD4+TRM signature found in both humans and mice consisting of 
444 differentially expressed one-to-one orthologous genes.  
Through an unbiased pathway analysis in the lung CD4+TRM gene signature common to 
mice and humans, we identified the transcription factor IRF4 as a potential key regulatory node in 
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a network of IRF4-regulated genes including PRDM1, RBPJ, IL12RB2, and IL-4R. Our findings 
suggested an IRF4-dependent signaling network contributing to tissue-retention or survival of lung 
CD4+TRM in vivo.  
Using loss-of-function genetic experiments, we demonstrated a novel requirement for IRF4 
in CD4+T cell differentiation and generation of lung CD4+TRM following influenza infection in 
vivo. IRF4−/− OT-II T cells were almost completely absent from the lung during the first two 
weeks of influenza infection, while at the secondary lymphoid organs lymph node and spleen, we 
observed a mild reduction in the proportion and abundance of IRF4-deficient effector T cells 
compared to wild type. In addition, during active infection IRF4−/− OT-II T failed to fully express 
CD44, and maintained high levels of CD62L compared to wild type, indicating a requirement for 
IRF4 in the generation of effector T cells with potential to take residence in the lung niche.  
In addition to promoting generation of new influenza-specific lung CD4+TRM, our 
findings suggest an active role for IRF4 during maintenance of already established TRM. It 
remains to be investigated what lung-specific factor contributes to the high expression of IRF4 in 
the absence of acute infection. We propose that, in the lung and mucosal sites continually exposed 
to environmental stimuli, low levels of cytokines such as IL-4, IL-12, and/or IL-33 contribute to 
the survival of TRM in an IRF4-dependent manner.  
Together, our combined bioinformatic and in vivo analysis contributes to an enhanced 
understanding of the transcriptional regulation of CD4+TRM generation in humans and mice. Lung 
CD4+TRM displayed a unique transcriptional profile distinct from memory T cells in lymphoid 
and peripheral sites, including up-regulation of a gene network induced by the transcription factor 
IRF4. The IRF4-regulated gene network in CD4+TRM provides new targets for the manipulation 
of lung immune responses. 
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Chapter 4 : Conclusions 
Although tissue-resident memory T cells possess unique protective capacities, there is a 
lack of mechanistic understanding of the factors that contribute to the generation of this memory 
subset in response to infection or vaccination. Infection models in mice have served to define 
several transcription factors required for generating TRM in mice, however the transcriptional 
divergence between humans and mouse models is often ignored. Despite the differences in TRM 
populations between humans and mice due to different histories of pathogen exposure and genetic 
variance, mouse models are, and will be, widely used in mechanistic studies of the adaptive 
immune system. The work presented here investigates the nature of TRM establishment following 
influenza infection in mice, with an emphasis on comparative analysis with human TRM in order 
to evaluate the translational potential of any mechanistic findings.  
 Using an adoptive transfer mouse model, we were able to generate and characterize 
influenza-specific memory OT-II T cells isolated from the lung and spleen of infected hosts. Our 
results indicate how influenza infection generates two subsets of T cell memory with substantially 
different transcriptional profiles. Lung OT-II T cells up-regulated key molecules found in previous 
TRM studies in mice, including Hobit, Prdm1, and Rbpj, while genes known to be down-regulated 
in TRM compared circulating populations such as Klf2, S1pr1, and Tcf1 were suppressed. 
Although previous work has demonstrated a unique gene expression profile of CD8+TRM, our 
study is the first to report a detailed transcriptional profiling of lung CD4+TRM. In addition to 
demonstrating a partially shared gene expression profile between CD4+ and CD8+TRM, we 
identify novel gene networks associated with tissue-residence of CD4+T cells. Notably, lung 
CD4+TRM up-regulated transcription factors associated with Th17 cell development or function 
such as Arid5a, Stat3, Irf4, Rora and Bhlhe40. Additionally, transcription factors associated with 
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tissue adaptation of regulatory T cells such as Maf, Id2, Ikzf3, and Irf4 were up-regulated in lung 
CD4+TRM. Further investigations of the similarities and differences between CD4+TRM and 
tissue-resident regulatory T cells will be necessary to identify potential avenues to manipulate the 
balance of the two subsets in tissues. However, our study highlights a novel paradigm that 
CD4+TRM and Tregs should be regarded as transcriptionally, phenotypically, and potentially 
functionally more similar than previously considered.  
We further investigated the potential of the newly reported CD4+TRM gene signature to 
be incorporated into the understanding of human TRM biology. Namely, we sorted and performed 
whole transcriptome profiling of CD69+CD103- (single positive, SP TRM) and CD69+CD103+ 
(double positive, DP TRM), CD4+ and CD8+T cells from human lung. Comparing the 
transcriptional profile of mouse and human lung memory T cell subsets, we defined a lung 
CD4+TRM gene signature common to both species. We were able to define a conserved gene 
expression profile consisting of 294 up-regulated and 150 down-regulated genes in lung 
CD4+TRM found in human and mouse. Focusing on cross-species conserved regulatory programs 
in the study of T cell subsets is crucial in guiding the use of mouse models towards investigations 
of molecular targets with translational potential.    
 Having described a lung CD4+TRM gene signature common to mice and humans, we next 
sought to search for cross-species conserved molecular pathways of TRM generation and/or 
maintenance. Using unsupervised Gene Set Enrichment Analysis, we found high expression of a 
network of IRF4-regulated genes in human and mouse lung CD4+TRM. IRF4 is rapidly up-
regulated upon T cell activation, and binds DNA to drive the expression of key genes during T cell 
activation and early effector differentiation [31, 32]. Despite reports of possible roles for IRF4 in 
TRM generation and/or maintenance [162, 166, 170, 193, 200, 224, 225], the effect of this 
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molecule on CD4+T cell differentiation into tissue-resident effector T cells has not been described 
in vivo. Given the abundance of ChIP-Seq studies involving IRF4 (and its binding partners BATF 
and JunB) we integrated publicly available next-generation sequencing data to define genes whose 
genomic loci are directly bound and regulated by this transcription factor. Specifically, our 
bioinformatics analysis predicted IRF4 binding and regulating important TRM genes, including 
PRDM1, RBPJ, RORA, BHLHE40, HIF1A, IKZF3, EPAS1, and MAF. Moreover, IRF4 potentially 
regulates transcription factors TCF1 and ID3 found to be down-regulated in the lung CD4+TRM 
gene expression profile. With these results, we proposed a model of transcriptional regulation of 
CD4+TRM wherein IRF4 plays a key role in maintenance of this particular T cell lineage in vivo.     
Having identified IRF4 as a conserved potential regulator in mouse and human TRM, we 
demonstrated a requirement for IRF4 in the generation of CD4+TRM in response to influenza 
infection in vivo. Specifically, IRF4 is required for the generation of lung homing effector OT-II 
CD4+T cells during the first two weeks of influenza infection. In contrast, at the site of activation 
(lymph node) and peripheral secondary lymphoid organs (spleen), IRF4-deficient effector T cells 
were able to proliferate in rates comparable to wild type T cells during the first two weeks of 
infection. Interestingly, at later time points post-infection (days 21-28), IRF4 is additionally 
required for the survival of memory OT-II T cells in the lymph node and the spleen. Furthermore, 
activated IRF4−/− OT-II T cells failed to fully express CD44, and maintained high levels of 
CD62L compared to wild type during influenza infection, suggesting a defect in complete 
differentiation into lung-tropic effector T cells. Further investigations will be required to categorize 
which IRF4-regulated genes are required for effector T cell differentiation in general, and which 
are particularly required for homing to the lung.  
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In addition to the role for IRF4 in the generation of lung CD4+TRM we hypothesize an 
important role for IRF4 in maintenance of already established TRM. We discovered that lung 
CD4+TRM in human and mouse constitutively expressed higher levels of IRF4 protein compared 
to circulating/lymphoid memory T cell populations. In the absence of acute infection and strong 
TCR signaling, it remains to be investigated what factors leads to the up-regulation of IRF4. The 
above bioinformatics analysis suggested potential signaling pathways involved in TRM 
maintenance, with IRF4 regulating the expression of cytokine receptors IL4R, IL12RB2, IL18R1 
and IL6R. Further experiments wherein the level of IRF4 expression is measured upon stimulation 
of lung CD4+TRM with cytokines such as IL-4 could reveal further avenues of modulation of TRM 
in tissues. Moreover, given the crucial role for IRF4 in effector T cell differentiation, it would be 
interesting to investigate a loss-of-function experiment wherein IRF4 is depleted in established 
TRM cells.     
Overall, our findings confirm lung CD4+TRM as a unique memory T cell subset regulated 
by tissue-specific transcription factors. Furthermore, by comparing whole transcriptome profiling 
of mouse and human lung memory T cell subsets, we provide a lung CD4+TRM gene signature 
common to both species. Together, these results map out the role of IRF4 in the generation of lung 
CD4+TRM and motivate future genetic studies that could lead to the complete identification of the 
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Figure 4-1. R script for gene expression analysis of lung TRM and spleen memory CD4+T 






#copy all kallisto output files to a sub-folder called 'kallisto' 
#retrieve sample names 
sample_id <- dir("/folder/with/input/files/kallisto/") 
#generate file paths to samples 
kal_dirs <- file.path(".", "kallisto", sample_id) 
#generate file paths to abundance files 
files <- file.path(".", "kallisto", sample_id, "abundance.h5" ) 
#name the file paths with the sample names 
names(files) <- sample_id 
#generate dictionary for aggregating transcript counts to gene counts 
library(biomaRt) 
mart <- useMart(biomart = "ENSEMBL_MART_ENSEMBL", 
                         dataset = "mmusculus_gene_ensembl", 
                         host = 'ensembl.org') 
#filter transcripts/genes for protein-coding 
transcript2gene <- getBM(attributes=c("ensembl_transcript_id",  
                                      "external_gene_name"), mart=mart,  
                         filters='biotype', values=c('protein_coding')) 
 
#order dictionary 
transcript2gene <- transcript2gene[order(transcript2gene$external_gene_name), ] 
 
library(tximport) 
#prep kallisto abundance for DESeq2, counts are generated from length-scaled TPMs 
txi_gene_length <- tximport(files, type = "kallisto", tx2gene = transcript2gene, 
                            ignoreTxVersion = TRUE, countsFromAbundance="lengthScaledTPM") 
#two variables for the DESeq2 comparion: tissue and batch  
tissue <- factor(c(rep("Lung", 5), rep("Spleen", 4))) 
 
batch <- factor(c(rep("One", 2), rep("Two", 3), 
                  rep("One", 2),rep("Two", 2))) 
 
#merge into coldata 
(coldata <- data.frame(row.names = colnames(txi_gene_length$counts), batch, tissue)) 
##       batch tissue 
## ml1b1   One   Lung 
## ml2b1   One   Lung 
## ml3b2   Two   Lung 
## ml4b2   Two   Lung 
## ml5b2   Two   Lung 
## ms1b1   One Spleen 
## ms2b1   One Spleen 
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## ms3b2   Two Spleen 
## ms4b2   Two Spleen 
#comparions should highilght tissue differences while correcting for batch 
dds <- DESeqDataSetFromTximport(txi_gene_length, colData=coldata,  
                                design=~batch + tissue) 
## using just counts from tximport 
#upregulation should describe genes high in lung compared to spleen 
dds$tissue <- relevel(dds$tissue, "Spleen") 
#run DESeq2 
dds <- DESeq(dds) 
#generate results 
res <- results(dds) 
#write untouched output file  
write.csv(res, file="output-mouse-DESeq2.csv") 
#generate output file that contains columns of TPMs  




mouse_sig <- subset(mouse_complete, padj < 0.05)  
 
mouse_sig <- subset(mouse_sig, log2FoldChange > 1 | log2FoldChange < -1) 
 
mouse_sig <- mouse_sig[complete.cases(mouse_sig),] 
 
#filter by TPM > 0.25 
 
mouse_sig_TPM <- subset(mouse_sig, select = c(ml1b1,ml2b1,ml3b2,ml4b2,ml5b2, 
                                              ms1b1,ms2b1,ms3b2,ms4b2)) 
mouse_sig_TPM_above_0_25 = apply(mouse_sig_TPM, 1, function(row) all(row > 0.25 )) 
 
mouse_sig <- mouse_sig[mouse_sig_TPM_above_0_25,] 
 
#order significant gene list 






Table 4-1 Gene expression analysis of lung TRM and spleen memory CD4+T cells in the 
adoptive transfer mouse model of influenza infection – all differentially expressed genes. 
(Positive log2FoldChange describes up-regulation in expression of a gene in the lung compared to 
the spleen) 
gene log2FC padj gene log2FC padj gene log2FC padj 
Ccr8 7.80 8.21E-153 AA467197 4.46 7.89E-73 Cish 3.75 9.57E-37 
Cdh1 7.05 7.16E-217 Kctd12 4.42 1.18E-47 Rgs1 3.74 2.20E-07 
Fgl2 6.52 2.11E-42 Pygl 4.42 3.91E-84 Ndrg1 3.73 1.13E-73 
Pmepa1 6.03 2.64E-220 Plac8 4.38 4.89E-82 Nek6 3.72 2.00E-67 
Pde4a 5.94 1.25E-100 Spsb1 4.36 9.26E-94 Socs2 3.71 5.29E-59 
Crem 5.77 1.70E-22 Lamc1 4.27 2.67E-16 Atf3 3.71 7.80E-05 
Litaf 5.77 0 Cdkn1a 4.27 7.79E-10 Tnfrsf1b 3.70 1.97E-111 
Fosl2 5.48 1.03E-15 Serpinb1a 4.27 9.49E-11 Rgs2 3.69 8.16E-09 
Tnfrsf9 5.46 3.90E-77 Gm49339 4.24 1.48E-54 Selenon 3.68 2.93E-40 
Rgs16 5.28 5.91E-57 Il2ra 4.18 3.70E-52 Dyrk3 3.67 3.80E-18 
Metrnl 5.27 8.68E-115 Grb7 4.17 5.04E-12 Klrc1 3.64 2.10E-29 
Pdcd1 5.26 3.67E-90 Ly6g5b 4.17 6.76E-56 Tnfsf11 3.64 8.97E-32 
Il12rb2 5.12 1.67E-58 Cpd 4.13 2.15E-82 Ifitm2 3.63 4.57E-44 
Lgals7 5.11 6.07E-38 Lgals3 4.10 6.16E-42 Dusp14 3.62 3.88E-26 
Galnt3 5.09 1.26E-47 Dapk2 4.09 2.11E-38 4932438H23Rik 3.61 6.12E-14 
Lmna 5.08 5.60E-53 Gzmc 4.08 7.22E-19 Ern1 3.58 1.50E-85 
Ppp1r3b 5.05 4.17E-90 Ctla2b 4.08 1.27E-15 Slc16a6 3.56 7.32E-45 
Ncmap 5.02 1.94E-47 Sv2c 4.03 2.07E-54 Tppp3 3.55 1.15E-09 
Dgat1 4.98 8.69E-51 Itga1 4.01 1.86E-78 Trim36 3.53 1.60E-24 
Csf1 4.95 1.38E-105 Smim3 4.01 3.61E-12 Xcr1 3.52 8.87E-21 
Rhoq 4.93 9.30E-104 Dennd4a 4.00 1.62E-08 Bub1b 3.51 8.59E-15 
Adgrg3 4.89 1.14E-115 Adam8 3.97 7.18E-68 Fam20a 3.50 1.14E-25 
Jdp2 4.87 3.64E-144 Ccr5 3.95 5.07E-192 Slc15a3 3.47 3.02E-16 
Xcl1 4.87 4.13E-32 Pik3ap1 3.93 3.58E-43 Tnfrsf4 3.45 2.20E-23 
Ccl4 4.77 1.35E-12 Plet1 3.92 1.69E-13 Skil 3.44 6.89E-12 
Fhl2 4.75 4.69E-88 Gpr34 3.89 5.31E-43 Gzmb 3.44 4.62E-31 
Osgin1 4.73 1.86E-50 Srxn1 3.87 9.70E-50 Hpgds 3.44 3.82E-22 
Ctla2a 4.66 1.79E-61 Ctla4 3.86 9.00E-09 Mxi1 3.42 7.55E-107 
Samd11 4.63 4.17E-52 Snx9 3.83 2.78E-43 Ccl3 3.41 3.28E-10 
Ell2 4.63 2.62E-222 Nabp1 3.82 1.09E-101 Neurl3 3.41 1.59E-29 
Perp 4.62 1.03E-65 Cxcr6 3.82 1.03E-44 Anxa1 3.36 4.50E-32 
Hilpda 4.59 6.75E-116 Csrp2 3.77 3.20E-11 Tex2 3.29 1.31E-80 
Itsn1 4.50 6.48E-74 Pvrig 3.77 7.07E-24 CR936839.1 3.29 4.44E-39 
Apol9b 4.50 1.70E-46 Gstm1 3.76 3.65E-08 Isy1 3.29 8.24E-71 
Itgae 4.48 4.64E-10 Nr4a2 3.76 9.80E-05 Dennd5a 3.29 1.18E-45 
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gene log2FC padj gene log2FC padj gene log2FC padj 
Chrne 3.28 2.08E-21 Ctsw 3.02 1.22E-48 Hist1h2bc 2.73 6.96E-15 
Styk1 3.28 4.88E-23 Nr4a3 3.00 0.001658 Kif11 2.72 3.26E-17 
Gm10197 3.27 1.03E-12 Nmrk1 2.99 3.15E-34 Odc1 2.72 1.35E-05 
Cass4 3.26 3.14E-34 Hip1 2.98 6.21E-56 Il1rl1 2.71 2.60E-15 
Fam110a 3.24 1.37E-69 Selenom 2.98 1.19E-13 C1qtnf12 2.71 1.68E-08 
Gm8897 3.23 1.69E-07 Eif4e3 2.97 8.53E-55 Fam129b 2.69 2.11E-12 
Lilrb4a 3.22 6.14E-22 Ccnb2 2.97 1.76E-05 Phlda1 2.69 2.65E-21 
Chst11 3.21 5.83E-69 Emp2 2.97 5.37E-07 Mapkapk3 2.68 3.77E-60 
Abcb1b 3.21 6.92E-124 Dkkl1 2.95 4.56E-55 Acvr2a 2.68 3.84E-12 
Pwwp2b 3.19 1.96E-26 Icos 2.93 5.89E-25 Bcl2a1d 2.67 2.74E-51 
Slamf1 3.19 1.13E-45 Ccr2 2.93 2.86E-24 Lmnb1 2.66 9.62E-40 
Trim16 3.19 2.25E-16 Osbpl3 2.92 3.44E-51 Klrc2 2.65 5.32E-12 
Ifitm3 3.18 1.70E-28 Vps37b 2.92 0.004258 Kif23 2.64 9.08E-27 
Gabarapl1 3.18 8.40E-41 Coro2a 2.91 8.42E-108 Prdm1 2.63 4.07E-29 
Samsn1 3.17 4.27E-49 Optn 2.90 1.60E-27 Dusp3 2.62 1.11E-12 
Ehd1 3.16 2.77E-54 Rbpj 2.90 3.95E-107 Ifngr1 2.62 2.32E-05 
Bhlhe40 3.16 1.12E-11 Ifng 2.89 0.003566 Rasgrp4 2.62 2.54E-17 
Nfil3 3.16 7.99E-09 Tgm2 2.89 0.00481 Tnnc1 2.61 0.000439 
Entpd1 3.16 2.43E-65 Hspa1a 2.89 0.0106 Slc35d1 2.60 2.41E-41 
Zeb2 3.15 1.98E-37 S100a4 2.88 7.93E-24 Tinf2 2.60 1.18E-60 
Itgb5 3.13 1.38E-31 Myadm 2.88 1.54E-23 Gpr171 2.60 1.65E-33 
Lin54 3.13 7.14E-90 Specc1 2.87 3.56E-40 Cobll1 2.58 2.44E-42 
Padi2 3.11 2.48E-74 Gcnt1 2.86 1.46E-34 Hist1h2bg 2.58 3.40E-08 
Got1 3.11 2.21E-09 Nr3c1 2.85 9.50E-55 Dusp5 2.58 0.002209 
Rora 3.11 1.33E-43 Ptprj 2.81 2.14E-37 Jaml 2.57 7.75E-30 
Lilr4b 3.10 3.75E-21 Ttc39c 2.81 3.23E-37 Fabp5 2.56 3.91E-35 
Gm45140 3.09 2.09E-69 Hk2 2.80 1.45E-47 Wdr90 2.56 3.74E-24 
Serpinb9 3.07 3.31E-37 Atp8b4 2.79 2.10E-32 Car2 2.55 8.44E-07 
Adam9 3.04 4.15E-83 Cystm1 2.77 5.66E-09 Cyb561 2.55 1.73E-10 
B4galnt4 3.04 7.72E-47 AI854703 2.77 9.64E-19 Tigit 2.54 5.57E-07 
Kdm2b 3.03 1.67E-58 Sema6d 2.76 7.05E-20 Mki67 2.54 7.94E-05 
F2r 3.03 2.56E-98 Diaph3 2.74 2.76E-12 Slc52a3 2.53 2.99E-19 
Smox 3.03 5.83E-40 Pdcd1lg2 2.74 3.31E-37 Kcnj8 2.53 1.26E-06 
Fam71f2 3.02 5.65E-15 Gm49392 2.74 4.59E-19 Epcam 2.53 1.41E-12 






gene log2FC padj gene 
log2F
C 
padj gene log2FC padj 
Apol9a 2.52 1.15E-05 Bcl2l11 2.37 3.86E-06 Prrg4 2.24 4.43E-10 
Aldh7a1 2.51 2.55E-19 Fasl 2.37 0.000157 Spry1 2.24 6.85E-14 
Cd80 2.51 2.41E-19 Mt3 2.36 0.012077 Arsb 2.23 4.14E-47 
Myo3b 2.50 1.14E-11 Homer1 2.36 3.56E-20 Edaradd 2.23 4.25E-12 




Ccrl2 2.49 5.21E-11 Phlda3 2.35 0.000329 Crip2 2.23 1.03E-12 
Ifitm1 2.48 2.96E-12 Hpse 2.35 6.19E-08 Trim46 2.22 2.93E-17 
Srgap3 2.47 4.38E-15 Tspan2 2.35 1.73E-11 Atp2b4 2.22 4.80E-14 
Arrdc3 2.47 4.34E-35 Bcl2l15 2.34 0.000436 Trf 2.21 0.008366 
Pde4d 2.47 2.25E-05 Impa2 2.34 4.61E-25 Orc1 2.21 3.30E-06 
Zdhhc23 2.47 2.46E-39 Ccna2 2.34 0.000135 Lrrc8d 2.20 1.33E-36 
Acsbg1 2.47 2.37E-40 Id1 2.34 1.18E-07 Abhd15 2.20 9.99E-21 
Slc16a3 2.46 2.97E-12 Lyn 2.34 9.35E-08 Icam1 2.19 2.30E-40 
B4galt4 2.46 2.32E-05 Frmd4b 2.33 1.46E-22 Ebi3 2.19 0.000123 
Ikzf4 2.45 1.26E-07 Baiap2 2.33 1.76E-55 Nmnat2 2.19 3.99E-08 
Qpct 2.45 3.39E-15 Ppm1n 2.33 0.001497 Glrx 2.19 3.73E-66 
Tnfrsf18 2.45 1.17E-34 Bcl2l1 2.32 3.64E-34 Gem 2.19 0.000265 
Asns 2.45 4.55E-22 Cebpb 2.32 8.10E-06 Nrarp 2.18 2.97E-27 
Birc5 2.45 4.09E-05 Myof 2.32 6.34E-06 Vim 2.18 6.17E-27 
Emp1 2.44 2.33E-18 Sytl2 2.31 5.17E-35 Tlr2 2.18 2.62E-05 
Dhrs3 2.44 4.97E-06 Cdk6 2.31 3.01E-17 Hist1h1c 2.18 8.95E-18 
Stmn1 2.43 7.14E-12 Ston2 2.31 3.75E-09 Il15 2.17 0.00014 
Rgcc 2.42 7.84E-22 Vill 2.31 1.16E-07 Hspa2 2.16 3.70E-09 
Ncald 2.42 1.20E-32 Cybb 2.30 0.037077 Irak2 2.16 3.90E-16 
Rbm47 2.42 1.09E-10 Akr1c12 2.29 2.57E-12 Fzd5 2.16 2.94E-20 
Ccdc63 2.42 1.47E-07 D16Ertd472e 2.29 1.65E-86 Mgst3 2.16 9.12E-10 
Slc37a2 2.42 1.28E-11 Emid1 2.29 6.54E-08 Usp2 2.15 0.004955 
Tnfaip2 2.41 0.032223545 Nedd4 2.27 1.41E-32 Sik1 2.15 0.002149 
Tmem16
3 
2.41 2.60E-20 Errfi1 2.26 5.16E-12 Tmem171 2.15 0.005244 
Prrt1 2.40 4.30E-16 2210418O10Rik 2.26 4.66E-06 Igflr1 2.14 9.44E-15 
Jup 2.40 7.96E-10 Bambi 2.26 0.00336 2010111I01Rik 2.14 1.77E-22 
Nt5e 2.40 2.59E-36 Tpx2 2.26 2.35E-06 Cxadr 2.14 1.23E-06 
Eef2k 2.40 5.49E-18 Ybx3 2.25 3.43E-54 Ctnna1 2.14 6.99E-34 
Ube2c 2.39 4.10E-05 Slc7a5 2.25 2.31E-14 Ckap2l 2.13 0.000413 






gene log2FC padj gene log2FC padj gene log2FC padj 
Lat2 2.12 2.26E-06 Ccnyl1 2.01 7.69E-17 Tmbim1 1.86 5.39E-34 
Prickle1 2.12 1.35E-12 Pon3 2.00 2.86E-09 Syne3 1.86 1.12E-08 
Il2rb 2.12 4.23E-29 Pqlc1 2.00 2.68E-12 Vav3 1.85 7.42E-19 
Rell1 2.11 1.98E-27 Arid5a 2.00 4.26E-05 Penk 1.85 0.008272 
P2ry10 2.11 0.001967776 Hic1 2.00 1.60E-11 Plp2 1.85 9.02E-17 
Aplp2 2.11 9.37E-25 Tbc1d16 1.99 1.20E-11 Rap2a 1.85 8.03E-17 
Tubb2a 2.11 1.27E-14 Sla2 1.99 1.53E-45 Arhgef10 1.85 4.76E-11 
Runx2 2.11 1.36E-33 Abcb9 1.98 8.21E-27 Tktl1 1.85 6.93E-10 
F2rl2 2.10 2.62E-11 Il4ra 1.97 2.11E-10 Cenpn 1.85 1.07E-07 
Il21r 2.10 5.52E-17 Muc3a 1.96 0.002181 Gna15 1.85 4.87E-29 
Anxa2 2.10 8.04E-19 Chst12 1.96 2.10E-14 Rnf125 1.84 1.20E-07 
Lgals1 2.09 1.79E-15 Tbx21 1.95 1.58E-16 Pld3 1.84 2.12E-18 
Gpr160 2.09 2.66E-12 Map2k3 1.94 1.17E-16 Tfip11 1.84 1.94E-28 
Ldlrad4 2.09 1.12E-28 Irf4 1.94 2.87E-23 Rrm2 1.84 7.04E-09 
Ppp1r16b 2.09 1.53E-45 Cnnm4 1.94 2.03E-11 Knl1 1.83 4.26E-05 
Clic4 2.08 2.61E-24 Slc5a3 1.93 8.59E-24 1810055G02Rik 1.83 1.41E-07 
Slc16a10 2.08 1.10E-09 C1qtnf6 1.93 8.57E-05 Angptl4 1.83 0.000142 
L1cam 2.08 1.02E-29 Serpine2 1.93 5.29E-15 Il17rd 1.83 1.20E-08 
Fbxo30 2.08 3.88E-18 Plk3 1.92 1.26E-22 Zc3hav1l 1.83 1.53E-18 
Mvk 2.07 1.79E-27 Uhrf2 1.92 3.06E-27 Angptl2 1.83 1.69E-27 
Kcnk5 2.07 1.17E-23 Armc2 1.92 4.08E-07 Eif2ak3 1.82 1.89E-17 
Bcl2a1b 2.06 1.40E-23 Tnfsf9 1.92 3.24E-08 Smad7 1.82 1.76E-20 
Tspan17 2.06 0.000141337 Pkig 1.91 2.04E-05 Suox 1.82 3.56E-11 
Nkg7 2.06 1.80E-21 Rnase4 1.91 8.28E-07 Crybg1 1.81 1.75E-23 
Osbpl1a 2.05 0.000560369 Lpl 1.90 2.25E-05 Rab43 1.81 1.42E-12 
Plcd1 2.05 4.91E-07 Tub 1.89 2.77E-08 Isg15 1.81 4.91E-10 
Atg9b 2.04 4.21E-07 Plekhg3 1.89 2.22E-24 Gadd45b 1.81 0.016682 
Rad51ap1 2.04 0.001495933 Neto2 1.89 6.03E-12 Ikzf2 1.81 8.06E-20 
Ahr 2.04 2.10E-25 Paxbp1 1.89 4.68E-40 Ralgds 1.81 1.20E-18 
Yes1 2.04 1.94E-10 Ubtd2 1.88 3.26E-08 Sult2b1 1.80 1.06E-12 
Furin 2.02 2.71E-19 S100a6 1.87 8.18E-13 43719 1.80 2.06E-24 
Wdr78 2.02 3.92E-10 Ckap2 1.87 0.000169 Orai1 1.80 1.74E-14 
Sh2d2a 2.02 1.70E-20 Mdfic 1.87 1.83E-18 Plod1 1.79 1.51E-11 
Hip1r 2.02 1.78E-35 Crmp1 1.87 3.67E-20 Abcb1a 1.79 1.24E-34 






gene log2FC padj gene log2FC padj gene log2FC padj 
Traf4 1.79 2.32E-17 Ildr1 1.71 7.47E-09 Rab20 1.65 2.70E-11 
Gfod1 1.79 5.99E-10 Dtx4 1.71 1.06E-06 Sema6c 1.65 0.000584 
Anxa4 1.78 1.08E-10 Il18r1 1.71 3.22E-19 Gdpd5 1.65 1.88E-14 
Cyp51 1.78 1.90E-30 N4bp3 1.71 7.62E-11 Eprs 1.65 3.80E-28 
Igf2r 1.78 1.09E-31 Lag3 1.71 0.007823 Plxnd1 1.64 0.000497 
Krt7 1.78 0.000138097 Tubb6 1.71 3.15E-08 Plek 1.64 6.10E-08 
Sapcd2 1.78 0.000135486 Prkcg 1.71 0.006011 Asb2 1.64 4.63E-06 
S100a1 1.77 2.36E-05 Pi4k2b 1.71 6.86E-10 Cdkl2 1.64 0.0005 
Dapk1 1.77 2.92E-05 Prkar2b 1.70 1.96E-05 Crip1 1.64 8.46E-09 
St6galnac3 1.77 1.75E-12 Raph1 1.70 8.17E-19 Lrrk1 1.64 2.16E-06 
Tut4 1.77 2.43E-23 Oplah 1.70 1.64E-06 Igfbp7 1.64 0.025866 
Gng2 1.76 6.76E-26 Ero1l 1.69 7.44E-13 Tmem218 1.64 4.26E-06 
Nup98 1.76 2.16E-41 Ndrg4 1.69 9.80E-05 Stau2 1.63 0.003237 
Tmem176b 1.76 1.23E-06 Slc3a2 1.69 1.46E-12 Farp1 1.63 4.12E-19 
Pip5k1b 1.76 0.001179567 Gsto1 1.69 7.44E-14 Actn2 1.63 1.17E-05 
Creb3l2 1.76 1.30E-12 Itk 1.69 1.11E-34 Sorbs3 1.62 1.19E-07 
E330009J07Rik 1.76 8.96E-13 Dnajc12 1.68 6.17E-05 Map1lc3a 1.62 1.39E-09 
Prnp 1.76 6.99E-09 Dnajb6 1.68 2.06E-16 Plpp5 1.62 3.90E-13 
Cxcr4 1.75 0.003333695 Ptpn3 1.68 1.32E-09 Csf2rb 1.62 0.041894 
Crot 1.75 7.17E-24 Kcnk7 1.68 7.56E-05 Serpinb6b 1.61 4.52E-10 
Mfsd6 1.75 2.28E-44 Shcbp1 1.68 0.000265 Fam161b 1.61 7.52E-05 
Rin2 1.75 0.000163355 Plaur 1.67 0.003427 Dhrs11 1.61 8.66E-13 
Plscr1 1.74 7.66E-23 Klrk1 1.67 0.009283 Tgfb1 1.61 2.56E-20 
Rad51 1.74 0.000475381 Tmem50b 1.67 7.84E-21 Tmem231 1.61 0.00035 
Lztfl1 1.73 7.81E-23 Pmaip1 1.67 5.20E-07 Cdk1 1.61 0.000138 
Jazf1 1.73 1.04E-07 Fbxw9 1.67 1.30E-13 Jmy 1.60 6.26E-07 
CAAA01147332.1 1.73 1.29E-10 Foxp3 1.67 0.003031 Ehd4 1.60 5.27E-17 
Ndc80 1.73 1.61E-15 Trex1 1.66 9.97E-11 Prdx6 1.60 7.96E-10 
Soat1 1.72 8.62E-15 Fgfrl1 1.66 2.72E-05 Mapkapk2 1.60 9.11E-19 
Cd86 1.72 1.17E-18 Gna13 1.66 0.00205 Itgav 1.60 8.77E-19 
Bpnt1 1.72 6.25E-11 Zfp683 1.66 0.034137 Ctsl 1.59 7.51E-08 
Atp8a2 1.72 7.14E-06 Sesn2 1.66 1.82E-12 Vcpkmt 1.59 5.43E-18 
Agpat4 1.72 1.16E-10 Gpnmb 1.65 0.000134 Hif1a 1.59 2.98E-14 
Ift43 1.72 0.009376703 Socs1 1.65 1.71E-13 Adora2a 1.58 2.97E-09 






gene log2FC padj gene log2FC padj gene log2FC padj 
Sh2d4b 1.58 6.89E-05 Gm49321 1.51 0.000166 Trim13 1.46 0.000287 
Irf5 1.58 8.38E-12 Cep55 1.51 0.007225 Plin2 1.46 2.61E-07 
Stx11 1.58 1.50E-17 Bmpr2 1.51 5.27E-10 Ska3 1.46 0.00131 
Aifm2 1.58 0.00483056 Themis2 1.51 3.26E-06 Top2a 1.46 4.94E-12 
Ogfrl1 1.57 2.50E-09 Spc25 1.51 0.004763 Psrc1 1.46 0.038353 
Pcyox1 1.57 3.75E-09 Cnnm2 1.51 1.19E-08 Hist1h1e 1.46 0.000389 
Efemp2 1.57 0.002100582 Ppp2r2c 1.50 9.13E-09 Gpc1 1.46 4.33E-06 
Ppp1cc 1.57 1.53E-15 Sytl3 1.50 1.80E-19 Klf10 1.46 4.99E-11 
Alcam 1.56 7.04E-05 Fndc9 1.50 4.23E-05 Nek8 1.45 1.39E-10 
Rrad 1.56 5.45E-07 Bcl3 1.50 1.31E-09 Pros1 1.45 0.000989 
4930562C15Rik 1.56 6.20E-05 March3 1.50 9.67E-05 Ets2 1.45 8.85E-09 
Gas2l1 1.56 5.08E-10 Rcor2 1.50 0.003676 Galc 1.44 3.05E-10 
Ctnnal1 1.56 6.20E-05 Gm20388 1.50 4.15E-08 Pgm2l1 1.44 3.80E-17 
Rnf130 1.56 7.19E-15 Ogfod2 1.50 6.89E-16 Rhpn2 1.44 0.00052 
Serinc3 1.56 7.44E-17 Sec24d 1.50 1.44E-21 Glmn 1.44 1.74E-12 
Lzts1 1.56 0.000633202 St6galnac6 1.49 9.93E-07 Ric1 1.44 2.18E-16 
Fth1 1.55 3.87E-46 Nol4l 1.49 0.000103 Nsmf 1.44 6.93E-09 
Zfp703 1.55 3.59E-12 Glul 1.49 8.66E-24 Carnmt1 1.44 1.89E-11 
Slc39a8 1.55 1.17E-06 Tbkbp1 1.49 9.49E-08 Tbc1d19 1.44 0.000857 
Chaf1a 1.54 2.88E-06 Sema4a 1.49 2.40E-21 Cd200r4 1.43 2.36E-11 
Tiparp 1.54 1.30E-10 Cd44 1.48 3.80E-17 Ago3 1.43 4.17E-17 
Emd 1.53 1.05E-15 Lig1 1.48 2.20E-12 Csrnp1 1.43 1.92E-08 
Rab8b 1.53 6.07E-22 Stat3 1.48 1.50E-14 Inf2 1.43 1.30E-12 
Spry2 1.53 0.007072433 Snx18 1.48 1.77E-05 Arl13b 1.43 5.02E-11 
Tlcd1 1.53 1.77E-08 Pbx3 1.48 2.65E-07 Cxcl16 1.42 0.004765 
Aurkb 1.53 0.033404695 Btg2 1.48 4.70E-11 Smpd5 1.42 7.58E-09 
D930048N14Rik 1.53 0.001753664 Simc1 1.48 2.72E-13 Myo1d 1.42 0.000875 
Kif13a 1.53 9.16E-12 Slc9b2 1.47 2.33E-06 Abcb4 1.41 0.000269 
Slc37a3 1.52 1.55E-17 Foxd2 1.47 0.001124 Hspa13 1.41 3.33E-12 
Ptpn22 1.52 1.32E-23 Cxcl10 1.47 0.000305 Zbtb42 1.41 2.31E-14 
Rbbp8 1.52 1.86E-14 Amz2 1.47 2.64E-08 Lxn 1.41 7.72E-11 
Ifrd1 1.52 1.10E-05 Isca1 1.47 4.48E-13 Fndc3b 1.41 0.000258 
Rnf24 1.52 1.73E-08 Spryd7 1.47 5.55E-10 Swap70 1.40 4.60E-20 
Lonrf1 1.52 2.40E-08 Cpne2 1.47 2.30E-06 Nt5dc2 1.40 0.048066 






gene log2FC padj gene log2FC padj gene log2FC padj 
Psd 1.40 9.33E-05 Neil3 1.34 0.014338 Antxr2 1.31 1.29E-11 
Cd200r1 1.40 2.20E-05 Bik 1.34 0.008177 Crybg2 1.31 1.38E-08 
Zbtb46 1.40 2.00E-05 Myo1e 1.34 0.000193 Tpmt 1.30 0.000545 
Abcb10 1.40 8.11E-08 Gas7 1.34 0.004248 1700029I15Rik 1.30 0.003701 
Acot7 1.40 6.66E-09 Actg1 1.34 3.67E-19 Ctsd 1.30 3.51E-24 
Id2 1.40 1.19E-06 E2f1 1.34 0.000122 Ankrd9 1.30 8.41E-05 
Ang 1.40 0.017209865 Cd82 1.34 9.39E-20 Carhsp1 1.30 2.05E-14 
Srrd 1.39 3.80E-21 43532 1.33 0.000743 Phactr2 1.30 7.75E-06 
Spag5 1.39 0.002905062 Il1r1 1.33 0.007436 Epn2 1.30 0.017966 
Slc27a1 1.38 1.56E-13 Ncapd2 1.33 1.92E-10 Tmem198 1.30 0.000122 
Gnb4 1.38 1.90E-11 1700017B05Rik 1.32 8.35E-12 Nol10 1.30 6.55E-16 
Gsdma2 1.38 0.010328729 Apbb1 1.32 0.000164 Disc1 1.29 0.001086 
Atp6v0a1 1.38 2.50E-05 Rnf149 1.32 9.13E-13 Cx3cr1 1.29 0.005616 
Grina 1.38 7.73E-24 Ubl3 1.32 1.55E-10 Egr1 1.29 0.021743 
Gm20721 1.37 1.38E-06 Cenpk 1.32 0.036947 Gpr65 1.29 2.85E-05 
Clic5 1.37 0.005148136 Pclaf 1.32 0.044144 Sytl1 1.29 2.66E-07 
Repin1 1.37 7.63E-06 Med10 1.32 1.03E-18 Snapc1 1.29 4.76E-13 
Faap100 1.37 2.81E-08 Smyd3 1.32 3.50E-20 Tmem123 1.29 1.17E-23 
Kif15 1.37 4.68E-05 Tmem159 1.32 0.005989 Spag9 1.29 4.28E-15 
Fndc3a 1.36 2.17E-15 Laptm4b 1.32 0.000399 Map4k5 1.28 4.67E-05 
Tmem176a 1.36 0.000278158 Nenf 1.32 0.000277 Ikzf3 1.28 3.31E-17 
Ltk 1.36 0.011599189 Ptms 1.32 5.59E-12 Cldn12 1.28 0.002715 
Dusp2 1.36 0.035346251 Kcnk6 1.31 2.64E-06 Hsd17b7 1.28 1.29E-13 
Tm2d2 1.36 6.75E-13 Hdc 1.31 0.000204 Pde4b 1.28 1.54E-06 
Wee1 1.36 1.27E-10 Hid1 1.31 1.55E-14 Tmem107 1.28 0.012297 
Lrp8 1.36 1.28E-09 Gm14296 1.31 6.88E-10 Gm8797 1.27 0.012772 
Vcl 1.36 3.40E-06 Nfkb1 1.31 8.82E-14 Ndfip1 1.27 1.59E-21 
Tle1 1.36 1.07E-06 Ms4a4a 1.31 0.00335 Foxm1 1.27 0.001401 
Ago2 1.35 5.33E-11 Tmtc3 1.31 8.82E-05 Tmem64 1.27 5.55E-08 
Pdxk 1.35 6.67E-07 Gm20431 1.31 0.048674 Dock5 1.27 1.51E-09 
Cul2 1.35 5.78E-17 Podnl1 1.31 2.99E-19 Rhoc 1.27 2.36E-08 
Fam129a 1.35 3.82E-22 Slc22a15 1.31 7.42E-12 Hist2h2aa1 1.27 8.17E-06 
Vgll4 1.35 3.90E-16 Lysmd3 1.31 6.03E-20 Sccpdh 1.27 0.001343 
Trip10 1.35 0.000777111 Ppfibp1 1.31 1.47E-09 Kif3a 1.26 1.08E-05 






gene log2FC padj gene log2FC padj gene log2FC padj 
Acat2 1.26 5.18E-17 Adam19 1.21 2.59E-06 Scamp1 1.17 0.019053 
Mpzl2 1.26 5.98E-05 Gpr132 1.20 0.001329 Cwc25 1.17 1.08E-05 
Gm29094 1.26 0.001498091 Impdh1 1.20 5.55E-20 Arpc3 1.17 1.34E-12 
Spdya 1.26 2.88E-05 Rmdn2 1.20 0.007502 Myo6 1.17 0.000334 
Zc3hav1 1.25 1.34E-05 Ust 1.20 4.32E-07 Tbc1d31 1.16 0.00092 
Dmrta1 1.25 0.010814997 Dhx40 1.20 6.32E-08 Smco1 1.16 0.048936 
Nfkb2 1.25 2.51E-05 Neil1 1.20 1.94E-05 Egr3 1.16 0.001967 
Itpripl2 1.25 0.00014861 Parp12 1.20 1.36E-10 Cd38 1.16 0.003986 
Ostf1 1.25 3.67E-21 Klf4 1.20 0.038829 Plpp2 1.16 0.013845 
Slc35e4 1.25 0.000237846 6430548M08Rik 1.20 0.000542 Dusp22 1.16 0.000532 
Mocos 1.24 5.20E-07 Stk38l 1.19 3.23E-09 Dnajb1 1.16 0.045985 
Serpina3g 1.24 0.004803487 Grn 1.19 2.38E-10 Klrd1 1.15 0.001754 
Olfr734 1.24 0.00902411 Hsph1 1.19 0.039665 Arf2 1.15 5.10E-08 
Olfr137 1.24 0.016070962 Mgat4a 1.19 1.99E-11 Usp49 1.15 0.009822 
Tpm4 1.24 6.20E-14 Cfap53 1.19 0.032021 Ptger4 1.15 5.24E-16 
Taf4b 1.24 2.60E-10 Zfp672 1.19 1.38E-18 Tm6sf1 1.15 2.77E-09 
Pak4 1.24 0.000128253 Slc15a1 1.19 0.018058 Srgn 1.15 1.43E-09 
Cdr2 1.24 4.74E-07 Fam102a 1.19 1.01E-12 Zfp619 1.15 5.80E-05 
Rhob 1.24 0.000176042 Galnt2 1.18 2.87E-07 Rasa4 1.15 0.000213 
Cstb 1.24 3.43E-20 Bbs5 1.18 0.035793 Hspa4l 1.15 3.34E-09 
Dst 1.23 2.25E-06 Numbl 1.18 0.004265 Slc2a3 1.15 2.67E-08 
Slc43a3 1.23 2.51E-07 Rab27b 1.18 0.031147 Tmem140 1.15 4.25E-07 
Cmtm7 1.23 1.48E-20 Dhrs1 1.18 1.44E-05 Zcchc24 1.15 0.001813 
Akap17b 1.22 2.49E-05 Dip2a 1.18 5.54E-07 Nucb2 1.14 0.006143 
Fam216a 1.22 2.01E-06 Ncapg2 1.18 0.001167 Dusp6 1.14 1.14E-06 
Dbf4 1.22 5.86E-06 Klre1 1.17 0.023799 Slk 1.14 3.95E-21 
Cep170b 1.22 1.81E-16 Smtn 1.17 9.78E-05 Sub1 1.13 3.07E-10 
Aplp1 1.22 1.20E-06 Stk11 1.17 0.000134 Cd34 1.13 0.027915 
Dnaja4 1.22 0.000151091 Mastl 1.17 0.009755 Fam185a 1.13 2.56E-05 
Cerk 1.22 9.28E-05 Tsc22d2 1.17 3.20E-09 Rpgrip1l 1.13 0.044673 
Nsl1 1.22 0.040268576 Lamb3 1.17 7.43E-06 Serac1 1.13 0.001452 
Gm10382 1.21 0.00485386 Prss30 1.17 0.002832 Frmd4a 1.13 3.40E-06 
Serpina3f 1.21 0.014950294 Ccnc 1.17 1.26E-11 Gsn 1.13 1.06E-07 
Mcrip2 1.21 4.89E-05 Tubb4a 1.17 0.002054 Xylb 1.13 0.010168 






gene log2FC padj gene log2FC padj gene log2FC padj 
Sh3bp5l 1.13 2.87E-07 Plekhm3 1.09 1.18E-07 Cercam 1.06 0.013243 
Sfn 1.13 8.37E-05 Dnajc25 1.09 0.000515 Cfb 1.05 0.033554 
Gm45716 1.13 0.001969871 Stn1 1.09 7.80E-10 Ncf1 1.05 0.03999 
Fam53c 1.12 1.88E-07 Sorl1 1.09 3.00E-10 Tbl2 1.05 1.59E-05 
Magohb 1.12 4.80E-05 Cks2 1.09 0.000133 Txnrd1 1.05 8.93E-14 
Adap1 1.12 4.67E-15 Chsy1 1.09 3.29E-08 Hist1h4i 1.05 0.008836 
Bcam 1.12 0.026962054 Ggh 1.09 7.50E-09 Epas1 1.05 0.003083 
B3glct 1.12 0.002903097 Nt5dc3 1.09 1.74E-05 Glce 1.05 6.40E-09 
Inpp5d 1.12 3.05E-13 Clcn5 1.09 0.004933 Marcks 1.05 0.025276 
Cln8 1.12 7.63E-07 Cdkn2c 1.08 0.000521 Rdh12 1.04 2.51E-07 
Gm9887 1.12 0.003523356 Arhgef39 1.08 8.68E-06 Crbn 1.04 1.47E-08 
Chn2 1.12 9.00E-06 Intu 1.08 0.007072 Cd2 1.04 8.53E-14 
Wdfy1 1.12 8.99E-08 Suco 1.08 1.01E-05 Chrnb1 1.04 0.005781 
Uap1 1.12 3.75E-09 Cblb 1.08 1.02E-06 Pja1 1.04 5.18E-11 
Ppp1r10 1.11 4.50E-06 Pop4 1.08 0.000195 Tfrc 1.04 0.002903 
Cd274 1.11 3.64E-05 Vsig10l 1.08 0.000571 Zgrf1 1.04 3.09E-07 
Ppp3ca 1.11 1.12E-15 Soat2 1.08 2.49E-05 9530077C05Rik 1.04 0.022172 
Mlkl 1.11 0.001088488 Sh2b1 1.08 3.15E-08 Pqlc3 1.03 3.23E-06 
Trp53i13 1.11 1.72E-06 Hist1h4d 1.08 0.024402 Elovl6 1.03 1.83E-05 
Selplg 1.11 3.49E-11 Slc16a1 1.08 3.29E-10 Ubc 1.03 5.99E-05 
Mcoln2 1.11 4.63E-06 Cysltr2 1.07 3.30E-05 Olfr12 1.03 0.006439 
Car5b 1.11 0.00027376 Ugcg 1.07 2.24E-07 Tax1bp3 1.03 1.89E-07 
Zfand4 1.11 0.001582397 Arhgap31 1.07 1.73E-07 Mxd3 1.03 0.048323 
Tmem97 1.11 5.35E-08 Myo5a 1.07 1.19E-09 Slc45a4 1.03 9.80E-11 
Stard6 1.11 0.048853913 Cnrip1 1.07 0.001426 H3f3b 1.03 3.18E-08 
Pdlim7 1.10 5.27E-06 Zfp948 1.07 0.008734 Mknk2 1.03 4.60E-06 
Rybp 1.10 2.08E-07 E030030I06Rik 1.07 0.006056 Fam213a 1.03 0.000362 
Lgals4 1.10 4.82E-06 Susd2 1.07 0.000135 Emb 1.03 0.001461 
Ptger2 1.10 0.000266958 Klf8 1.07 0.009641 Socs4 1.02 0.000115 
Ttl 1.10 5.26E-06 Trib3 1.07 0.001247 Ube2j1 1.02 1.19E-06 
Acoxl 1.10 0.023423143 Zfp874b 1.07 3.12E-06 Phlpp1 1.02 7.65E-06 
Fancf 1.10 7.41E-09 Mxd4 1.07 3.00E-09 Fam204a 1.02 3.21E-07 
Yap1 1.10 0.01279867 Dctn4 1.07 3.74E-09 Alpk2 1.02 0.02127 
Maf 1.09 1.85E-05 Gas2 1.06 0.032611 Adarb1 1.02 0.015302 






gene log2FC padj gene log2FC padj gene log2FC padj 
Atp10a 1.02 8.43E-11 Men1 -1.02 4.81E-05 Endov -1.04 9.33E-05 
Ifi44 1.02 0.006719775 B3galt4 -1.02 0.000444 Slc9a7 -1.04 4.69E-05 
Rad54l 1.02 0.034928599 Aven -1.02 6.07E-05 Arl4c -1.04 7.04E-05 
Pcgf2 1.01 0.006099904 Pglyrp1 -1.02 0.002518 Sh2b3 -1.04 6.57E-09 
Elovl5 1.01 4.74E-09 Mrps18b -1.02 4.10E-10 Klhdc2 -1.04 1.99E-07 
Gm4070 1.01 2.68E-05 Eid2 -1.02 0.006816 Tcea2 -1.04 1.11E-06 
Cdca8 1.01 0.045636251 Cyp2s1 -1.02 8.94E-06 Sp100 -1.05 9.42E-10 
Far1 1.01 1.03E-10 Tcof1 -1.02 7.30E-11 Commd5 -1.05 0.008821 
Qsox1 1.01 3.60E-06 Trappc1 -1.02 6.42E-08 Mrpl34 -1.05 0.000346 
Sertad1 1.01 0.000744541 Tirap -1.02 0.037991 Gstt2 -1.05 8.55E-05 
Fancc 1.01 3.12E-06 H2-DMa -1.02 4.34E-05 Zfp946 -1.05 0.001083 
Cers4 1.01 7.25E-14 Rtel1 -1.02 1.42E-08 Yae1d1 -1.06 0.000916 
Endod1 1.00 1.39E-06 Grk2 -1.02 3.09E-08 Otulinl -1.06 1.76E-08 
Arhgap21 1.00 0.003785093 Arv1 -1.02 5.96E-06 Ttll4 -1.06 0.001823 
Atp6v0d1 1.00 4.10E-08 Sh3bp1 -1.03 6.44E-08 Ifi206 -1.06 1.69E-05 
Tgfbr3 1.00 6.50E-07 Dcdc2b -1.03 0.039914 Gm17018 -1.06 0.000558 
P3h1 1.00 0.024401072 Lage3 -1.03 4.28E-05 Zfp526 -1.06 0.006265 
Iqgap1 1.00 6.73E-13 Stard5 -1.03 1.40E-06 Gm28042 -1.06 0.023126 
Stard3nl 1.00 1.61E-06 Mettl9 -1.03 1.35E-09 Nod1 -1.06 7.70E-06 
Fam98c -1.00 1.71E-11 Arid1a -1.03 8.55E-15 AI606181 -1.06 0.000689 
Platr17 -1.00 0.024153182 Igip -1.03 0.036372 Il7r -1.06 0.000508 
Gm15446 -1.00 0.000948113 Snapc4 -1.03 4.48E-12 Trmt61a -1.06 5.71E-05 
Ung -1.00 0.003409224 2810021J22Rik -1.03 0.006413 Als2cl -1.06 7.05E-05 
Zfp442 -1.00 0.001981099 Rars2 -1.03 7.26E-07 Rgl2 -1.06 2.82E-06 
Upf2 -1.00 6.33E-08 Cdpf1 -1.03 1.67E-05 Farsb -1.06 5.49E-08 
Jpt2 -1.00 1.64E-06 Atic -1.03 8.96E-06 Pus1 -1.06 2.10E-09 
Grk6 -1.00 4.43E-12 Lpar5 -1.03 0.00376 Relt -1.06 1.23E-05 
Mvd -1.01 0.002121242 Tns2 -1.03 0.022354 Maml3 -1.06 0.000155 
Tmem229b -1.01 2.86E-05 Fez2 -1.03 2.81E-10 Mccc2 -1.06 0.005918 
Trub1 -1.01 9.29E-05 Mypop -1.03 0.000206 Nat8f4 -1.07 0.029492 
Xrn2 -1.01 5.85E-08 Cab39l -1.03 5.03E-07 Cyb5rl -1.07 0.000543 
Ext1 -1.01 2.35E-05 Ebag9 -1.04 0.000209 2610301B20Rik -1.07 0.000453 
Rad1 -1.01 0.001739588 Mllt6 -1.04 5.27E-10 Prmt3 -1.07 1.44E-10 
Emc9 -1.01 0.00107754 Atp13a2 -1.04 0.000213 Zfp213 -1.07 4.40E-06 






gene log2FC padj gene log2FC padj gene log2FC padj 
Vamp5 -1.07 7.41E-05 Rgs14 -1.10 2.64E-12 Traf3ip3 -1.13 3.42E-10 
AW146154 -1.07 0.000439452 Usp3 -1.10 2.45E-13 Zfp217 -1.13 0.000481 
Nadsyn1 -1.07 4.58E-05 Ppp1r14b -1.10 4.13E-09 Cep131 -1.13 0.000916 
Stxbp1 -1.07 0.000144168 Fgfr1op -1.10 2.63E-11 Zbtb26 -1.13 0.002164 
Crtc3 -1.07 1.34E-11 5430403G16Rik -1.10 0.010227 Inafm1 -1.14 9.20E-05 
Tmem143 -1.07 0.00263176 Abcc4 -1.11 7.12E-09 Bcl2l12 -1.14 2.24E-05 
Gm42688 -1.07 0.000177749 Ptpdc1 -1.11 0.020997 Zc4h2 -1.14 0.030541 
Ndufa4 -1.07 4.87E-14 Tab1 -1.11 0.00011 Tmem186 -1.14 3.88E-07 
Telo2 -1.07 4.73E-12 Lgmn -1.11 0.013273 Zbtb18 -1.14 0.006325 
Orc5 -1.07 6.37E-09 Plekha8 -1.11 0.002953 Ifi214 -1.14 0.00047 
A530064D06Rik -1.07 0.003861429 Csk -1.11 6.14E-09 Krcc1 -1.14 7.24E-07 
Kbtbd11 -1.07 0.002141503 Fhl3 -1.11 0.000609 Mss51 -1.14 0.004649 
Serpinc1 -1.08 1.74E-05 Bicdl1 -1.11 7.22E-09 Cnp -1.14 4.33E-09 
Ikzf1 -1.08 3.03E-14 Tubb5 -1.11 5.33E-07 Kat2a -1.14 8.54E-12 
Itga6 -1.08 1.03E-12 Tspan4 -1.11 0.015725 Trim56 -1.14 2.05E-06 
Vars2 -1.08 0.006141536 Nmnat3 -1.11 0.00065 1110008L16Rik -1.14 0.000555 
Gm28035 -1.08 0.011713708 Igsf23 -1.11 0.003642 Pla2g6 -1.15 2.72E-05 
Ccdc142 -1.08 0.013052309 Ap1g2 -1.12 7.32E-17 Slfn1 -1.15 5.91E-08 
Gm2237 -1.08 0.023028897 Nrros -1.12 1.36E-07 Dcp1b -1.15 5.27E-10 
1700056E22Rik -1.08 0.010704761 Trmu -1.12 0.000855 Kctd2 -1.15 2.31E-11 
Dennd4b -1.08 5.38E-07 Dhx58 -1.12 2.60E-07 Krba1 -1.15 2.01E-06 
Dpp4 -1.09 1.96E-05 Stoml1 -1.12 1.32E-06 Mrpl58 -1.15 2.21E-08 
Ccm2 -1.09 1.76E-17 Btbd11 -1.12 4.05E-08 Pard6b -1.15 0.016977 
Psmg1 -1.09 3.54E-08 Ppargc1b -1.12 2.50E-06 Kctd1 -1.15 0.001531 
Ndst2 -1.09 1.30E-05 Zfp422 -1.12 0.000582 Pdcd4 -1.15 4.84E-19 
Cd3eap -1.09 1.87E-05 Wdr89 -1.12 0.00127 Kat14 -1.15 2.38E-10 
Smad5 -1.09 1.04E-06 Ptgr2 -1.13 3.69E-10 Cep95 -1.16 2.27E-08 
Zfp512 -1.09 1.04E-08 9930111J21Rik2 -1.13 3.36E-07 Zfp771 -1.16 0.026117 
Fam53b -1.09 3.15E-07 Ppp1r21 -1.13 2.89E-07 Galk1 -1.16 0.000902 
Lrrc61 -1.09 2.11E-06 Washc3 -1.13 6.03E-09 Tbc1d1 -1.16 5.05E-20 
Dguok -1.09 1.24E-08 Wdr46 -1.13 1.79E-11 Klhl6 -1.16 2.01E-05 
Plcb4 -1.09 0.00535779 Pex26 -1.13 4.01E-05 Tnfrsf23 -1.16 0.00011 
Crlf3 -1.09 1.51E-13 Zfpm1 -1.13 1.96E-08 Tceanc -1.16 1.44E-05 
Pinx1 -1.09 0.001685386 Smpdl3a -1.13 4.12E-10 Mllt11 -1.16 0.001653 






gene log2FC padj gene log2FC padj gene log2FC padj 
Rpa1 -1.16 1.55E-12 Hrh2 -1.20 2.49E-10 Zfp992 -1.23 0.000351 
1110059E24Rik -1.16 2.53E-05 Nudt6 -1.20 4.71E-07 Trim32 -1.24 0.000314 
Trim8 -1.17 6.91E-11 3110009E18Rik -1.20 0.003392 Hdac10 -1.24 2.80E-09 
Itgb3bp -1.17 8.01E-05 Zfp493 -1.20 0.002815 Msl3l2 -1.24 1.70E-05 
Dnaja3 -1.17 1.62E-09 Il1rl2 -1.20 4.39E-18 Tfam -1.24 5.31E-13 
Ncoa7 -1.17 6.16E-05 Tert -1.20 0.001065 Sh2d3c -1.24 3.64E-13 
Cd5 -1.17 4.65E-13 Orai2 -1.20 5.07E-20 Bcdin3d -1.24 6.38E-05 
Sap25 -1.17 5.19E-05 Cfap97 -1.20 7.76E-08 Rasgrf2 -1.24 0.004097 
Asap2 -1.17 7.67E-07 Fam69a -1.21 1.86E-09 Olfr381 -1.25 0.01273 
Zfp661 -1.17 0.00388494 Ifi27l2a -1.21 1.01E-10 Oxld1 -1.25 0.039091 
Nudt22 -1.17 1.66E-05 Lbh -1.21 5.45E-10 Ifi209 -1.25 2.39E-06 
Utrn -1.17 1.67E-12 Rras -1.21 3.50E-07 Ephb6 -1.25 4.99E-09 
Khdrbs2 -1.17 0.019587593 Dzip1 -1.21 1.56E-05 Etv3 -1.25 1.51E-13 
Ears2 -1.18 5.17E-06 Lipa -1.21 3.22E-26 Calhm6 -1.25 3.26E-07 
Ldlr -1.18 1.02E-06 Prkcq -1.21 5.39E-18 Zfp873 -1.25 0.020247 
Shpk -1.18 9.22E-05 Mfsd3 -1.21 0.008128 Smc4 -1.25 1.15E-10 
Dck -1.18 8.53E-07 1500011B03Rik -1.22 4.66E-13 AB124611 -1.25 2.01E-16 
Icam2 -1.18 7.37E-09 Mtmr4 -1.22 2.48E-14 Ice2 -1.25 0.002348 
Qprt -1.18 2.00E-07 Mks1 -1.22 1.96E-05 Phf7 -1.25 2.62E-06 
Zfp964 -1.18 4.15E-05 Haao -1.22 0.022 Scmh1 -1.25 0.002636 
Krt10 -1.18 0.035937116 Lhfpl5 -1.22 0.038866 Dzip3 -1.26 2.18E-06 
Ltb -1.18 5.29E-11 Rmnd1 -1.22 2.35E-12 Fas -1.26 5.45E-09 
Tmtc4 -1.18 7.59E-09 Tmem265 -1.22 0.001711 Pcsk4 -1.26 0.021034 
Rdh5 -1.18 0.001912927 Trim34a -1.22 3.07E-08 Smim8 -1.26 1.52E-08 
2810004N23Rik -1.19 1.29E-12 Zfp143 -1.22 2.75E-07 Nudt14 -1.26 1.23E-06 
Fam78a -1.19 1.20E-06 Poli -1.22 6.22E-09 Sez6l2 -1.26 0.003963 
Parp3 -1.19 5.05E-06 Smyd4 -1.23 1.86E-07 Trerf1 -1.26 3.71E-13 
Ube2cbp -1.19 0.032927337 Trim12a -1.23 4.75E-18 Hsh2d -1.27 1.13E-07 
Dtwd1 -1.19 0.001700382 Ttc32 -1.23 0.000719 Prrt2 -1.27 0.005368 
C330018D20Rik -1.19 0.000243625 B3gat2 -1.23 0.000865 Plin3 -1.27 2.10E-06 
Parp11 -1.19 0.000239231 Pdlim2 -1.23 1.45E-08 Dlg4 -1.27 0.000653 
Polr3e -1.19 1.27E-15 Rbm38 -1.23 2.55E-05 Pctp -1.28 0.001361 
Psen2 -1.19 1.41E-08 Rap2b -1.23 0.000124 Alkbh2 -1.28 1.52E-05 
Hmga1 -1.20 2.22E-06 Abraxas1 -1.23 2.30E-08 Prr12 -1.29 1.08E-07 






gene log2FC padj gene log2FC padj gene log2FC padj 
Tagap -1.29 1.89E-09 D130040H23Rik -1.34 1.83E-08 Hddc2 -1.39 6.16E-11 
Rgmb -1.29 0.000107425 Tmem268 -1.34 1.60E-06 Arl5c -1.40 3.58E-08 
Ankmy2 -1.30 3.67E-17 Zfp169 -1.34 6.98E-09 3300002I08Rik -1.40 0.022837 
Ms4a2 -1.30 0.001929854 Xylt2 -1.35 4.88E-06 Rtn4rl1 -1.40 1.13E-12 
Pced1b -1.30 2.82E-07 Grtp1 -1.35 1.82E-07 Arhgap5 -1.40 3.61E-15 
Gm4841 -1.30 0.000823096 Tnfrsf13b -1.35 8.60E-07 Tspoap1 -1.40 2.84E-05 
Zfp937 -1.30 0.00011114 Rcsd1 -1.35 1.86E-17 Homez -1.40 7.68E-05 
Prpf40b -1.30 0.00076063 Fntb -1.35 3.77E-07 Zkscan7 -1.41 1.56E-06 
Cpt2 -1.30 0.000731956 Dyrk2 -1.36 1.07E-21 Cacnb1 -1.41 6.89E-14 
Vps26c -1.30 3.51E-08 Ttc13 -1.36 1.35E-09 Dctd -1.41 0.008128 
Fbxl4 -1.30 8.33E-06 Tmc4 -1.36 0.000693 Gimap7 -1.41 6.95E-07 
Ppm1m -1.30 2.41E-09 Bbs12 -1.36 0.001963 Pbx2 -1.41 4.11E-09 
Prrg1 -1.31 7.42E-06 Mettl1 -1.36 1.31E-06 Rftn2 -1.41 0.000181 
Pde6d -1.31 3.27E-06 Sfmbt2 -1.36 0.003796 Tarbp1 -1.42 6.08E-11 
Zfp512b -1.31 3.97E-11 Pus7l -1.36 0.00025 Ptger1 -1.42 1.87E-05 
Elmo3 -1.31 0.0028464 Stambpl1 -1.36 8.38E-19 Oas1c -1.42 1.81E-07 
Inpp5b -1.32 3.12E-09 Rgs19 -1.36 1.56E-18 Atp1b3 -1.42 5.73E-24 
Zfp82 -1.32 0.001393527 Zfp831 -1.37 6.99E-10 Sertad3 -1.42 0.00027 
Sptbn1 -1.32 3.20E-32 Myc -1.37 1.75E-05 Tnfrsf22 -1.43 1.29E-16 
Rpp40 -1.32 0.002828233 Sgsh -1.37 1.13E-11 Car7 -1.43 0.002215 
Ccar2 -1.32 5.40E-19 Zfp773 -1.37 4.84E-14 Ralgps2 -1.43 2.37E-11 
Trip6 -1.32 0.000688673 Scrn3 -1.37 5.20E-11 Cand2 -1.43 1.16E-07 
Bid -1.32 9.14E-07 Sash3 -1.37 1.01E-17 Axin2 -1.43 1.22E-11 
Abtb2 -1.33 4.05E-13 Mylpf -1.37 6.14E-07 Vmn2r84 -1.44 8.38E-08 
Ehd3 -1.33 3.33E-21 Bcl7a -1.37 1.53E-06 Ift80 -1.44 3.17E-17 
Mob3b -1.33 1.72E-05 Hspbap1 -1.37 1.75E-12 Zfp974 -1.44 9.39E-07 
Gimap6 -1.33 1.88E-08 Trim5 -1.37 2.09E-18 Abca3 -1.45 1.62E-10 
AI467606 -1.33 0.000453588 Mterf1a -1.37 2.14E-05 Apex1 -1.45 3.69E-15 
Ganc -1.33 2.91E-09 Bin2 -1.38 3.79E-15 Tmc8 -1.45 1.70E-08 
Slc14a1 -1.33 1.75E-10 Max -1.38 1.37E-13 Gcat -1.45 1.85E-07 
Thap3 -1.33 1.46E-05 Thada -1.38 5.41E-25 F2rl3 -1.45 4.04E-07 
Gm35315 -1.34 0.005305685 Phf11a -1.39 1.91E-05 Ift81 -1.46 0.014264 
Fcgr2b -1.34 0.007193345 Eml3 -1.39 1.46E-14 Klhl3 -1.46 3.14E-10 
Oas3 -1.34 1.70E-20 Wdr72 -1.39 0.003306 St3gal1 -1.46 1.10E-07 






gene log2FC padj gene log2FC padj gene log2FC padj 
Traf3ip2 -1.46 1.57E-25 Gpr155 -1.52 7.14E-09 Usp33 -1.61 1.18E-37 
E2f2 -1.47 0.000203095 Ifi208 -1.52 7.08E-16 Foxk1 -1.61 2.76E-10 
Nhsl2 -1.47 0.007271239 Lancl3 -1.52 6.74E-07 Cers6 -1.61 4.39E-11 
Ado -1.47 5.82E-12 Dnah8 -1.53 9.21E-17 Dand5 -1.61 3.59E-05 
2610002M06Rik -1.47 2.76E-18 Prkd2 -1.53 2.63E-17 Gm20708 -1.61 0.001507 
Csprs -1.47 4.20E-06 Napepld -1.53 3.56E-06 Oas2 -1.61 2.65E-05 
Boll -1.47 0.025699314 Cd200 -1.53 0.000292 Rab3ip -1.62 7.37E-17 
Cep68 -1.47 7.67E-16 Zc3h12d -1.53 1.90E-14 Plxnc1 -1.62 9.90E-12 
L3mbtl3 -1.48 1.30E-25 Zfp987 -1.53 9.04E-05 Det1 -1.62 3.93E-09 
Gnaq -1.48 2.24E-08 Inpp5f -1.54 7.54E-22 Sp6 -1.62 0.00043 
Arpc5l -1.48 1.87E-15 Bmp7 -1.54 1.10E-14 Zfp14 -1.62 3.34E-05 
Pecam1 -1.48 7.30E-11 Bbc3 -1.54 3.23E-09 Bank1 -1.62 0.005762 
Vcam1 -1.48 0.006498784 Patj -1.54 6.16E-06 Ccdc91 -1.63 2.51E-10 
Dph5 -1.49 1.30E-21 Pou2f2 -1.55 3.46E-07 Cntn1 -1.63 0.000745 
Dnaaf5 -1.49 5.11E-09 Vmn2r96 -1.55 0.000389 Gm3636 -1.63 0.000114 
Arhgef3 -1.49 2.98E-29 Wdr73 -1.55 6.04E-09 Zc3h6 -1.64 9.49E-08 
Ccdc71 -1.49 3.55E-05 Hsdl1 -1.56 2.49E-20 Zfp710 -1.64 8.66E-18 
Zfp467 -1.49 8.65E-11 Wdr12 -1.56 1.44E-12 Arhgef18 -1.65 6.86E-21 
Scml4 -1.49 6.12E-15 Ccdc28b -1.57 4.87E-05 Arhgef4 -1.65 1.20E-15 
Tmem136 -1.49 0.007648515 Acyp1 -1.57 3.93E-10 Fam117a -1.65 1.50E-18 
B3gnt5 -1.49 2.50E-14 AC147512.1 -1.57 0.014325 Tmem71 -1.65 3.90E-22 
Tnfrsf14 -1.49 1.46E-08 Zscan12 -1.57 2.87E-05 Ifit2 -1.65 3.71E-12 
A630001G21Rik -1.50 1.07E-13 Tmlhe -1.57 5.08E-10 Actr6 -1.65 9.53E-12 
Ass1 -1.50 8.95E-21 Tgfbr3l -1.58 0.001434 Cpm -1.65 5.27E-13 
Mboat1 -1.50 1.16E-10 Gabrr2 -1.58 0.031166 Cd2ap -1.66 2.35E-24 
A430078G23Rik -1.50 3.80E-14 Ggt5 -1.59 3.09E-07 Gpatch4 -1.66 4.03E-15 
Nav2 -1.50 2.58E-09 Fam49a -1.59 2.58E-19 Klhl5 -1.67 5.14E-37 
Khdc3 -1.51 0.025218384 Dgkz -1.59 4.80E-18 Lef1 -1.67 1.68E-30 
Scg5 -1.51 0.012700919 Thra -1.59 1.07E-06 Ube2e2 -1.68 0.015552 
Mfhas1 -1.51 1.14E-11 Acp5 -1.59 8.98E-14 Rangrf -1.69 0.000208 
Bmyc -1.51 2.15E-06 Stk38 -1.60 6.75E-49 Lyrm7 -1.70 0.003707 
Bicra -1.52 1.55E-21 Kif21b -1.60 9.18E-20 Zbtb7b -1.70 8.19E-07 
Raver2 -1.52 1.61E-08 Rere -1.60 6.82E-16 Rap1gap2 -1.70 5.01E-06 
Zdhhc12 -1.52 6.18E-07 Ispd -1.60 0.000265 Ccdc69 -1.70 1.94E-12 






gene log2FC padj gene log2FC padj gene log2FC padj 
Thtpa -1.71 2.09E-14 Tespa1 -1.88 8.00E-24 Phf11c -2.08 5.57E-24 
Tlr6 -1.72 5.31E-05 Pycard -1.89 1.23E-33 Gm3468 -2.10 0.00012 
A230050P20Rik -1.72 2.46E-10 Tha1 -1.89 2.15E-08 Tmem221 -2.11 9.59E-09 
Usp17lc -1.72 0.001138582 Tbxa2r -1.89 1.12E-06 Prg4 -2.12 2.57E-07 
Tspyl3 -1.73 5.75E-15 Add3 -1.90 2.35E-47 Zfhx2 -2.13 4.02E-36 
Rassf2 -1.73 1.52E-16 Mlh3 -1.91 8.59E-23 Ggt1 -2.14 1.04E-07 
Igfbp4 -1.74 2.79E-05 Rgs12 -1.92 4.04E-06 Sema4b -2.14 1.40E-14 
Dlg3 -1.75 2.63E-05 Decr1 -1.93 7.32E-19 Mgst2 -2.15 6.57E-14 
Kremen2 -1.76 6.94E-08 Cd55 -1.93 8.72E-14 D830030K20Rik -2.15 2.10E-05 
A830005F24Rik -1.77 0.004313601 Lypd6b -1.93 1.74E-06 Pik3r2 -2.17 1.03E-09 
Gemin6 -1.77 0.000200734 Pigw -1.94 0.000264 Popdc2 -2.17 5.07E-08 
Arhgef2 -1.77 6.41E-22 Nckap5l -1.94 1.44E-14 Fcgrt -2.18 1.95E-05 
Gpm6b -1.78 1.14E-08 Pdlim1 -1.94 3.58E-15 Amigo2 -2.18 7.47E-09 
Ptrh1 -1.78 1.17E-05 Ldlrap1 -1.94 1.10E-20 Ccdc126 -2.19 1.11E-11 
Ipcef1 -1.78 1.27E-17 Sh3bp5 -1.96 2.92E-10 Itga4 -2.19 4.52E-43 
Rundc3a -1.78 7.52E-05 Nedd4l -1.96 8.66E-18 Bcl9 -2.20 1.50E-15 
H2-T24 -1.79 1.43E-08 Gpr18 -1.97 1.13E-18 Klhdc1 -2.21 3.48E-12 
Oasl2 -1.79 1.68E-05 Pagr1a -1.97 0.04177 Trat1 -2.21 1.16E-40 
Lrp12 -1.79 6.32E-06 Idh2 -1.98 1.70E-20 Dennd2d -2.21 3.29E-26 
Mettl8 -1.81 7.30E-13 Ikbke -1.98 2.59E-33 Traf5 -2.22 3.02E-34 
Cdc25b -1.81 6.67E-34 Plcb2 -1.98 2.97E-27 Gm8369 -2.25 1.47E-25 
Pym1 -1.82 6.05E-20 Adk -1.98 5.43E-18 Dgka -2.26 5.91E-57 
Thumpd2 -1.82 2.77E-11 Gm6904 -1.99 1.49E-05 Fhit -2.26 0.008873 
Phf23 -1.82 4.28E-11 Daxx -2.01 3.34E-25 Slc17a9 -2.26 5.95E-30 
Ifit1bl1 -1.83 0.004436036 Hmgn3 -2.01 0.000857 Rasgrp2 -2.27 1.93E-69 
Filip1l -1.84 1.81E-07 Cacna1a -2.02 1.83E-07 Glis3 -2.27 6.66E-06 
2010005H15Rik -1.85 0.027587033 Spice1 -2.03 1.98E-20 Shld1 -2.27 4.35E-36 
Cd9 -1.86 9.73E-08 Echdc1 -2.04 4.06E-15 Snn -2.29 5.46E-10 
Nxpe3 -1.86 4.30E-22 Slfn5 -2.04 3.52E-14 P2rx7 -2.29 4.04E-20 
Mpp1 -1.86 1.33E-43 Il17rb -2.05 8.48E-06 Sh2d1a -2.30 3.42E-25 
Scd2 -1.87 5.15E-37 Rasa3 -2.06 6.09E-52 Cnga1 -2.32 3.26E-08 
Pitpnm2 -1.87 1.86E-11 Pdk1 -2.07 6.80E-18 1700025G04Rik -2.32 9.61E-08 
Pex11g -1.87 2.31E-05 Rom1 -2.07 1.91E-09 Nbn -2.32 5.07E-19 
Cerkl -1.87 2.02E-06 Cd81 -2.08 6.88E-05 Cdh23 -2.32 3.88E-07 






gene log2FC padj gene log2FC padj gene log2FC padj 
G430095P16Rik -2.32 5.27E-10 Ephx1 -2.76 9.25E-33 Tlr1 -3.79 1.91E-53 
Ms4a4d -2.33 2.14E-06 Fbxo17 -2.76 1.04E-17 Mapk11 -3.90 4.61E-34 
Plp1 -2.34 1.49E-06 F2rl1 -2.77 1.78E-33 Tdrp -3.90 1.55E-27 
Klf2 -2.34 2.28E-13 Pik3ip1 -2.80 2.37E-33 Aff3 -3.97 9.58E-34 
Limd2 -2.36 1.29E-31 Myb -2.80 3.34E-06 Clec2i -4.03 1.08E-37 
Asap1 -2.39 5.95E-60 Cd7 -2.80 4.28E-11 Ccr7 -4.08 3.08E-10 
Ripor2 -2.39 6.34E-83 Klf3 -2.82 7.74E-60 Slamf6 -4.63 6.44E-45 
Ntrk3 -2.40 1.20E-23 Il6st -2.86 6.15E-46 Gm14085 -4.64 1.17E-48 
H2-Q2 -2.42 2.21E-14 Hmgn1 -2.96 1.28E-32 H2-Ob -4.75 3.11E-44 
Ggact -2.42 3.48E-21 Baiap3 -2.99 1.61E-24 Rflnb -4.87 8.41E-22 
Kntc1 -2.43 1.02E-05 Vipr1 -3.00 8.06E-111 Nsg2 -5.87 7.89E-65 
Usp28 -2.43 1.60E-51 Mettl27 -3.03 2.24E-12 Dtx1 -6.23 8.32E-27 
Pkp4 -2.44 9.10E-28 Pacsin1 -3.08 8.35E-52 Sell -6.49 4.55E-22 
Txk -2.45 3.63E-22 Gpr146 -3.09 1.15E-26 Art2b -6.63 1.50E-36 
Gramd4 -2.45 1.08E-37 Tspan32 -3.11 9.68E-59    
Rnf144a -2.46 2.88E-26 Tnfrsf25 -3.11 4.61E-38    
Trib2 -2.47 9.96E-18 Cacna2d4 -3.11 8.32E-31    
2510009E07Rik -2.48 5.15E-09 S1pr1 -3.15 8.27E-30    
Ly6c2 -2.49 0.008978813 Ly6c1 -3.18 5.20E-05    
Msrb2 -2.52 1.73E-16 Afp -3.18 5.29E-15    
Pmel -2.52 7.75E-21 Tnfrsf26 -3.18 6.44E-53    
Bcl9l -2.54 6.34E-33 Fbln2 -3.19 0.035937    
Tnfsf14 -2.55 2.03E-10 Rasal1 -3.24 4.41E-11    
Chst15 -2.55 2.77E-14 St6gal1 -3.28 4.89E-34    
Cpq -2.61 6.12E-10 Id3 -3.29 2.81E-08    
Lbp -2.62 5.77E-08 Itga7 -3.31 2.53E-24    
Degs2 -2.64 6.25E-11 Btla -3.42 4.24E-45    
Plekhg2 -2.65 2.71E-17 Espn -3.62 2.29E-28    
BC147527 -2.66 1.34E-16 Tox2 -3.64 4.64E-24    
Ms4a4c -2.70 2.77E-06 Tcf7 -3.65 4.41E-135    
Armcx2 -2.71 1.93E-20 Sidt1 -3.67 4.36E-58    
Fgf13 -2.71 5.77E-22 Cmah -3.69 7.79E-60    
Actn1 -2.73 2.70E-31 Cd22 -3.77 1.04E-30    
Chil5 -2.75 6.09E-15 Il6ra -3.79 4.25E-77    





Figure 4-2 R script for gene expression analysis of mouse TRM and TEM memory CD8+T 






#copy all kallisto output files to a sub-folder called 'kallisto' 
#retrieve sample names 
sample_id <- dir("/home/xubuntu/October 2018 Sequencing/Mackay/all CD8/kallisto/") 
#generate file paths to samples 
kal_dirs <- file.path(".", "kallisto", sample_id) 
#generate file paths to abundance files 
files <- file.path(".", "kallisto", sample_id, "abundance.h5" ) 
#name the file paths with the sample names 
names(files) <- sample_id 
#generate dictionary for aggregating transcript counts to gene counts 
library(biomaRt) 
mart <- useMart(biomart = "ENSEMBL_MART_ENSEMBL", 
                         dataset = "mmusculus_gene_ensembl", 
                         host = 'ensembl.org') 
#filter transcripts/genes for protein-coding 
transcript2gene <- getBM(attributes=c("ensembl_transcript_id",  
                                      "external_gene_name"), mart=mart,  
                         filters='biotype', values=c('protein_coding')) 
#order dictionary 
transcript2gene <- transcript2gene[order(transcript2gene$external_gene_name), ] 
#prep kallisto abundance for DESeq2, counts are generated from length-scaled TPMs 
txi_gene_length <- tximport(files, type = "kallisto", tx2gene = transcript2gene, 
                            ignoreTxVersion = TRUE, countsFromAbundance="lengthScaledTPM") 
#two variables for the DESeq2 comparion: cell type and batch  
cell_type <- factor(c(rep("EM", 2), rep("TRM", 2), 
                      rep("EM", 4), rep("TRM", 4))) 
#batch categorization is based on different infection models 
batch <- factor(c(rep("One", 4), rep("Two", 8))) 
#merge into coldata 
(coldata <- data.frame(row.names = colnames(txi_gene_length$counts), batch, cell_type)) 
##           batch cell_type 
## HSVEMs1     One        EM 
## HSVEMs2     One        EM 
## HSVTRMsk1   One       TRM 
## HSVTRMsk2   One       TRM 
## LCMVEMl1    Two        EM 
## LCMVEMl2    Two        EM 
## LCMVEMs1    Two        EM 
## LCMVEMs2    Two        EM 
## LCMVTRMg1   Two       TRM 
## LCMVTRMg2   Two       TRM 
## LCMVTRMl1   Two       TRM 
## LCMVTRMl2   Two       TRM 
158 
 
#comparions should highilght tissue differences while correcting for batch 
dds <- DESeqDataSetFromTximport(txi_gene_length, colData=coldata,  
                                design=~batch + cell_type) 
#upregulation should describe genes high in TRM compared EM subset 
dds$cell_type <- relevel(dds$cell_type, "EM") 
#run DESeq2 
dds <- DESeq(dds) 
#generate results 
res <- results(dds) 
#write untouched output file  
write.csv(res, file="output-mouse-DESeq2.csv") 
#generate output file that contains columns on TPMs  
mouse_complete <- cbind(as.data.frame(res),as.data.frame(txi_gene_length$abundance)) 
write.csv(mouse_complete, "output-mouse-DESeq2-with-abundance.csv") 
#####filter  
mouse_sig <- subset(mouse_complete, padj < 0.05)  
 
mouse_sig <- subset(mouse_sig, log2FoldChange > 1 | log2FoldChange < -1) 
 
mouse_sig <- mouse_sig[complete.cases(mouse_sig),] 
 
#filter by TPM > 0.25 
colnames(mouse_sig) 
mouse_sig_TPM <- subset(mouse_sig, select = c(HSVEMs1, HSVEMs2, HSVTRMsk1, 
                                              HSVTRMsk2, LCMVEMl1, LCMVEMl2,  
                                              LCMVEMs1, LCMVEMs2, LCMVTRMg1, 
                                              LCMVTRMg2, LCMVTRMl1, LCMVTRMl2)) 
mouse_sig_TPM_above_0_25 = apply(mouse_sig_TPM, 1, function(row) all(row > 0.25 )) 
 
mouse_sig <- mouse_sig[mouse_sig_TPM_above_0_25,] 
 
#order significant gene list 





Table 4-2. Gene expression analysis of mouse TRM and TEM memory CD8+T cells 
published in Mackay et al., 2016 – all differentially expressed genes. 
(Positive log2FoldChange describes up-regulation in expression of a gene in the TRM compared 
to the TEM subset) 
gene log2FC padj gene log2FC padj gene log2FC padj 
Cdh1 6.85 1.76E-21 Pip5k1b 3.48 3.44E-06 Carmil1 2.78 0.001254 
Itgae 6.71 4.95E-09 Car9 3.44 0.000145 Sh2d4a 2.78 0.019167 
Gpr34 5.75 2.22E-16 Sik1 3.42 2.67E-08 Erbb3 2.78 0.002484 
B4galnt4 5.63 8.02E-18 Dusp6 3.33 1.44E-40 Eps8 2.77 0.003913 
Hpgds 5.49 3.44E-19 Chchd10 3.23 0.000293 Hist1h2bc 2.76 0.011157 
Rgs1 5.34 5.73E-24 Irs2 3.23 0.000111 Acvr1b 2.75 3.78E-15 
2900026A02Rik 5.28 6.22E-49 Blnk 3.21 0.000335 Itga3 2.73 7.41E-09 
Nr4a1 5.09 1.97E-07 Litaf 3.18 2.49E-10 Nfix 2.72 0.000668 
Tjp1 5.01 6.13E-09 Pafah2 3.16 0.000683 Tnfrsf9 2.72 1.53E-05 
P2rx7 5.01 4.14E-05 43532 3.15 2.12E-05 Fam83h 2.71 0.001966 
Nr4a2 4.9 4.50E-07 Gpr55 3.15 6.18E-13 Egr3 2.71 1.10E-06 
43713 4.75 4.18E-05 Trib1 3.13 1.14E-07 Hic1 2.68 0.002519 
Ppp1r3b 4.68 4.02E-16 Cdkn1a 3.12 0.001099 Epb41l3 2.66 0.027522 
Maoa 4.67 2.50E-05 Src 3.12 0.00025 Klf4 2.65 0.004838 
St8sia1 4.53 5.62E-10 Kntc1 3.07 2.69E-08 Slc16a10 2.63 4.34E-09 
Fosb 4.43 2.50E-05 Dusp1 3.07 8.38E-06 Pak6 2.62 3.03E-14 
Ccr9 4.34 0.000471 Cpd 3.05 0.000122 Lgals4 2.62 0.004693 
Hbegf 4.33 1.41E-05 Fam174b 3.04 1.86E-12 Ccl4 2.6 5.28E-16 
Fos 4.2 1.04E-05 Rhpn2 3.03 0.005289 Cd69 2.55 6.32E-06 
Fnbp1l 4.18 3.10E-05 Rgs10 3.03 1.01E-12 Arrdc4 2.55 0.000735 
Ifitm2 4.16 0.000164 Jun 2.99 3.81E-07 Sel1l3 2.54 0.019345 
Ahr 4.15 5.90E-08 Gng12 2.98 0.005553 Ccdc136 2.53 0.003291 
Snx7 4.05 0.000176 Tsc22d1 2.96 0.001237 Myo10 2.53 0.000379 
Ldlr 3.98 5.38E-09 Plk2 2.96 0.000737 Ctla4 2.51 0.003718 
Ceacam1 3.93 0.003872 Smagp 2.93 0.02646 Prom1 2.5 0.017412 
Myo6 3.92 6.50E-30 Cers6 2.93 3.60E-08 Map7 2.49 0.003662 
Chn2 3.89 7.28E-13 Mtss1 2.91 5.33E-06 Parva 2.48 0.028397 
Mlxipl 3.86 0.006605 Pard6b 2.91 0.000176 Ccl25 2.47 0.020015 
Egr2 3.82 2.93E-15 Tnfaip3 2.88 6.81E-06 Plk3 2.45 1.87E-07 
Mpzl2 3.73 0.000378 Cd244a 2.87 5.57E-29 Trat1 2.41 9.34E-08 
Gcnt1 3.7 7.04E-15 Papss2 2.85 0.03128 Ets2 2.41 0.002876 
Dsg2 3.66 0.0002 Cep170b 2.84 4.89E-27 Slc6a8 2.4 0.007913 
Car2 3.58 0.000987 Ccnd1 2.8 0.013256 Zfp683 2.39 8.99E-31 
Cd24a 3.57 0.003932 Shroom3 2.79 0.014017 Sh3d19 2.38 0.000512 




gene log2FC padj gene log2FC padj gene log2FC padj 
Armc2 2.37 4.89E-09 Cdc42ep1 2.13 0.021397 Dhcr24 1.99 1.09E-07 
Pdcd1 2.37 7.75E-05 Ldlrad4 2.12 0.001648 Tpd52 1.99 0.000273 
Hook1 2.36 1.36E-06 Haspin 2.12 0.001701 Tjp2 1.99 0.008959 
Asph 2.35 0.005737 Ifngr2 2.12 0.00935 Ckap2l 1.99 0.003856 
Neurl3 2.35 3.16E-09 Arhgap21 2.12 0.003251 Slc15a1 1.98 0.018082 
Abi3 2.34 2.33E-06 Spint2 2.11 1.74E-05 Mvb12b 1.98 1.50E-10 
Actn2 2.34 1.28E-05 Aldh2 2.1 0.046227 Farp2 1.97 0.002316 
Arhgef39 2.34 0.000233 Junb 2.1 0.002154 Ctnna1 1.97 0.000157 
Rgs2 2.33 0.000358 Gas2l3 2.1 0.001236 Tigit 1.97 4.44E-37 
Serpinb1a 2.33 0.007517 Nusap1 2.09 0.001306 Elovl6 1.96 2.71E-05 
Frmd4b 2.32 1.57E-11 Tmc4 2.09 0.009629 Rnf149 1.96 1.84E-07 
Nol4l 2.32 5.47E-05 Ddr1 2.08 0.042528 Kif11 1.96 0.00088 
B3galt5 2.31 1.39E-15 Klf9 2.07 0.000523 Ttk 1.96 0.007769 
Mt1 2.31 0.032391 Sqle 2.07 2.22E-05 Ank3 1.95 0.005402 
Tbc1d16 2.31 1.25E-10 Anln 2.06 0.000222 Pitpnm2 1.95 3.11E-06 
E2f8 2.3 0.001508 Ppp1r15a 2.06 4.24E-05 Dst 1.95 0.012781 
Susd2 2.3 0.000508 Sec14l2 2.05 0.02668 Gngt2 1.94 0.002401 
Inpp4b 2.29 2.71E-40 Plac8 2.05 0.017577 Arhgef5 1.94 0.00107 
Phactr2 2.28 3.26E-07 Cenpv 2.04 0.001489 Kif15 1.94 2.17E-05 
Rhob 2.27 0.000148 Gadd45b 2.04 0.00042 Plcb3 1.93 0.015278 
Gm49395 2.26 3.70E-12 Tpx2 2.04 0.001107 Tmem176a 1.93 0.006555 
Gstt3 2.24 0.001516 Slco2a1 2.03 0.000204 Dstn 1.93 0.021361 
Lgr5 2.23 0.027763 Ccnb2 2.03 0.012082 Lzts1 1.93 1.15E-11 
Ccl3 2.22 3.72E-30 Sh3gl2 2.02 0.025195 Dok4 1.92 0.000686 
Fam84a 2.21 0.001415 Lag3 2.02 0.001274 Pcyox1 1.91 7.38E-05 
Grtp1 2.21 0.022095 Pkig 2.02 0.023109 Slc25a15 1.91 0.013036 
Idi1 2.19 4.10E-06 Ggt5 2.01 1.19E-05 Acpp 1.9 8.11E-06 
Slc44a1 2.19 0.000421 Acvr2a 2.01 0.000495 Smox 1.9 0.00738 
Fndc3b 2.19 1.17E-07 Spats2 2.01 5.57E-09 Nfib 1.9 0.019445 
Ctsl 2.18 0.005284 Zfyve28 2 6.85E-06 Foxred2 1.89 4.26E-05 
Ndrg1 2.18 0.000663 St14 2 0.000121 Atp6v0a1 1.89 0.030742 
Tmem86a 2.17 0.011863 Igf2bp2 2 0.000902 Iqgap3 1.89 0.044262 
Nr4a3 2.17 0.001865 Anxa4 1.99 0.02668 Hilpda 1.89 0.001249 
Fosl2 2.16 0.003137 Cish 1.99 1.10E-13 Nuf2 1.88 0.007759 







gene log2FC padj gene log2FC padj gene log2FC padj 
Fahd1 1.87 0.043826 Unc13a 1.72 0.038201 Hpse 1.59 0.00072 
Coro2a 1.87 5.76E-15 Ect2 1.71 0.000861 Csrnp1 1.59 0.010602 
Styk1 1.87 0.049245 Abhd15 1.69 6.25E-06 Gdpd5 1.58 0.000623 
Cd101 1.86 5.28E-16 Plxna1 1.69 0.022338 Fdft1 1.57 0.000735 
Cd7 1.86 0.00017 Mical3 1.69 0.029949 Plekha7 1.57 8.72E-05 
Zcchc24 1.85 5.59E-08 Sdr42e1 1.68 6.50E-05 Fam234b 1.57 6.40E-06 
Itga1 1.85 1.94E-14 Sult2b1 1.67 0.001848 Agrn 1.57 4.87E-05 
Per2 1.85 9.18E-10 Cd93 1.67 1.28E-05 Baiap2 1.56 0.001259 
Dag1 1.84 0.011676 Irf4 1.67 7.90E-07 Fgr 1.55 2.37E-05 
Pvrig 1.84 2.47E-12 Gzmb 1.67 1.93E-08 Etv3 1.55 3.16E-34 
Per1 1.83 0.000187 Lrrc75a 1.66 0.003316 Clspn 1.54 3.10E-06 
Tnf 1.83 0.000402 Ctif 1.65 2.19E-09 Birc5 1.53 0.031532 
Crem 1.83 0.003802 Fancd2 1.65 0.001505 Twsg1 1.53 9.55E-11 
Mvk 1.82 1.20E-05 Insig1 1.65 0.00036 Rad54b 1.53 0.042015 
Eya2 1.81 3.30E-07 Bpnt1 1.65 0.030035 Prkra 1.53 0.000175 
Bnip3 1.8 0.00712 Irf8 1.64 2.40E-06 Nek8 1.53 2.23E-06 
Prrt2 1.8 8.59E-05 Mical2 1.64 1.38E-10 Cyp51 1.52 0.012774 
Dusp16 1.8 0.001237 Kctd12 1.64 7.66E-05 Abcd3 1.52 0.001451 
Tmem44 1.79 0.005067 Zfp36 1.63 0.003718 Il1rl2 1.52 0.02528 
Pheta1 1.78 0.023899 Mki67 1.63 0.004413 Ncf1 1.52 4.26E-05 
Oat 1.78 0.029348 Zfyve21 1.63 0.037855 Adam19 1.52 3.51E-23 
Aurkb 1.78 0.013533 Tmem97 1.63 0.043368 Ifng 1.52 2.50E-05 
Cdc42bpg 1.78 0.01165 Pi4k2b 1.63 0.000111 Dbi 1.52 0.00615 
Tmem176b 1.76 0.006118 Cdk1 1.62 0.005541 Fdps 1.51 7.56E-05 
Cebpb 1.76 0.000137 Odc1 1.62 0.000182 H1f0 1.51 0.005598 
Mccc2 1.75 3.24E-05 Cenpe 1.61 0.001859 Gk5 1.51 0.021916 
Pde4a 1.75 0.001823 Fam213a 1.61 0.000788 Bcl2l11 1.5 3.49E-31 
Cdca3 1.75 0.022609 Coq7 1.61 0.005995 Casz1 1.5 0.001326 
Sbf2 1.74 0.003442 Dgat1 1.61 0.001542 Mpp5 1.5 0.000318 
Ccrl2 1.74 0.006519 Coq8a 1.61 0.004873 Hmgcs1 1.49 0.003334 
Lgalsl 1.74 0.00613 Jaml 1.6 2.82E-11 Sipa1l2 1.49 1.02E-12 
Gsto1 1.74 0.031898 Wfs1 1.6 0.001047 Grb7 1.49 0.02146 
Traf4 1.73 0.000271 Gmds 1.6 0.017029 Pde6h 1.48 0.024308 
Bcl2a1b 1.73 0.000246 Trp53inp2 1.59 0.000701 Slc25a10 1.48 0.005042 







gene log2FC padj gene log2FC padj gene log2FC padj 
Gabarapl1 1.48 0.001662 Spc24 1.38 0.033071 Kdm6b 1.28 0.025261 
Clip2 1.47 0.014067 Smim3 1.37 6.77E-05 Fads1 1.28 0.000157 
Plxna2 1.47 0.000811 Lonrf1 1.37 0.008689 Pim3 1.28 0.023712 
Zdhhc23 1.46 0.0002 Glmn 1.37 4.95E-08 Smad1 1.28 0.02959 
Luzp1 1.46 0.000612 Phlpp1 1.36 0.011335 Axl 1.27 8.53E-05 
Ppa1 1.46 0.013058 Cxcr6 1.36 5.10E-09 Il17rd 1.27 8.42E-05 
Pank1 1.45 0.000222 Ehd1 1.35 0.019392 Fam69b 1.27 0.002783 
Frmd4a 1.45 1.39E-10 Irak2 1.35 6.43E-05 Exo1 1.27 0.025309 
Cep85l 1.45 7.68E-06 Zfp976 1.35 0.002199 Zfp991 1.27 0.019345 
Arhgap11a 1.45 0.002323 Adora3 1.34 0.024467 Fgl2 1.27 0.001287 
Tex2 1.44 1.40E-07 Glrx 1.34 8.74E-17 Nfkbid 1.26 0.005322 
Tnfsf10 1.44 2.86E-11 Top2a 1.34 0.000254 Slc31a1 1.26 0.015865 
Prr11 1.44 0.023067 Bend4 1.33 0.007826 Sccpdh 1.26 0.005541 
Dynlt3 1.44 0.0001 Nfil3 1.33 0.022007 Fzd5 1.26 0.016464 
Adgrg3 1.44 0.008102 Pdlim7 1.33 0.014067 Qsox1 1.25 7.74E-11 
Icos 1.43 0.000276 Hyal2 1.33 0.015128 Mpp7 1.25 0.005367 
Espl1 1.42 0.009245 Myc 1.33 5.32E-06 Ifi30 1.25 0.043966 
Sesn3 1.42 5.95E-19 Pkp4 1.32 0.00051 Dennd4a 1.25 2.86E-05 
Fntb 1.42 2.55E-05 Pdk2 1.32 0.016822 Sgo2a 1.25 0.01372 
Tpi1 1.42 0.008302 Prdx6 1.32 9.04E-05 Fn1 1.24 0.013674 
Cnr2 1.42 0.023388 Btbd16 1.31 0.003577 Gpr171 1.24 3.37E-05 
Havcr2 1.42 0.039395 Hsd17b7 1.31 2.10E-08 Slc30a4 1.24 0.008734 
Cemip2 1.41 6.04E-05 Ppfibp1 1.31 0.018304 Rbpj 1.24 6.08E-07 
Gas8 1.41 0.001361 Znrf1 1.31 6.72E-07 Tnfsf8 1.24 0.015254 
Ptger4 1.41 1.01E-09 Hexa 1.3 0.001307 Dstyk 1.24 0.000646 
Syne2 1.4 8.53E-08 Hspa5 1.3 5.81E-07 Bmp2k 1.24 5.11E-07 
Kif14 1.4 0.032117 Gsdme 1.3 0.00617 Tcn2 1.23 0.000891 
Il4ra 1.4 2.06E-05 Ergic1 1.3 1.08E-05 Hemk1 1.23 0.017163 
Dapk2 1.4 2.95E-07 Abcb9 1.29 0.00117 Dtl 1.23 0.028335 
Vav3 1.4 0.005452 S100a3 1.29 0.008286 Apol10b 1.22 4.50E-05 
Dhrs11 1.39 0.000462 4930539E08Rik 1.29 0.002517 Msmo1 1.22 0.001367 
Hist1h2bg 1.39 0.024054 Aim2 1.29 7.68E-10 Galns 1.22 2.68E-25 
Skil 1.38 1.54E-05 Gm45716 1.29 0.025659 Patj 1.22 0.002936 
Mis18bp1 1.38 0.028751 Gm10392 1.29 0.016951 Tex9 1.22 6.52E-06 







gene log2FC padj gene log2FC padj gene log2FC padj 
Arrdc3 1.22 0.00117 Ralgps2 1.15 0.011676 Tyro3 1.07 0.000199 
Btbd8 1.22 0.008033 Trib2 1.14 0.000208 Acnat1 1.07 0.032764 
Uhrf1 1.22 0.033012 Scrn2 1.14 0.041552 Mpp6 1.07 0.007676 
Spred1 1.22 4.21E-10 Tgif2 1.14 0.003929 Kifc1 1.07 0.048293 
Abcb8 1.22 0.014338 Ncapg2 1.14 0.037925 Vps37b 1.07 0.010591 
Cdc25a 1.21 0.006623 Net1 1.14 0.039713 Chka 1.06 0.042543 
Rnf130 1.21 4.16E-06 Tmem38b 1.14 2.73E-11 Cpne2 1.06 0.033948 
Rab3a 1.21 0.011399 Ptpn3 1.13 0.028963 Fmnl3 1.06 2.39E-05 
Il12rb1 1.21 5.40E-08 Psrc1 1.13 0.048863 Mxd4 1.06 8.71E-05 
Rrad 1.21 0.000471 Abcb1a 1.13 1.42E-09 Tnfrsf1b 1.06 0.000614 
Il6st 1.2 4.64E-05 Acad11 1.13 5.00E-05 Abr 1.06 8.26E-09 
Ptp4a1 1.2 0.000679 Slc39a6 1.13 0.00128 Bcl6 1.06 0.000626 
Stard4 1.2 4.37E-05 Slc25a25 1.12 0.009134 Entpd7 1.05 0.001292 
Nek6 1.2 0.047783 Bckdhb 1.12 8.03E-05 Casp6 1.05 0.019345 
Tmlhe 1.2 0.041605 Kyat3 1.12 0.033212 Il12rb2 1.05 0.023196 
Slc27a1 1.19 8.14E-06 Il21r 1.12 1.25E-10 Mapkapk3 1.05 4.38E-05 
Tmem9 1.19 1.01E-05 Padi2 1.12 1.88E-08 Engase 1.05 0.012795 
Itpripl2 1.19 9.50E-06 Fasl 1.11 5.98E-17 Diaph3 1.04 0.001409 
Zfp821 1.19 1.62E-09 Fhl3 1.11 4.82E-05 Ddx3x 1.04 4.01E-05 
Smco4 1.19 0.036423 Map4k3 1.1 0.008603 Lmln 1.04 0.041168 
Arhgap39 1.19 0.001907 Insr 1.1 0.001034 Fndc3a 1.04 0.003029 
Mgat4a 1.18 0.000293 Tulp2 1.1 0.028707 Mafk 1.04 0.013087 
Agfg1 1.17 1.48E-14 Ubc 1.1 0.000285 Edaradd 1.04 0.000289 
Ubald2 1.17 0.008392 Prpf40b 1.09 0.000522 Ssbp2 1.03 0.002063 
Pccb 1.17 0.008673 Maf 1.09 0.024755 Retreg1 1.03 6.12E-19 
Cd3g 1.17 6.04E-08 Cenpn 1.08 0.010455 Tube1 1.03 0.014232 
Acsf2 1.16 1.27E-09 Rundc3b 1.08 1.84E-07 Mast1 1.03 0.010356 
Acsl1 1.16 0.041125 Arrb1 1.08 5.07E-05 Gstt2 1.03 0.02694 
Cryzl2 1.16 0.01453 Klhl5 1.08 0.027259 Stk39 1.02 1.64E-06 
Bri3bp 1.15 0.004984 Mgrn1 1.08 0.001655 Lrrc1 1.02 0.001732 
Ssh3 1.15 0.03471 Itm2c 1.08 0.001543 Tgtp1 1.02 0.021119 
AW011738 1.15 7.11E-09 P2ry10 1.07 0.007913 Rnf122 1.02 6.95E-05 
Slc39a4 1.15 2.26E-06 Mns1 1.07 0.000261 Map4k5 1.02 0.00169 
Lztfl1 1.15 0.001505 Wee1 1.07 0.03621 Slc22a15 1.02 0.008302 







gene log2FC padj gene log2FC padj gene log2FC padj 
Rabggtb 1.01 0.019402 Txk -1.09 0.021066 Tagln2 -1.18 2.41E-06 
Rassf7 1.01 0.039639 Chst10 -1.09 0.000119 Gm6904 -1.18 0.041726 
Slc16a6 1.01 3.03E-05 Ccne1 -1.1 0.028335 Gbp3 -1.18 0.030035 
Rb1 1.01 3.93E-07 Fas -1.1 0.045735 Slc16a4 -1.19 0.027485 
D030056L22Rik 1.01 0.036616 Zfp169 -1.1 1.58E-06 Lyst -1.19 0.016458 
Txn1 1 0.006977 Ifit2 -1.11 0.03974 Fam69a -1.19 9.29E-11 
Ly6e 1 5.34E-08 Limd2 -1.11 0.035751 Ifi209 -1.2 0.016061 
Gla 1 0.043642 Ret -1.11 0.043826 B3gnt9 -1.2 0.002803 
Pced1b -1 0.000123 Palm3 -1.11 0.017121 Prkcq -1.21 9.06E-06 
B3galt4 -1 0.004873 Cacna2d4 -1.11 0.016733 Hexb -1.21 1.20E-14 
Slc25a51 -1 6.18E-11 Ier3 -1.11 0.04724 Phf11b -1.22 0.020463 
Iqgap2 -1.01 0.001289 Gab3 -1.12 2.42E-06 Ncln -1.22 9.48E-15 
Katnb1 -1.01 3.30E-07 Sh2d5 -1.12 0.01493 Gprin3 -1.22 0.000277 
Dcp1b -1.01 2.92E-09 Baiap3 -1.12 0.012503 G0s2 -1.22 0.011195 
Setd4 -1.01 2.20E-11 Nacad -1.13 0.035474 Snx30 -1.23 0.03128 
Orai2 -1.02 5.48E-09 Fgd6 -1.13 0.030043 Tuba1a -1.23 1.35E-06 
Nfatc3 -1.02 1.00E-07 Cd1d1 -1.14 0.000178 Sike1 -1.24 0.000113 
Tmc6 -1.02 0.00098 Xdh -1.15 0.001899 Capn2 -1.24 3.20E-05 
Ttc7b -1.02 0.000169 Ccdc85b -1.15 0.010704 Scml4 -1.24 0.030134 
Fam89b -1.03 1.97E-05 Alcam -1.15 0.026895 Vopp1 -1.25 2.50E-05 
Cd46 -1.03 0.008108 Slc17a9 -1.15 3.18E-06 Rap2b -1.25 2.76E-05 
43719 -1.03 0.00169 Snx10 -1.15 3.69E-09 Klrc1 -1.26 0.000495 
Rnf138 -1.03 1.82E-10 Ms4a6b -1.15 0.001096 Nfic -1.26 1.60E-06 
Ttc39c -1.04 0.007088 Crybg3 -1.16 0.000299 Syt11 -1.26 0.035617 
Zfp760 -1.04 0.005654 Cdkn2d -1.16 7.03E-05 Scand1 -1.27 0.030404 
Ssh1 -1.05 0.004202 Aven -1.16 3.65E-11 Pltp -1.28 0.000909 
Thtpa -1.05 2.16E-06 AI467606 -1.16 0.005995 Il17ra -1.28 1.17E-07 
Xrn2 -1.05 3.63E-29 Ms4a4b -1.16 0.000296 Kbtbd11 -1.28 3.91E-05 
Asrgl1 -1.05 0.000653 Tnfrsf13c -1.16 7.28E-06 Adora2a -1.28 0.034472 
Fam53b -1.05 2.18E-11 Nod1 -1.17 0.003348 Sfxn3 -1.29 9.06E-07 
Tbkbp1 -1.05 7.97E-07 Gm527 -1.17 0.015519 Fam117a -1.29 7.81E-08 
Lrrc8a -1.06 3.00E-09 Tnfaip8l2 -1.17 0.001859 Olfr31 -1.3 6.85E-11 
Zfp354c -1.06 0.021945 2410004P03Rik -1.18 2.35E-07 Samhd1 -1.3 0.000998 
Itgb2 -1.07 0.008344 Klrd1 -1.18 4.27E-05 Alox8 -1.3 0.010356 







gene log2FC padj gene log2FC padj gene log2FC padj 
Fry -1.3 0.011568 Piezo1 -1.44 3.02E-10 Cd84 -1.68 0.007522 
Zfp658 -1.31 4.16E-06 Osm -1.45 2.89E-06 Gm9887 -1.68 0.009565 
Stk38 -1.31 7.53E-73 Kcnn4 -1.45 1.58E-12 Flna -1.69 0.000502 
Xkr8 -1.32 0.022235 Fam49a -1.45 3.38E-06 Adgre5 -1.69 0.008821 
Stx1a -1.32 7.87E-06 Mylip -1.46 0.000233 Bcl9l -1.69 1.31E-10 
Bin2 -1.32 4.49E-08 Ifi214 -1.46 0.020687 Arhgap26 -1.7 5.43E-13 
Zfp874b -1.32 0.000433 Cdc14b -1.47 3.59E-07 Il1rl1 -1.72 0.003352 
Nck2 -1.33 1.94E-07 Lfng -1.47 7.39E-05 Cpm -1.73 0.00017 
Zfhx2 -1.33 9.96E-09 Spn -1.47 7.78E-06 Lgals1 -1.74 0.02288 
Ypel1 -1.33 5.60E-07 Mpnd -1.47 2.35E-10 Dnah8 -1.75 0.000461 
Dixdc1 -1.33 0.027033 Plek -1.48 0.007409 Heatr9 -1.75 0.005797 
Rarg -1.35 0.010435 Tub -1.48 0.001251 Car5b -1.76 0.009126 
Ahnak -1.36 0.007067 Adamts14 -1.48 0.038701 Il18r1 -1.76 1.45E-05 
Galnt2 -1.36 0.000849 Inf2 -1.49 0.026264 Cdc25b -1.77 9.44E-08 
Nat14 -1.36 0.025548 Fgf13 -1.5 3.49E-07 Pxylp1 -1.77 3.15E-05 
Atp2b1 -1.36 4.24E-09 Vmn2r84 -1.51 3.20E-10 Stx2 -1.79 1.02E-12 
Slc25a33 -1.37 0.000727 Myl6b -1.51 0.001652 Tcf7 -1.81 5.37E-11 
Pkd1l3 -1.38 0.002107 Nebl -1.52 0.04045 Hmox1 -1.83 0.04517 
Lair1 -1.38 0.006502 Rap2a -1.52 0.000789 Pianp -1.83 0.010578 
Olfr1221 -1.39 6.52E-06 Ms4a2 -1.52 0.000113 Slc15a3 -1.84 0.002207 
Gm8369 -1.39 0.006014 Stard10 -1.53 0.000686 Sgk1 -1.85 0.001742 
Ms4a6c -1.41 0.000435 Kif5c -1.54 0.040512 Nfe2 -1.85 0.000281 
Ifitm10 -1.42 7.64E-08 Cmklr1 -1.54 0.048293 Arl4c -1.85 1.17E-05 
Dock5 -1.42 2.01E-14 Gsap -1.55 0.00169 Wdr95 -1.86 0.001206 
Txndc5 -1.42 4.44E-11 Arl5c -1.56 0.000687 Dlg4 -1.86 2.77E-13 
Kcnab2 -1.42 1.72E-11 Nipal3 -1.56 6.46E-11 Ccl5 -1.86 0.014672 
Tmem71 -1.42 2.87E-07 Bbc3 -1.56 0.000633 E2f2 -1.88 4.56E-05 
Spice1 -1.42 1.37E-22 Phf13 -1.57 5.86E-05 Tmem136 -1.89 2.84E-08 
Rec114 -1.42 1.38E-06 St3gal1 -1.58 4.02E-10 Icam2 -1.92 5.04E-06 
Rara -1.42 0.004354 Klrc2 -1.59 6.83E-11 AB124611 -1.92 0.036705 
Runx1 -1.43 0.007676 Gmfg -1.6 0.003111 Lpin1 -1.93 1.57E-06 
Ehd3 -1.43 1.08E-11 Racgap1 -1.64 3.54E-17 1700025G04Rik -1.94 0.002225 
Emp3 -1.43 0.006456 Rhebl1 -1.64 8.83E-12 B3gnt5 -1.94 1.05E-06 
Prune1 -1.43 2.33E-06 Tcp11 -1.66 0.00023 Qprt -1.94 1.47E-05 







gene log2FC padj gene log2FC padj 
Pik3r5 -1.96 6.40E-08 Kcnc1 -2.78 2.98E-09 
Atp1b3 -1.97 1.21E-14 Kcnj8 -2.81 3.49E-31 
Slc9a7 -1.97 2.03E-10 Cxcr4 -2.83 1.86E-12 
D1Ertd622e -2 1.37E-14 Sidt1 -2.87 1.10E-09 
Gramd4 -2 4.44E-37 A430078G23Rik -2.89 4.38E-14 
Lef1 -2.01 0.000499 Pde2a -2.89 0.000233 
Acp5 -2.01 0.001317 Klre1 -2.93 0.00085 
Dmrta1 -2.07 0.000197 Prss12 -2.94 3.08E-09 
Haao -2.08 6.71E-13 Gzmm -3.01 3.71E-09 
Ripor2 -2.08 4.72E-10 Ccl9 -3.04 3.79E-07 
Prkcg -2.08 0.000684 Zeb2 -3.09 4.52E-25 
Olfr1160 -2.08 3.54E-05 Ly6c2 -3.28 0.001203 
Klf3 -2.11 0.000223 Cx3cr1 -3.4 0.004301 
Gna15 -2.12 1.40E-06 Klrb1c -3.45 9.91E-08 
Cmah -2.17 2.70E-06 Rap1gap2 -3.83 2.33E-31 
Serpini1 -2.2 2.19E-05 Klf2 -4.01 2.02E-16 
Klhl6 -2.2 5.87E-20 S1pr1 -4.66 1.96E-15 
Sh3bp5 -2.22 0.00022    
S1pr4 -2.25 1.03E-11    
Rasgrp2 -2.27 3.07E-09    
Itga4 -2.27 0.002221    
Klrc3 -2.29 1.65E-09    
Sema4f -2.39 1.80E-27    
Borcs7 -2.39 2.22E-23    
Ctxn1 -2.4 0.01077    
Itgb1 -2.41 6.76E-17    
Gpr146 -2.47 0.000269    
Rasa3 -2.52 2.77E-13    
Arhgef18 -2.57 1.92E-18    
Vcam1 -2.63 0.006686    
Sbk1 -2.66 1.31E-10    
Il18rap -2.67 9.21E-20    
Tlr1 -2.68 2.60E-05    
Nrp1 -2.68 2.41E-06    





Table 4-3. List of BATF-IRF4-dependent genes induced in CD4+T cells upon in vitro TCR 
stimulation under Th2 conditions (anti-IFNgamma, anti-IL-12 and IL-4)  (Part 1/2) 
Batf Igfbp4 Atf3 Gpd2 Ppp1r3b 
Cd24a Ighe Atp2b4 Gpnmb Ppp2r3a 
Ctla2a Il12rb1 Atp6v0d2 Gpr65 Prnp 
Lilr4b Il1rl1 B430306N03Rik Grina Pth 
Ifitm3 Itpr1 Basp1 Gsn Ptpn4 
Il10 Klf6 Batf3 H2-Q10 Ptprj 
Il21 Lif Bcl3 Haao Rab33a 
Il24 Maf Casp6 Hamp Rabgap1l 
Inhba Mfsd2a Cd200r1 Hif1a Rapgef5 
Lilrb4a Moxd1 Cd63 Hipk2 Rbp1 
Ly6a Nckap1 Cd93 Ifitm6 Rhoq 
Mt2 Ndrg1 Cdh17 Il12rb2 Rnf128 
Nts Nfil3 Cpd Il13 Rnf208 
Adamtsl3 n-R5s54 Creb3l2 Il18r1 Sccpdh 
Ak4 Olfr60 Crem Il1r2 Sdc3 
Aldoc Penk Ctla2b Il4 Sdcbp2 
Anxa2 Prdm1 Ctla4 Il5 Selenbp1 
Anxa5 Rbpj Cxcr2 Inha Selenbp2 
Asb2 Rnf19b Cyp2s1 Itga3 Selenom 
Atxn7l1 Rps6ka5 Cysltr1 Itga7 Sema4f 
B3galt2 S100a6 Arfgef3 Jup Serpinf1 
Bhlhe40 Scd1 Dennd3 Kif3a Sft2d2 
Ccr2 Scd2 Dgat1 Klhl6 Slc17a6 
Ccr4 Selp Dnm1 Lama5 Smim3 
Ccr8 Slc2a3 Dntt Lamc1 Smox 
Cdkn1a Snord118 Dock5 Lpxn Socs3 
Crip1 Snx9 Ecm1 Ly75 Stfa2 
Cyp11a1 St3gal1 Egfr Maged1 Stfa2l1 
Dusp16 Stom Emp1 Map3k5 Stra6 
Dusp6 Tanc2 Enah Mboat2 Sval1 
Egln3 Tigit Ermn Mir22 Tcp11l2 
Epas1 Trpm6 F730043M19Rik Mir22hg Tec 
Etv6 Ttc39c Fam114a1 Mt1 Tgfb3 
Fads2 Vim Tcaf2 Myo10 Tgm1 
Tent5a 1600014C10Rik C1qtnf12 Nabp1 Tgm2 
Focad 4932438H23Rik Fam183b Ncs1 Timp1 
Gcnt1 Dglucy Fchsd2 Nedd4 Tmem140 
Glrx AA467197 Fosl2 n-R5s64 Tnfrsf26 
Gm14005 Abi3 Frmd4b P4ha2 Tnfrsf8 
Gpm6b Adamtsl4 Galc Padi2 Tspan6 
Gpr174 Adarb1 Gatm Parp16 Ubash3b 
Gpr68 Afg3l2 Castor1 Paxbp1 Ube2d2b 
Gstk1 Ahr Gbp2 Pde1a Vdr 
Gzmb Ajuba Gbp2b Phxr4 Vldlr 
H2-Ab1 Akr1c18 Gem Pik3ap1 Nsd3 
Hgf Anxa4 Gimap7 Pkp2 Map3k20 
Hsd17b7 Appl2 Gipr Plcd1 Zc3h12c 
Htr1b Armcx3 Gja1 Plin2 Zcchc24 
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Table 4-4. List of BATF-IRF4-dependent genes induced in CD4+T cells upon in vitro TCR 
stimulation under Th2 conditions (anti-IFNgamma, anti-IL-12 and IL-4)  (Part 2/2) 
 
  
4930562F07Rik Isg20 Tox 
Add3 Itih5 Trat1 
AI504432 Kcnmb1 Trim12c 
Ankrd55 Klf3 Txk 
Arhgap20 Klk1b22 Utf1 
B630019A10Rik Lax1 Ier3 
Bcl2a1b Lin7a Arrb1 
Bcl2a1c Marcksl1 Gm24622 
Bzw2 Mir363 Pparg 
Ccl22 Ms4a4b 4930523C07Rik 
Ccr9 Ms4a4c Ifi203 
Cd226 Ms4a6b Iigp1 
Cd44 Ms4a6c Ipcef1 
Cd69 Nipal1 Tnfsf10 
Cd74 Nod1 Tnfsf11 
Cd79b Nr4a3 Tnfsf9 
Cd83 Nrp1  
Cd9 Nsg2  
Cd96 Ostn  
Cep85l Parp8  
Chn2 Pdlim1  
Clec2i Phtf2  
Cmah Ptger4  
Csf1 Ifi209  
Csn1s2a Qser1  
Csn2 Rel  
Cth Serpinb6b  
Ctss Slc14a1  
Dapl1 Slc9a7  
Dhrs3 Slfn1  
Dock10 Slfn3  
Emp3 Smpdl3a  
Fam129a Sprr2a2  
Fcrls St8sia6  
Foxp1 Tbc1d4  
Foxp3 Tcf7  
Gen1 Tdgf1  
Gm8995 Tdgf1-ps1  
Gpr183 Tespa1  
H60b Tex35  
Hdc Tlr7  
Hist1h1a Tnfrsf13c  
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Explanation of updated gene names  
* since the mouse genome annotation has change since the publication of the list, it had to be 
cleaned for missing/renamed genes 
 
Lilr4b ← Gp49a 
Lilrb4a ← Lilrb4 
Tent5a ← Fam46a 
Dglucy ← 9030617O03Rik 
Arfgef3 ← D10Bwg1379e 
Tcaf2 ← Fam115c 
C1qtnf12 ← Fam132a 
Castor1 ← Gatsl3 
Selenom ← Selm 
Nsd3 ← Whsc1l1 
Map3k20 ←Zak 
Gm8995 ← Gm10021 
Gpr183 ← Gm10838 
H60b ← Gm9900 




Table 4-5. List of IRF4-dependent genes induced upon CD4+T cell activation in vivo (Part 
1/2) 
Pde2a Ly6c2 Rnf144a Vangl2 Samd9l 
Atp8b4 Pkn3 Lats2 Pik3ip1 Egr3 
Nedd4 Neurl3 Serpinc1 Treml2 St3gal5 
Ms4a4c Tnfsf10 Smpd5 Rexo5 Sidt1 
Cxxc5 Dok3 Slc25a53 Il4ra Mb21d1 
Chdh Scml4 Rasgrp2 Irf7 Etv5 
Cd24a Ulbp1 Trio Bspry Susd1 
Tnfrsf19 Fam129c Ifi27 Tcn2 43532 
Fcrl1 Mcoln3 Ift80 Scn8a Cd5 
Lad1 Oasl2 Cmtm7 Apobr Ccrl2 
Xdh Lmna Mgst2 Ikzf3 Gm3468 
Nkg7 Ptk2 Fam160a2 Gm3739 Arhgap33 
Prrg4 Cd72 Foxp1 Cnbd2 Frmd4a 
Ifi214 Usp18 Cd86 Anxa2 Plec 
St3gal6 Ecm1 Capg Igf1r Lpar2 
Ifi213 Igfbp7 Crmp1 Cd96 Igf2bp3 
Qser1 Il10ra Cd79b Spry1 Itgb3 
Ppm1j Gm5239 Rasgrp1 Tmem158 Itgam 
Actg2 Rnf213 Sesn1 Axl Zfhx2 
Nrgn Cerk Ypel1 Hip1r Ehd4 
Cask Sytl2 Igfbp4 Ikzf2 Inf2 
Gstm1 Ddx58 Camk2b Pax6 Slfn8 
1500009L16Rik Sgk1 Tmem198 Spata6 Tmsb15b1 
Il17rb Rtp4 Emp3 Plxdc2 Arhgef18 
Ppic Ddx60 Bcl2l11 Etfbkmt 2310022B05Rik 
Ifi206 Chn2 Eno3 Tsc22d1 Lamb3 
Oas2 Apobec2 Tspan17 Usp20 Anxa6 
Plaur Adamtsl4 Ifi203 Rreb1 Trim34a 
Mcoln2 Bach2 Igf2r Hsh2d Upk1a 
Dglucy Cmpk2 Cnr2 Appl2 1110032F04Rik 
Snx9 Cnksr3 Pde8a Ranbp10 Capn3 
Oasl1 Gvin1 Pheta1 Cd9 Emc9 
Sox4 Rundc3a Cd160 Plek Mlkl 
Gm14085 Kctd12 Gramd4 Mndal Mapk12 
Itih5 Nod1 Id3 Ptprs Ldlrap1 
Shf Ston1 Chst11 Xylt1 Pmaip1 
Pglyrp1 Dhx58 Rps6ka5 Gdpd5 Ano8 
Parp12 Nt5e Zfp219 Pik3r5 Clip2 
Dapl1 Bmp7 Rasd1 Pex6 Oas1c 
Gbp7 Nme4 Plk2 Armcx4 Tmem71 
Sema4c Golm1 Sytl1 Phldb3 Gm45716 
Ifi209 Lcn4 Nat8f4 A430078G23Rik Aig1 
Cd55 Tmbim1 Tm6sf1 S100a10 Ttc28 
Colq Sell Tdrd7 Fgr St3gal4 
Arvcf Ubash3b Pabpc1l Crim1 Plpp1 
H2-Q6 Zfp395 Oaf Acp5 Eef2k 
Zbtb10 Itga6 Tet1 Prkd3 Aldh2 
Oas1a Zdhhc1 Ccdc125 Rsph3b Myb 
Ifi208 H2-Ob Gpsm1 H2-Q7 Zfp827 
Myo1e Ifit1 Rasa3 D830030K20Rik Rhob 
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Table 4-6. List of IRF4-dependent genes induced upon CD4+T cell activation in vivo (Part 
2/2) 
Tcp11l1 Aldoa Ccdc102a Pdcd1lg2 Stx11 
Gm9844 Lpxn Syt11 Lrba Cd22 
Rhoc Stard5 Ctdspl Ipmk Il17f 
Rab4a Plcb4 Asap1 Tmem176b Ccr4 
Nrarp Fam110a Raver2 Cdkn1a Serpinf1 
Usp28 2700097O09Rik Tesc Nr1d1 Smim3 
Xaf1 Ada Bcl2a1d Podnl1 Plekho1 
Cdc42ep3 Irf8 Gm49342 Lif Coro2b 
Itga4 Lrp8 H2-DMa Fam234a Egln3 
Pdgfb Dnaja4 Arhgef39 Mafg Lgals7 
Cep85 Jdp2 Ccdc63 Ccr8 Maf 
Herc6 Sla Adam12 Lsp1 H2-Q2 
Ttyh3 Icam1 Emp1 Nav2 Cxcr5 
Abcg3 Stk39 Il6ra Tgfbr3 Tigit 
Sh3pxd2a Glrx Aldh7a1 Hif1a Cxcr3 
Zfp28 Rapgef5 Bmp2k Rora  
Epsti1 Chrm4 Dgkh Atf6  
Plscr3 Smco4 Dmwd Grhl1  
Nrn1 43716 Nxpe3 Derl3  
Myd88 C2cd2 Mcur1 Cpd  
Pmepa1 Dnph1 Casp1 Lancl3  
Gngt2 Gna15 Olfr1310 Ispd  
Ksr1 Lag3 Il2rb Tbc1d4  
Optn Nfkbiz Mapre2 Ctla4  
Pmvk Plcl1 Slc16a3 Tmem2  
Slc46a3 Malt1 Gorasp1 Vdr  
1700025G04Rik Bhlhe40 Hmox1 Icos  
Fut8 St8sia1 Kctd17 Susd3  
Eya2 Tnfsf11 Galm Ptrh1  
Lpin2 Abtb2 P2rx7 Oxsr1  
Fam241a Jazf1 H1f0 Tor1aip1  
Farp1 B3gnt5 Trpm6 Gcnt1  
Il18rap Slc16a6 Itpk1 Mpp2  
Prnp Cltb Gpr155 Tnfrsf4  
Tnfrsf25 Armcx6 Kit Bcl6  
Prkcb Serinc5 Abi3 Osbpl3  
Chchd10 Smtn Desi2 Frmd4b  
Fhdc1 Ahr Cd40lg Tent5c  
Ddit4 D1Ertd622e Pqlc1 Cdk5r1  
Tnp2 Sqor Chst10 Itpr1  
Nek6 Dkkl1 Btbd19 Nebl  
Pkp3 Lime1 Ica1l Trerf1  
Gng12 Reep2 Cd8b1 Kcnk5  
Caskin2 H2-DMb2 Ly6a Tnfrsf8  
Rufy1 Tdrkh Atp9a Itgb1  
Arhgap31 Asns Wdfy2 Stom  
Lmo4 Akr1b8 Tspan5 Adam19  
Il12rb1 Slc11a2 Iffo2 Maats1  
Akap2 Angptl2 Xk Ptpn13  
Synpo Tspan2 Pacsin1 Adap1  
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CD69 is not required for the generation of lung CD4+TRM  
 
CD69 expression is a key distinguishing marker of mouse and human TRM [68, 256]. The 
functional role for CD69 in generation or maintenance of TRM has not been thoroughly 
investigated. We assessed whether CD69−/−CD4+T cells can generate TRM in response to 
influenza infection. After viral clearance (>4 weeks post-infection), the frequency of lung 
CD69−/− CD4+T cells protected from i.v. anti-CD90.2 labeling was comparable to infected control 
mice (Figure 4-3A, left). CD69-deficiency in the lungs of influenza-experienced KO mice was 
confirmed on the protein level (Figure 4-3A, middle). Additionally, the majority of CD69-deficient 
CD4+T cells in the lung of influenza-infected mice differentiated into CD44+CD62L- effector 
memory T cells, suggesting normal development of the TRM phenotype despite CD69-deficiency 
(Figure 4-3A, right). In conclusion, we found that CD69−/− mice 4 weeks after influenza infection 




Figure 4-3. CD69 is not required for the generation of lung CD4+TRM 
 (A) CD69 KO or WT (BALB/c or B6) mice were infected with PR8 virus. Flow cytometric 
analysis of lung CD4+T cells labeled by or protected from intravenously administered fluorescent 
anti-CD90.2 antibody at day 29 post-infection (left). Histograms of CD69 expression in i.v. labeled 
(Circ = circulating) or protected (Resident) T cell subsets in the lung of CD69 KO or WT mice 
(middle). Expression of CD44 and CD62L in the lung CD4+T cell of CD69 KO or WT mice (right). 
(B) Frequency of lung CD4+T cells that are protected from in vivo CD90.2 labeling (left) and 
frequency of effector memory CD4+T cells (CD44+CD62L-). Graphs display mean±SEM.    












Figure 4-4. R script for generation of Complex Heatmap figure of IRF4-regulated genes in 
mouse and human CD4+TRM 
library(ComplexHeatmap) 
## Loading required package: grid 
## ======================================== 
## ComplexHeatmap version 1.20.0 
## Bioconductor page: http://bioconductor.org/packages/ComplexHeatmap/ 
## Github page: https://github.com/jokergoo/ComplexHeatmap 
## Documentation: http://bioconductor.org/packages/ComplexHeatmap/ 
##  
## If you use it in published research, please cite: 
## Gu, Z. Complex heatmaps reveal patterns and correlations in multidimension
al  
##   genomic data. Bioinformatics 2016. 
## ======================================== 
#gather TPMs 
mouse <- read.csv("data_batch_correct_logged.csv", header = TRUE) 
head(mouse) 
##               X    ml1b1    ml2b1    ml3b2    ml4b2    ml5b2    ms1b1 
## 1 0610009B22Rik 1.550985 1.828793 1.623051 1.756856 1.644672 1.837752 
## 2 0610010F05Rik 2.040325 2.174313 2.023575 1.904260 2.109336 1.970070 
## 3 0610010K14Rik 4.093769 4.303098 4.348065 4.256330 4.132528 4.430611 
## 4 0610012G03Rik 2.919841 2.886509 2.890614 2.997630 3.153565 3.074242 
## 5 0610030E20Rik 2.706252 2.614955 3.001629 2.963876 2.849007 3.090255 
## 6 0610037L13Rik 3.634954 3.640080 3.683263 3.495263 3.587691 3.936632 
##      ms2b1    ms3b2    ms4b2 
## 1 1.355756 1.915137 1.180540 
## 2 1.848422 1.867531 2.123216 
## 3 4.569572 4.466852 4.383850 
## 4 3.227922 2.926096 3.002364 
## 5 3.638075 3.185777 2.874555 
## 6 3.887078 3.999712 3.907661 
human <- read.csv("human_TPM.csv", header = TRUE, row.names = 1) 
human <- log(human+1) 
human$X <- row.names(human) 
#get dictionary for combining one-to-one gene orthologs  
library(biomaRt) 
mart <- useMart(biomart = "ENSEMBL_MART_ENSEMBL", 
                dataset = "mmusculus_gene_ensembl", 
                host = 'ensembl.org') 
 
mouse_homology <-getBM(attributes = c('external_gene_name', 
                                      'hsapiens_homolog_associated_gene_name'
, 
                                      'hsapiens_homolog_orthology_type'), 
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                       mart = mart) 
###attach dictionary to mouse tpms 
mouse_w_homology <- merge(mouse, mouse_homology, by.x = "X", by.y = "external
_gene_name") 
###combine with human tpms 
combined <- merge(mouse_w_homology, human, by.x = "hsapiens_homolog_associate
d_gene_name", by.y = "X") 
###filter for one-to-one orthologs 
combined <- combined[combined$hsapiens_homolog_orthology_type == "ortholog_on
e2one",] 
##dupplicate removal 
subset(combined, hsapiens_homolog_associated_gene_name == "IGF2") 
##  [1] hsapiens_homolog_associated_gene_name 
##  [2] X                                     
##  [3] ml1b1                                 
##  [4] ml2b1                                 
##  [5] ml3b2                                 
##  [6] ml4b2                                 
##  [7] ml5b2                                 
##  [8] ms1b1                                 
##  [9] ms2b1                                 
## [10] ms3b2                                 
## [11] ms4b2                                 
## [12] hsapiens_homolog_orthology_type       
## [13] bld1                                  
## [14] bld2                                  
## [15] bld3                                  
## [16] bld4                                  
## [17] bld5                                  
## [18] d332                                  
## [19] d340                                  
## [20] d346                                  
## [21] d347                                  
## [22] s332                                  
## [23] s340                                  
## [24] s346                                  
## [25] s347                                  
## <0 rows> (or 0-length row.names) 
combined <- subset(combined, X != "Gm49394")  
####get gene names into row names  
rownames(combined) <- combined$hsapiens_homolog_associated_gene_name 
###gene list  
gene_list <- read.csv("clusters1234.csv",header = FALSE) 
gene_list <- as.character(gene_list$V1) 
### 
#gene list KO 
gene_list_ko <- read.csv("mouse_sig_IRF4_KO.csv",header = TRUE) 





##       hsapiens_homolog_associated_gene_name     X    ml1b1    ml2b1 
## AAAS                                   AAAS  Aaas 3.677386 3.725050 
## AACS                                   AACS  Aacs 3.110116 2.891383 
## AAGAB                                 AAGAB Aagab 3.531317 3.390548 
## AAK1                                   AAK1  Aak1 4.107191 4.233362 
## AAMDC                                 AAMDC Aamdc 3.013730 3.146901 
## AAMP                                   AAMP  Aamp 5.121675 4.947147 
##          ml3b2    ml4b2    ml5b2    ms1b1    ms2b1    ms3b2    ms4b2 
## AAAS  3.611560 3.518921 3.598442 3.723432 3.851843 4.070391 3.829751 
## AACS  3.054077 3.448918 2.947613 3.167719 3.473903 3.161120 3.084409 
## AAGAB 3.636357 3.626317 3.542035 3.190903 3.173535 2.895368 3.103511 
## AAK1  4.017115 4.247817 4.222603 3.913756 4.145389 4.183881 4.024845 
## AAMDC 3.334168 2.857828 3.148375 3.047206 3.479654 3.339491 2.965480 
## AAMP  4.955335 5.127662 5.075919 4.926840 5.125120 4.865575 5.139694 
##       hsapiens_homolog_orthology_type     bld1     bld2     bld3     bld4 
## AAAS                 ortholog_one2one 4.101718 4.034979 4.225357 4.217423 
## AACS                 ortholog_one2one 2.794520 2.411691 2.536145 2.507960 
## AAGAB                ortholog_one2one 3.843280 3.929460 4.101067 4.031746 
## AAK1                 ortholog_one2one 5.263166 5.774763 5.608167 5.570502 
## AAMDC                ortholog_one2one 3.384361 3.332187 3.319673 3.266637 
## AAMP                 ortholog_one2one 4.793644 4.547747 4.841949 4.699539 
##           bld5     d332     d340     d346     d347     s332     s340 
## AAAS  4.047416 2.926499 3.141613 3.334636 4.472312 2.761531 2.912584 
## AACS  2.513628 2.957017 3.020174 3.512376 3.808777 2.749837 2.923797 
## AAGAB 4.032075 3.316430 3.075287 2.813214 3.768211 3.062711 3.294220 
## AAK1  5.379732 4.790295 4.682912 5.279575 5.020583 4.677508 4.470484 
## AAMDC 3.390703 2.674068 2.908701 2.705763 3.858044 3.011166 2.889091 
## AAMP  4.820683 4.745523 4.487542 4.878193 4.867262 4.721426 4.734357 
##           s346     s347 
## AAAS  3.402629 3.701456 
## AACS  3.391026 3.426425 
## AAGAB 2.512694 3.614606 
## AAK1  5.509516 5.436006 
## AAMDC 2.894747 3.735785 
## AAMP  4.701600 4.996253 
###get rid of non TPM columns 
combined_mat <- subset(combined, select = -c(hsapiens_homolog_associated_gene
_name, 
                                                X, hsapiens_homolog_orthology
_type)) 
### 
###see which of the cluster genes are found in the mouse-human dataset 
head(mouse_homology) 
##   external_gene_name hsapiens_homolog_associated_gene_name 
## 1              mt-Tp                                       
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## 2              mt-Tt                                       
## 3            mt-Cytb                                MT-CYB 
## 4              mt-Te                                       
## 5             mt-Nd6                                MT-ND6 
## 6             mt-Nd5                                MT-ND5 
##   hsapiens_homolog_orthology_type 
## 1                                 
## 2                                 
## 3                ortholog_one2one 
## 4                                 
## 5                ortholog_one2one 
## 6                ortholog_one2one 
mouse_homology_clusters <- subset(mouse_homology, mouse_homology$external_gen
e_name %in% gene_list) 
#keeping only the one-to-one orthologs  
mouse_homology_clusters_one_to_one <- mouse_homology_clusters[mouse_homology_
clusters$hsapiens_homolog_orthology_type == "ortholog_one2one",] 




### list of conserved genes in mouse Lung vs Spleen and Human DP vs Blood TPM 
shared <- read.csv("shared_up_down_dp_text.csv", header = TRUE) 
shared_list <- as.character(shared$hsapiens_homolog_associated_gene_name) 
head(shared_list) 
## [1] "ABCB9"   "ACOXL"   "ADAM9"   "AGO2"    "AGPAT4"  "ALDH7A1" 
#### 
###see which of the KO genes are found in the mouse-human dataset 
head(mouse_homology) 
##   external_gene_name hsapiens_homolog_associated_gene_name 
## 1              mt-Tp                                       
## 2              mt-Tt                                       
## 3            mt-Cytb                                MT-CYB 
## 4              mt-Te                                       
## 5             mt-Nd6                                MT-ND6 
## 6             mt-Nd5                                MT-ND5 
##   hsapiens_homolog_orthology_type 
## 1                                 
## 2                                 
## 3                ortholog_one2one 
## 4                                 
## 5                ortholog_one2one 
## 6                ortholog_one2one 
mouse_homology_ko <- subset(mouse_homology, mouse_homology$external_gene_name 
%in% gene_list_ko) 









combined_mat <- combined_mat[shared_list,] 
head(combined_mat) 
##            ml1b1    ml2b1    ml3b2    ml4b2    ml5b2     ms1b1     ms2b1 
## ABCB9   4.441242 4.525741 4.528647 4.666876 4.640863 3.0725189 3.5397453 
## ACOXL   1.315288 1.642090 1.454887 1.122615 1.594492 0.7729676 0.9916927 
## ADAM9   3.110959 3.257243 3.119242 3.278599 3.173724 1.3938825 1.3738440 
## AGO2    4.573424 4.486045 4.315388 4.669023 4.617462 3.3614205 3.9080097 
## AGPAT4  2.784508 2.584447 3.031004 2.760004 3.067341 1.9688016 1.9680680 
## ALDH7A1 3.030018 2.595947 2.870657 2.932567 2.872304 1.5845342 1.2588801 
##             ms3b2    ms4b2      bld1      bld2      bld3      bld4 
## ABCB9   3.0791830 3.239563 1.6833883 1.3563898 1.3982296 1.1417382 
## ACOXL   0.7355957 1.279700 0.2694643 0.3641335 0.3892661 0.2708917 
## ADAM9   1.4015050 1.390679 0.7223889 1.0489865 1.1559766 1.0745059 
## AGO2    3.5380308 3.767044 3.3220587 3.4252426 3.2750841 3.1050557 
## AGPAT4  1.5298761 1.726842 2.2357384 2.8458821 2.2482387 2.3127313 
## ALDH7A1 1.5260050 1.162244 0.9546136 1.2879790 1.4120355 1.2964879 
##              bld5      d332      d340      d346     d347      s332 
## ABCB9   1.7203954 1.7187222 1.7412532 2.0752639 2.337417 1.3934005 
## ACOXL   0.3583187 0.8481937 0.7550732 1.5415026 1.200502 0.7773697 
## ADAM9   1.0371589 1.6522697 1.6612477 0.8991772 1.745030 1.4735723 
## AGO2    3.1808844 5.5519160 5.9334066 4.9448948 5.350844 5.2684289 
## AGPAT4  2.2017065 3.5504825 4.1024095 3.6324119 3.729638 3.3647391 
## ALDH7A1 1.1748569 1.4118971 1.2684860 2.0723083 2.093027 1.4910881 
##              s340     s346     s347 
## ABCB9   2.0577297 2.341386 2.243005 
## ACOXL   0.6497139 1.531719 1.720760 
## ADAM9   1.6891125 1.387938 2.025921 
## AGO2    5.8637181 4.803085 4.936569 
## AGPAT4  4.3852585 3.677878 3.929825 
## ALDH7A1 1.6648416 2.237910 2.242298 
dim(combined_mat) 
## [1] 424  22 
#arrange rows according to log2FC in the shared genes table  
fold_change_arranged_shared <- shared[order(shared$log2FoldChange.x, decreasi
ng = T),] 
fold_change_arranged_shared_list <- as.character(fold_change_arranged_shared$
hsapiens_homolog_associated_gene_name) 






labels <- which(rownames(combined_mat) %in% gene_list_clusters_human) 
combined_mat <- t(scale(t(combined_mat))) 
head(combined_mat) 
##             ml1b1     ml2b1     ml3b2     ml4b2     ml5b2      ms1b1 
## PMEPA1  0.9444844 0.8477133 1.0291345 1.0811341 0.9989957 -0.9195002 
## PDE4A   0.5644751 0.3165816 0.7983367 0.6047991 0.6825274 -1.4742400 
## CREM    0.8932268 0.8368657 0.7013731 0.6657683 0.6359885 -1.3097569 
## FOSL2   1.2381228 1.0705514 1.0260505 1.1374390 1.1125260 -1.2694917 
## TNFRSF9 0.9602759 1.0128793 1.2176894 1.1530030 1.2436552 -0.9973069 
## RGS16   1.6703564 1.3825291 1.4792071 1.6830889 1.9492774 -0.3135985 
##              ms2b1      ms3b2      ms4b2       bld1       bld2       bld3 
## PMEPA1  -0.9160261 -1.1531585 -0.9926054 -1.3488478 -1.1835237 -1.4231545 
## PDE4A   -1.4301883 -1.7483989 -1.7474601 -0.9278132 -0.6306130 -0.6077564 
## CREM    -1.6273009 -1.5666378 -0.8886990 -0.9807417 -0.8960324 -1.1775197 
## FOSL2   -1.2763277 -1.6107286 -0.6031984 -1.3595376 -0.7286755 -1.1375293 
## TNFRSF9 -1.2083294 -1.3178215 -1.5044532 -0.7022950 -1.1864975 -0.5279363 
## RGS16   -0.7302870 -0.8545182 -0.5199710 -0.8006871 -1.1667938 -1.0805381 
##               bld4       bld5       d332       d340      d346        d347 
## PMEPA1  -1.3667930 -0.9907921  0.6012010  0.9322153 0.2996491  0.75520577 
## PDE4A   -0.7684616 -0.4728929  0.5722967  1.1226363 0.8499062  1.18363644 
## CREM    -1.0871483 -0.8263247  0.8398653  0.7701620 0.8562591  0.66986603 
## FOSL2   -1.1439319 -0.9290326  0.7237992  0.3498982 0.6491013  0.51368120 
## TNFRSF9 -0.9163346 -0.8854557  0.6278196  1.1680022 0.3448274 -0.87108397 
## RGS16   -1.0162934 -1.1364363 -0.1904813 -0.2719113 0.1529490  0.06087501 
##               s332       s340      s346       s347 
## PMEPA1   0.6378066  1.0081351 0.3751379 0.78358856 
## PDE4A    0.5812469  1.1232115 0.5649718 0.84319863 
## CREM     0.9303460  0.8486696 0.9157406 0.79603046 
## FOSL2    0.6909462  0.6178828 0.6527927 0.27566216 
## TNFRSF9  0.9534194  0.8281519 0.4022042 0.20558653 
## RGS16   -0.2592890 -0.3200074 0.1886436 0.09388609 
### 
 
labels_ko <- which(rownames(combined_mat) %in% gene_list_ko_human) 
 
ko <- rownames(combined_mat) %in% gene_list_ko_human 
cluster <- rownames(combined_mat) %in% gene_list_clusters_human 
 
#probably need to have the column annotation in the same place as the dendrog
ram  
#the heatmap annotations need to be vertically, rather than horisontally alig
ned 
#think the solution is the make a list and then control the location of each 
part using draw() 
#attempt: 
class(labels) 
## [1] "integer" 
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labels_complete = c(labels ,labels_ko) 
class(labels_complete) 
## [1] "integer" 
head(labels_complete) 
## [1]  3  4  9 11 18 19 
####test 
library(ComplexHeatmap) 
column = HeatmapAnnotation(df = data.frame(type1 = c(rep("Mouse Lung", 5), re
p("Mouse Spleen", 4), 
                                                     rep("Human Blood", 5), r
ep("Human Lung", 8))), 
                           annotation_legend_param = list(title ="Sample", nr
ow=1, title_position="leftcenter", title_gp = gpar(fontsize = 8), 
                                                          labels_gp = gpar(fo
ntsize = 8)), 
                           col = list(type1 = c("Mouse Lung" =  "green", "Mou
se Spleen" = "yellow", 
                                                "Human Lung" =  "dark green", 
"Human Blood" = "orange"))) 
 
h1 <- Heatmap(combined_mat, show_column_names = FALSE, show_row_names = FALSE
, top_annotation = column, show_row_dend = FALSE, cluster_rows = FALSE,  
              heatmap_legend_param = list(title = "Row Z Score", title_gp = g
par(fontsize = 5))) 
h2<- Heatmap(ko + 0, column_title = "IRF4 KO", column_title_side = "bottom",  
             column_title_gp = gpar(fontsize = 4), col = c("0" = "white", "1" 
= "purple"),  
             show_heatmap_legend = FALSE, width = unit(5, "mm")) 
h3<-Heatmap(cluster + 0, column_title = "IRF4-BATF", column_title_side = "bot
tom",col = c("0" = "white", "1" = "black"), 
            column_title_gp = gpar(fontsize = 4), show_heatmap_legend = FALSE
, width = unit(5, "mm")) 
h4<-rowAnnotation(link = row_anno_link(at = labels_complete, labels_gp = gpar
(fontsize = "6"), labels = rownames(combined_mat)[labels_complete]),  
                  width = unit(1, "cm") + max_text_width(rownames(combined_ma
t)[labels_complete])) 
 
hlist <- h1+h2+h3+h4 
pdf("enrichment030219-.pdf", width = 6, height = 8) 
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Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the 
Pathogenesis of Allergic Asthma. 
Turner DL, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, Cao M, Dave R, Tanna 
N, D'Armiento JM, Farber DL. 
J Immunol. 2018 Mar 1;200(5):1561-1569. doi: 10.4049/jimmunol.1700257. Epub 2018 Jan 17. 
Asthma is a chronic inflammatory disease mediated by allergen-specific CD4 T cells that 
promote lung inflammation through recruitment of cellular effectors into the lung. A subset of lung 
T cells can persist as tissue-resident memory T cells (TRMs) following infection and allergen 
induction, although the generation and role of TRM in asthma persistence and pathogenesis remain 
unclear. In this study, we used a mouse model of chronic exposure to intranasal house dust mite 
(HDM) extract to dissect how lung TRMs are generated and function in the persistence and 
pathogenesis of allergic airway disease. We demonstrate that both CD4+ and CD8+ T cells 
infiltrate into the lung tissue during acute HDM exposure; however, only CD4+ TRMs, and not 
CD8+ TRMs, persist long term following cessation of HDM administration. Lung CD4+ TRMs 
are localized around airways and are rapidly reactivated upon allergen re-exposure accompanied 
by the rapid induction of airway hyperresponsiveness independent of circulating T cells. Lung 
CD4+ TRM activation to HDM challenge is also accompanied by increased recruitment and 
activation of dendritic cells in the lungs. Our results indicate that lung CD4+ TRMs can perpetuate 
allergen-specific sensitization and direct early inflammatory signals that promote rapid lung 
pathology, suggesting that targeting lung CD4+ TRMs could have therapeutic benefit in alleviating 
recurrent asthma episodes. 
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Reduced generation of lung tissue-resident memory T cells during infancy. 
Zens KD, Chen JK, Guyer RS, Wu FL, Cvetkovski F, Miron M, Farber DL. 
J Exp Med. 2017 Oct 2;214(10):2915-2932. doi: 10.1084/jem.20170521. Epub 2017 Aug 30. 
Infants suffer disproportionately from respiratory infections and generate reduced vaccine 
responses compared with adults, although the underlying mechanisms remain unclear. In adult 
mice, lung-localized, tissue-resident memory T cells (TRMs) mediate optimal protection to 
respiratory pathogens, and we hypothesized that reduced protection in infancy could be due to 
impaired establishment of lung TRM. Using an infant mouse model, we demonstrate generation 
of lung-homing, virus-specific T effectors after influenza infection or live-attenuated vaccination, 
similar to adults. However, infection during infancy generated markedly fewer lung TRMs, and 
heterosubtypic protection was reduced compared with adults. Impaired TRM establishment was 
infant-T cell intrinsic, and infant effectors displayed distinct transcriptional profiles enriched for 
T-bet-regulated genes. Notably, mouse and human infant T cells exhibited increased T-bet 
expression after activation, and reduction of T-bet levels in infant mice enhanced lung TRM 
establishment. Our findings reveal that infant T cells are intrinsically programmed for short-term 
responses, and targeting key regulators could promote long-term, tissue-targeted protection at this 
critical life stage. 
